University of New Mexico

UNM Digital Repository
Linguistics ETDs

Electronic Theses and Dissertations

Spring 5-10-2019

Using Electrophysiology to Investigate Changes in
Brain Activation in Individuals with Chronic Stroke
Sarah G. Dalton
University of New Mexico

Follow this and additional works at: https://digitalrepository.unm.edu/ling_etds
Part of the Linguistics Commons
Recommended Citation
Dalton, Sarah G.. "Using Electrophysiology to Investigate Changes in Brain Activation in Individuals with Chronic Stroke." (2019).
https://digitalrepository.unm.edu/ling_etds/63

This Dissertation is brought to you for free and open access by the Electronic Theses and Dissertations at UNM Digital Repository. It has been
accepted for inclusion in Linguistics ETDs by an authorized administrator of UNM Digital Repository. For more information, please contact
amywinter@unm.edu.

i

Sarah Grace Hudspeth Dalton
Candidate

Linguistics
Department

This dissertation is approved, and it is acceptable in quality and form for publication:
Approved by the Dissertation Committee:
Holly Jacobson, Chairperson
Richard Arenas
Jill Morford
Jessica Richardson

ii

USING ELECTROPHYSIOLOGY TO INVESTIGATE
CHANGES IN BRAIN ACTIVATION IN INDIVIDUALS WITH
CHRONIC STROKE

by
SARAH GRACE HUDSPETH DALTON
B.S.Ed., Communication Sciences and Disorders, University of
Georgia, 2010
M.S.P., Communication Sciences and Disorders, University of South
Carolina, 2012

DISSERTATION
Submitted in Partial Fulfillment of the
Requirements for the Degree of
Doctor of Philosophy
In Linguistics
The University of New Mexico
Albuquerque, New Mexico
May 2019

iii
DEDICATION
In memory of Anne Alexander and Jerry Hudspeth, whose unconditional love and
acceptance helped provide the foundation of the woman I am.
In memory of Oliver Ender Russell, you will not be forgotten.
&
In dedication to individuals who have experienced a stroke and their families. Your
courage and tenacity inspire me to never give up.
&
In dedication to Lenorah, Matthew, Jackson, Mark, Madison, Piper, Ava, Isabelle, and
Lena. Keep your dreams as big as the stars. I can’t wait to see how you make this world
your own. I love you more than words can express.

iv
ACKNOWLEDGEMENTS
There are so many people who have earned my gratitude throughout this process.
I am so happy to have a space to thank everyone. I would like to start by acknowledging
and thanking my committee members: Drs. Holly Jacobson, Jill Morford, Rick Arenas,
and Jessica Richardson. Thank you for the time and wisdom you have invested in me
during this process. I have appreciated your support, encouragement, and belief in me.
I would also like to acknowledge my co-workers and the students with whom I
have worked for the past six years. Each of you has helped me grow as a clinician and
person. Christie, thank you for always bringing a fresh perspective and a laugh to our
meetings. Janet, thank you for all of your help with data collection. I knew that with your
care and attention to detail any data you helped with was in good hands! Vic and Isabel –
thank you for the many hours long phone calls, evening and weekend Skype work dates,
text check-ins, and pet photos to make me smile. You helped keep my sanity intact. I am
lucky to have two such incredible friends.
To my family, thank you for encouraging me to always pursue my dreams and
then supporting me throughout the process. Thank you for putting up with my
stubbornness. I am so grateful for the visits and phone calls. Thank you for providing a
space to vent on the bad days and celebrate on the good days.
Jacob, my wonderful spouse. You moved all the way across the country so that I
could keep pursuing my dreams. You’ve single-handedly kept a roof over our heads, kept
us fed and clothed, and handled all of the day to day aspects of our life so that I could
focus on my PhD. You made me laugh and smile and keep going on the days when all I
wanted to do was curl up in a ball and pretend the world did not exist. Our relationship
brings me joy daily, and I am so glad that you are my partner in life. Thank you for being
so generous with your time and energy. Thank you for your relentless positivity and
unwavering faith in me. I love you, and I absolutely could not have done this without
you.
And finally, thank you to Jessica. How do I adequately convey the depths of
gratitude for a decade of friendship and mentoring? How do I explain the ways you have
inspired me? You were the first person to put a face on this vague dream I had of wanting
to do research. You helped me see that we are what researchers look like and that being a
university professor wasn’t just a pipe dream for a southern girl from the middle of
nowhere. You have helped me become not just a better researcher, speech-language
pathologist, supervisor, and teacher, but more importantly, a better person with more
compassion and empathy for others. I am awed by the depth of your commitment to the
community and individuals you work with. Thank you, for investing in me, for believing
in me, for supporting me. Thank you for including me in your family. I can’t wait to see
where the next decade of friendship and collaboration takes us!

v
Using Electrophysiology to Investigate Changes in Brain Activation in Individuals
with Chronic Stroke
by
Sarah Grace Hudspeth Dalton
B.S.Ed., Communication Sciences and Disorders, University of Georgia, 2010
M.S.P, Communication Sciences and Disorders, University of South Carolina, 2012
Ph.D., Linguistics with emphasis in Speech and Hearing Sciences, University of New
Mexico, 2019
ABSTRACT
Many individuals who have experienced a stroke also experience persistent
decrements in several domains, such as sensorimotor, language, and cognition. While
rehabilitation for these deficits is helpful even decades after a stroke, there is limited
information available to determine the most effective pairing of treatment with individual
deficits. Further, despite decades of neuroimaging research, our understanding of optimal
recovery patterns following stroke is relatively poor. In order to improve outcomes for
individuals living with chronic deficits due to stroke, neurophysiological biomarkers
corresponding to recovery patterns and treatment response are needed.
Electroencephalography (EEG) holds great potential for identifying biomarkers as it
directly measures brain activation, and is non-invasive, reliable, replicable, and portable.
Further, almost all individuals post-stroke are able to tolerate EEG recording. In addition,
different methods of analyzing EEG data allow multiple information streams to be
gleaned from a single dataset.
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In this study, 27 persons with chronic stroke (PWCS) and 27 neurologically
healthy controls completed speech, language, cognitive, and sensorimotor behavioral
assessments. Participants also completed two EEG sessions approximately one month
apart which included recording of brain activity at rest and during language, cognitive,
and motor tasks. Spectral EEG and event-related potential (ERP) analyses revealed
significant differences between neurologically healthy controls and PWCS both at rest
and during an auditory oddball task. Test-retest reliability measured across a one-month
interval varied by group, task, and electrode montages or regions of interest from poor to
excellent. The spectral EEG analysis showed changes previously reported during the
acute and sub-acute phase of recovery persist into the chronic phase. ERP analysis
demonstrated that individuals with a wide range of post-stroke deficits perform
significantly differently during a cognitive task. However, no statistically significant
differences were observed between healthy controls and this mixed group during
language tasks. Finally, reliability findings indicate some tasks and measures may be
appropriate for use in determining treatment response. These results provide support for
the use of EEG as a biomarker in the chronic phase in a general stroke population. Future
research should investigate the utility of EEG in specific subgroups of persons with
chronic stroke.
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Chapter 1
Shared Introduction
Stroke is a leading cause of adult disability in the United States and is the only
leading cause for which prevalence has increased across the past two decades (US
Burden of Disease Collaborators, 2013). Each year, approximately 795,000 individuals in
the US experience a stroke, and approximately 650,000 are stroke survivors (Benjamin et
al., 2019). While strokes can occur at any age, older individuals are at greater risk of
stroke than younger individuals. The higher incidence of stroke in older adults combined
with an aging population in the US means stroke prevalence is expected to continue to
increase in the coming decades. Stroke carries with it high economic costs. In 2015, the
total cost of stroke, in terms of both direct expenses related to medical care and indirect
expenses such as wages lost due to disability, was approximately $45 billion. This is
expected to more than double by 2035, increasing to approximately $129 billion
(Benjamin et al., 2019). Still, these numbers underestimate the burden of stroke, as they
only include costs directly related to the individual who had the stroke. Strokes have
wide-ranging effects on the family unit as well. Often a spouse or close relative must
assume caregiving responsibilities that limit opportunities to work for pay, volunteer,
access education, or engage in social and recreational activities (Grawburg, Howe,
Worrall, & Scarinci, 2013), further driving up stroke-related costs.
Post-Stroke Impairments
Stroke recovery is generally divided into three phases: acute, sub-acute, and
chronic. Variability exists regarding the definition of onset and length of each phase, but
among rehabilitation professionals, the acute phase is generally recognized as the period
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beginning one day after stroke and extending one to two weeks after the stroke. The subacute phase begins after the first or second week and extends up to six months poststroke. Finally, the chronic phase begins six months to one year after stroke and extends
to the individual’s death (Bernhardt et al., 2017; Kiran, 2012). A range of functional
impairments are observed in the acute phase and contribute to the high cost of stroke. For
example, a population study of individuals living in the UK who had a first-time stroke
reported the following immediately post-stroke: 26% experienced visual field cuts, 20%
experienced visual neglect, >70% experienced upper and/or lower limb motor
impairment, ~30% experienced upper and/or lower limb sensory impairment, 45%
experienced swallowing impairment, 41% experienced motor speech impairment, 23%
experienced language impairment, 48% experienced urinary incontinence, and 44%
experienced cognitive impairment (Lawrence et al., 2001). An examination of the number
of different impairments and the proportion of individuals experiencing each reveals that
many individuals post-stroke experience more than one kind of impairment. Indeed, in
this sample, only 6% of individuals had one or two impairments, whereas a staggering
50% experienced 6-10 impairments. It is difficult to determine how comparable these
percentages are between the US and UK, as there seems to be no similar populationbased study of acute stroke deficits for the US. In addition, much of the information in
the literature regarding prevalence of post-stroke deficits in the US is several decades out
of date. More recent studies generally do not present results in a way that is comparable
to Lawrence and colleague’s report.
Individuals who have a stroke experience a great deal of spontaneous recovery in
the first six months to one year following their stroke. Despite this, many stroke survivors
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do not regain full functioning in all areas of initial impairment, and therefore require
continued rehabilitation to reduce the impact of disability. These persistent deficits that
last for the remainder of a stroke survivor’s life are referred to as chronic impairments.
Systematic investigations of the prevalence of multiple chronic post-stroke deficits are
lacking, although some studies report the prevalence of a single chronic post-stroke
impairment. Depression and other mood disorders are a common consequence of stroke,
with 33% - 50% of individuals reporting post-stroke depression (Hackett & Pickles,
2014; Kouwenhoven, Kirkevold, Engedal & Kim, 2011). Cauraugh and Kim (2003)
reported 60% of their chronic stroke sample experienced some kind of motor impairment,
although prevalence of specific diagnoses varied. When investigating other domains,
approximately 33% of stroke survivors experienced impaired hand sensation (Bowden,
Lin, & McNulty, 2014), approximately 30% experienced cognitive impairment (Henon et
al., 2001; Pohjasvaara et al., 1998), and approximately 30% of stroke survivors
experienced chronic aphasia (e.g., Berthier, 2005; Go et al., 2014, Maas et al., 2012;
Simmons-Mackie, 2018), a communication disorder that diminishes spoken and/or
written language production and/or comprehension abilities. Aphasia results in
limitations of activity and participation, poorer quality of life, and higher incidence of
depression compared to post-stroke individuals without aphasia matched for social
support, well- being, and physical ability (Hilari, 2011; Hilari et al., 2012; Wallace,
2010). Further, aphasia incurs an additional economic cost (above the cost of stroke with
other disabilities) in terms of medical treatment (~$2,200) in the first year following
stroke (adjusted for 2019 inflation; Ellis, et al., 2012). Individual response to aphasia
treatment varies and restoration of communication abilities in the chronic phase is rare.
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Despite the documented negative impacts of aphasia on recovery and quality of life, these
individuals are often excluded from general stroke research due to their language
difficulties.
Optimal Brain Reorganization Post-Stroke
In the healthy brain, the left and right hemispheres are highly interconnected and
in constant communication both at rest and during completion of a variety of tasks.
Specific brain areas are recognized as necessary (but not sufficient) for completion of
particular tasks or processing of stimuli. For example, literate adults develop highly
specialized activation of the left fusiform gyrus (which spans occipital and temporal
lobes) during word viewing and reading, so that it is now referred to as the “visual word
form area” (e.g., McCandliss, Cohen, Dehaene, 2003). This activation is specifically
observed as greater in the left than right hemisphere. Specialized activation of the left
fusiform gyrus allows for fast and efficient processing of visual word forms independent
of case, font, size, and other non-essential visual features such as color. In addition to
brain regions being specialized, they are also highly interconnected. Widely distributed
functional networks (and not just specialized brain areas) are brought online during tasks.
Different regions are able to inhibit activation in the corresponding (or homologous)
region in the opposite hemisphere in order to bring online the most efficient network for
completing a given task. In regard to the previous example, the left fusiform gyrus
inhibits the right homologue during word viewing or reading tasks. Conversely, the right
fusiform gyrus inhibits the left homologue during viewing of faces, as this processing has
been localized to the right fusiform gyrus (e.g., Kanwisher, McDermott, & Chun, 1997).
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There is a long history of studying this inhibition (referred to variously as
interhemispheric inhibition, balance, or symmetry) in stroke, specifically in individuals
with post-stroke aphasia or motor deficits. (Review of the literature will focus on motor
and aphasia research, although interhemispheric inhibition is also being investigated in
other domains such as cognition.) A stroke disrupts the natural system of mutual
inhibition in the brain, and homologous regions in the opposite hemisphere may restrict
the contribution of surviving tissue around the brain lesion (perilesional tissue) that is
specialized for a given behavior, potentially leading to less efficient processing. For
example, in healthy individuals, left hemisphere frontal, temporal, and parietal areas are
primarily responsible for language processing. These areas inhibit right hemisphere
homologues during language production and processing. Inhibition is enacted via the
corpus callosum, the largest white matter structure in the brain, which connects the two
hemispheres. In a normally functioning brain, fibers originating in the left hemisphere
(referred to as glutamatergic fibers because they release the neurotransmitter glutamate)
travel through the corpus callosum and activate inhibitory interneurons in the right
hemisphere. These inhibitory interneurons then reduce activation in right hemisphere
homologues. Following damage to left hemisphere language areas, homologous right
hemisphere areas receive less, or no, inhibition (due to the death or disconnection of
glutamatergic fibers) and may increase their level of activation during language
production and processing, bringing online a less efficient language system.
A similar process is observed in the motor cortex following stroke. Research
shows that primary motor cortex of the non-lesioned hemisphere exerts much greater
inhibition of the motor cortex in the lesioned hemisphere than is observed in healthy
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brains. Further, this increased inhibition is related to decrements in performance on motor
tasks during both the sub-acute and chronic phases (Murase, Duque, Mazzocchio, &
Cohen, 2004; Ward, Brown, Thompson & Frackowiak, 2003). Clinicians have sought to
use this knowledge to develop treatment methods for motor recovery (such as constraint
induced motor therapy [CIMT]; Kwakkel, Veerbeek, van Wegen, & Wolf, 2015) that
leverage our understanding of beneficial and maladaptive brain changes (Xerri, ZennoAzogui, Sadlaoud, & Sauvajon, 2014). However, despite the large body of research
examining brain activation following behavioral rehabilitation (i.e., physical,
occupational, or speech-language therapy), there is still no consensus regarding the role
of the contralesional hemisphere in stroke recovery (Bertolucci, Chisari, & Fregni, 2018;
Turkeltaub et al., 2012), although it is likely to be individualized and dependent on lesion
anatomy and size. Further, response to treatment is difficult to predict with current
knowledge and pairing treatments with individual deficits is not straightforward.
Measuring Post-Stroke Recovery
Many technologies are available for measuring brain structure and function.
Positron emission tomography (PET) and computed tomography (CT) are primarily used
in clinical settings, while structural or functional magnetic resonance imaging (sMRI;
fMRI), electroencephalography (EEG), and transcranial doppler (TCD) have mixed
clinical and research usage. Others, such as near infrared spectroscopy (NIRS) and
magnetoencephalography (MEG), are used primarily for research. Each technology has
benefits and limitations compared to the others, but all have the potential to provide
insight into post-stroke recovery. Despite the wealth of information gained from studies
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using these imaging technologies, there is a lack of neurophysiological biomarkers that
can improve prognosis and individualization of rehabilitation planning.
Currently, two of the best predictors of stroke recovery are lesion site and size
(Stinear & Ward, 2013). Research has shown that individuals with larger lesions
experience poorer recovery over time (e.g., Hope, Seghier, Leff, & Price, 2013), as do
individuals with right hemisphere strokes (e.g., Aszalos, Barsi, Vitrai, & Nagy, 2002). In
contrast, individuals with specific behavioral deficits may exhibit different patterns of
recovery. For example, in a sample of individuals with aphasia, posterior left hemisphere
lesions were most predictive of poor outcome (Fridriksson, Richardson, Fillmore, & Cai,
2012), while in the motor recovery literature, one of the best predictors of function is the
degree of damage to the corticospinal tract (Burke Quinlan, et al., 2014). While structural
MRI data such as lesion site and size are strong predictors of overall recovery following
stroke, these measures cannot assess the functioning of intact tissue. Indeed, research
regarding the role of the right hemisphere in recovery suggest that lesion size is a key
factor in whether right hemisphere activation is compensatory or maladaptive. But lesion
site and size are not the only variables that ought to be considered when attempting to
predict or report on stroke recovery. Previous research has also suggested that intact
blood flow in brain regions around the lesion (Richardson et al., 2011) or degree of
interhemispheric connection (Burke Quinlan et al., 2014) may also play an important
role. Further research into these additional variables may help elucidate the role of the
intact brain in recovery.
Task-related fMRI (task-fMRI), such as picture naming or finger tapping while in
the scanner, is most commonly used to image recovery and treatment-induced brain
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changes (Breier et al., 2007; Davis & Harrington, 2006; Fridriksson, 2010; Fridriksson et
al., 2012; Hillis, 2006; Hodics, Cohen, & Cramer, 2006; Leger et al., 2002; Meinzer et
al., 2006; Meinzer et al., 2007; Page et al., 2009; Peck et al., 2004; Postman-Caucheteux
et al., 2010; Richardson et al., 2012; Rosen et al., 2000; Schaechter et al., 2002;
Takahashi et al., 2008; You et al., 2005), but inferences are difficult to make with this
clinical population. Blood flow in the brain during task completion (referred to as the
hemodynamic response) in healthy controls follows a well-described pattern. Beginning
1-2 seconds after task onset and peaking 4-6 seconds after task onset, there is an increase
of blood flow to regions engaged in completing the task (Bandettini et al., 1992).
However, the hemodynamic response, upon which MRI signals are based, is altered
following stroke and blood flow does not necessarily follow the canonical time pattern
(Altamura et al, 2009; Krainik, Hund-Georgiadis, Zysset, & von Cramon, 2005).
Analysis of brain activation which relies upon typical blood flow timing assumptions
may not adequately characterize brain activation changes in people post-stroke
(Bonakdarpour, Parrish, & Thompson, 2007; Richardson et al., 2011; Thompson et al.,
2017; Wierenga et al., 2006). Also, individual variability due to error production and/or
the differential effort required to complete tasks makes interpretation difficult (Price,
Crinion, & Friston, 2006; Veldsman, Cumming, & Brodtmann, 2015).
Task-fMRI research has been useful for confirming that the brain can change in
individuals with chronic stroke, but current knowledge and the unique characteristics of
this population do not allow straightforward testing of brain reorganization hypotheses.
Resting state fMRI (rest-fMRI), where participants are asked to rest quietly without
performing a task or thinking about anything in particular, may be a promising alternative
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to task-fMRI for understanding brain reorganization following stroke. Investigation of
resting state networks reveals disruptions not just in areas adjacent to the lesion, but in
distributed nodes in the left and right hemisphere (for a review see Rehme & Grefkes,
2013). Additionally, several research teams have identified motor and language-specific
networks (Baldassare, Metcalf, Shulman, & Corbetta, 2019; Sandberg, 2017; Thiel &
Vahdat, 2015; Vahdat, Darainy, & Ostry, 2014). In motor specific networks, individuals
post-stroke show reduced communication among network nodes compared to healthy
controls (Bhajaj, Butler, Drake, & Dhamala, 2015; James, Lu, & VanMeter, 2009).
Additionally, individuals with aphasia generally have fewer connections and more rightlateralized networks compared to healthy controls (Sandberg, 2017). In a sample of
individuals with acute stroke, more right-lateralized networks following stroke
correspond to more severe aphasia (Guo et al., 2018). An alarming finding with restfMRI (and corroborated with other imaging modalities) is the fact that spared and
seemingly healthy perilesional tissue is hypo-connected in people with post-stroke
deficits in a way that corresponds directly to severity of those deficits (Chen & Schlaug,
2013; Gleichgerrcht et al., 2016; James et al., 2009; Sandberg, 2017). Still, like taskfMRI, rest-fMRI is an indirect measure of brain activation, complicating the inferences
which can be drawn from this modality.
EEG approaches have long been used to study stroke recovery (e.g., Assenza et
al., 2013; Cillessen et al., 1994; Cuspineda et al., 2003; de Vos, van Maarseveen,
Brouwers, & van Putten, 2008; Dobel et al., 2002; Dubovik et al., 2013; Faught, 1993;
Finnigan et al., 2004; Finnigan, Walsh, Rose & Chalk, 2007; Finnigan, Wong, & Read,
2016; Friederici, Von Cramon, & Kotz, 1999; Gorisek et al., 2016; Hagoort, Brown, &
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Swaab, 1996; Hagoort, Wassenaar & Brown, 2003; Hensel et al., 2004; Ilvonen et al.,
2003; Laganaro, Python, & Toepel, 2013; Leon-Carrion et al., 2009; Nicolo et al., 2015;
Petrovic et al., 2017; Pettigrew et al., 2005; Pulvermuller, Mohr, & Lutzenberger, 2004;
Schaul, Green, Peyster, & Gotman, 1986; Schleiger et al., 2014; Sheorajpanday et al.,
2009; Sheorajpanday et al., 2011; Song et al., 2015; Spironelli & Angrilli, 2015;
Spironelli, Angrilli, & Pertile, 2008; Swaab, Brown, & Hagoort, 1997; Szelies, Mielke,
Kessler, & Heiss, 2002; ter Keurs, Brown, Hagoort, & Stegeman, 1999). EEG is reliable,
replicable and portable, all important factors for use in clinical settings. EEG also has the
added benefit of being safe for almost all individuals who have experienced a stroke.
Critically, EEG directly measures electrical brain activation via scalp electrodes,
providing excellent temporal resolution of activation compared to other modalities.
Furthermore, EEG is already used clinically to monitor some patients post-stroke, which
would help ease the transition to more widespread use. Clinical EEG systems are
designed to output measures online which means the data is quickly available for clinical
decision-making.
Finally, EEG findings have been validated against the gold standard of MRI to
ensure results are consistent across imaging modalities. Indeed, entire books have been
written on the topic of successfully integrating EEG and MRI during research (e.g.,
Mulert & Lemieux, 2009). Validation specific to persons with stroke has also been
conducted. For example, correlations between EEG measures and 1-month outcomes
were equivalent to correlations between blood flow in the brain measured by MRI and 1month outcomes, and outperformed correlations between white-matter structural MRI
and 1-month outcomes (Finnigan et al., 2004). At a single timepoint, EEG measures at
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ipsilesional and contralesional locations correlated with stroke severity and lesion size
(Wu et al., 2016). When examining rest-fMRI and EEG, Deligianni and colleagues
(2014) reported that EEG data was significantly better at predicting fMRI data than fMRI
data was at predicting EEG. Together, this body of validation work suggests that EEG
corresponds strongly with MRI data, and that EEG data provides additional valuable
information about brain function beyond what is available through MRI alone.
Due to EEG’s reliability, replicability, portability, safety, low-cost, and
relationship with gold standard neuroimaging, it is well-suited for use in clinical
populations such as stroke, where there is a dire need to better understand optimal
recovery patterns in order to provide the most appropriate rehabilitation. In addition, the
development of sensitive and reliable neurophysiological biomarkers via EEG may help
clinicians make more informed treatment decisions and improve prognosis for individuals
with chronic post-stroke deficits. EEG also provides a great deal of flexibility in data
analysis, with two commonly used analysis methods (spectral EEG and event-related
potential) providing complementary but distinct information. The same data can be
subjected to both analytic methods, although that is rarely done for the same population.
In the following papers, we will examine both methods of EEG analysis in the same
population of healthy controls and people post-stroke. We are including individuals with
post-stroke aphasia in our sample (and carefully characterizing their language
performance) because aphasia is a relatively common deficit, occurring in approximately
one-third of chronic stroke survivors. Unfortunately, much of the general stroke literature
actively excludes individuals with aphasia due to reported difficulties with consent,
greatly limiting our understanding of how individuals with aphasia recover from stroke,
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and whether their experience is similar to or different from individuals with other poststroke deficits.
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Chapter 2
Introduction
Spectral EEG
Neural activity is observed even when individuals are resting quietly and not
engaged in a task. Research using rest-fMRI has identified multiple functional networks
that engage during on-task behavior, as well as a default mode network which seems to
be most active when there is no task to be completed (e.g., Damoiseaux et al., 2006; De
Luca et al., 2006; Greicius, Krasnow, Reiss, & Menon, 2003; Rosazza & Minati, 2011).
Findings from these investigations demonstrate that functionally related brain regions
communicate even when not engaged for task completion. Similar findings have been
observed using spectral EEG (sEEG) to measure the rate (or frequency) at which brain
regions are activated.
Historically in sEEG analysis, the speed of brain activation has been divided into
four frequency bands: delta (1-4Hz), theta (~4-8Hz), alpha (~8-13Hz), and beta (~1330Hz) (see Figure 1). Because populations of neurons and different brain regions carry
Figure 1. Examples of 4Hz, 8Hz, 13Hz, and 30Hz sine waves that demonstrate dividing
frequencies between each classic band.
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on multiple “conversations” at once, recordings of brain activation will simultaneously
show activity in each of the frequency bands. Power is calculated to quantify the amount
of activity occurring in a frequency band. To calculated power, a fast Fourier transform
(FFT) is used to decompose the signal into amplitude at each frequency, and the
amplitude value is squared. Then, segments of activity are summed to determine the
power in a frequency band. In neurologically healthy adults, slow wave delta is
associated with sleep states and theta activity is associated with rest and inhibition of
unrelated brain regions during a task. Alpha and beta activation are higher frequency or
fast wave activation. Alpha activity is associated with relaxed states while beta activity is
associated with on task behaviors. For individuals in the acute and sub-acute phases poststroke, slow wave activity is increased relative to fast wave activity, even when patients
are awake and engaged in a task. sEEG can also be used to measure coherence, or the
strength of communication between brain areas, by determining the similarity of power in
different regions (Ruchkin, 2005). The more strongly two regions are connected, the
larger the correlation between their measured power values, and the greater the coherence
between the regions.
sEEG Corresponds to General Functional Recovery after Stroke
As noted above, EEG has been widely used to study stroke recovery in the acute
(1 day to 1-2 weeks) and sub-acute (1-2 weeks to 3-6 months) phases (for a review, see
Finnigan & van Putten, 2013). A wide range of sEEG measures derived from restingstate EEG recordings have been reported, from Z-scores of the frequency bands, to
relative power, to measures of the relationship between activation in network nodes or
hemispheres (coherence). Across studies, sEEG variables measured shortly after stroke
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onset are correlated with functional outcomes (e.g., modified Rankin Scale [mRS; van
Swieten et al., 1988], Canadian Neurological Scale [CaNS; Cote et al., 1989], NIH Stroke
Scale [NIHSS; Goldstein, Bertels, & Davis, 1989]) in the sub-acute and chronic phases
(de Vos et al., 2008; Dubovik et al., 2013; Finnigan et al., 2007; Leon-Carrion et al.,
2009; Nicolo et al., 2015; Sheorajpanday et al., 2011). That is, increased delta and/or
theta activity, decreased alpha and/or beta activity, or reduced coherence is related to
more severe impairments in motor skills, cognition, and language. A few studies have
reported that sEEG measures are equally or more strongly related to functional outcomes
than behavioral measures such as the Rankin and modified Rankin Scale (mRS),
Canadian Neurological Scale (CaNS), or NIH stroke scale (NIHSS) scores at onset, both
within the first 72 hours (Cuspineda et al., 2003), and at one year post-stroke (Cillessen et
al., 1994).
Given these results confirming a relationship between sEEG measures and
functional recovery, Assenza and colleagues (2013) sought to determine if sEEG
measures could predict “effective recovery” following stroke in a sample of 42 patients
(20 healthy controls were enrolled for comparison). Effective recovery was calculated for
each individual as the change in NIHSS score from baseline (T0) to 6 months after stroke
(6mo) divided by the difference between control NIHSS scores and the individual’s
NIHSS score at stroke onset (ER = NIHSST0 - NIHSS6mo/NIHSST0 - NIHSSControl).
Regression analysis revealed two predictors of recovery at six months: delta power in the
contralesional hemisphere and baseline NIHSS score. Further analyses revealed that
increased delta power in the contralesional hemisphere was associated with a decrease in
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inter-hemispheric coherence (i.e., a weakening of the relationship between activation in
the left hemisphere and activation in the right hemisphere).
Despite the demonstrated relationship between sEEG changes and recovery, the
large number of sEEG measures used limits generalizability across studies. A recent
study sought to determine which measures corresponding to functional recovery most
accurately classify participants as healthy controls or persons with stroke (PWS) in the
sub-acute phase (Finnigan et al., 2016). The measures examined included power in delta,
theta, alpha, and beta frequency bands relative to total power across the spectrum (130Hz), delta/alpha ratio (DAR), delta+theta/alpha+beta ratio (DTABR) (sometimes also
referred to as the power ratio index, PRI; e.g., Finnigan et al., 2007; Leon-Carrion et al.,
2009), and delta+theta/total power (Qslowing). In a sample of 28 neurologically healthy
controls and 18 individuals in the acute phase post-stroke, all sEEG measures were
significantly different between the two groups. Consistent with previous findings, relative
delta, relative theta, DAR, DTABR, and Qslowing were significantly greater in individuals
who had experienced a stroke than in healthy controls. Relative alpha and beta power
showed the opposite pattern. Despite these significant differences, DAR was the only
measure which classified individuals into the correct group with 100% accuracy, with a
reported cut-off of 3.7. In their sample, any individual with a DAR greater than 3.7 had
experienced a stroke, and any individual with a DAR less than 3.7 had not.
sEEG Corresponds to Early Recovery of Specific Stroke-Induced Deficits
In addition to informing on the prognosis of overall stroke recovery, sEEG may
provide prognostic value for the recovery of specific stroke-induced deficits such as
aphasia, cognition, or motor impairments in the acute and sub-acute phases. For example,
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increased left hemisphere frontal theta and decreased left hemisphere occipital alpha were
predictive of improvements in language abilities in a group of 23 patients with aphasia
eight weeks after stroke (Szelies et al., 2002). Additionally, during the first year of stroke
recovery, decreased left hemisphere slow wave delta activity corresponded to language
recovery, but similar decreases were not observed in the second year following stroke.
This was interpreted as confirmation that spontaneous recovery was not a factor after the
first year (Hensel et al., 2004). In a study examining working memory in individuals with
Broca’s aphasia, two networks (one theta and one gamma) implicated in working
memory were shown to be disrupted (Gorisek et al., 2016). Importantly, the gamma
network (which the authors hypothesized was related to the phonological loop of working
memory) was more severely impacted than the theta network, which was also consistent
with the speech and language difficulties observed in this population. Similar
investigations examining recovery of cognitive functions in individuals without aphasia
have also demonstrated the prognostic value of sEEG. In particular, frontal delta and
whole-head alpha power are predictive of cognitive outcomes in the sub-acute phase of
stroke (Schleiger et al. 2014), and sEEG values may not return to baseline even when
behavioral performance does (Petrovic et al., 2017).
sEEG in the Chronic Phase of Recovery
There is clear and consistent evidence that sEEG measures correspond to both
general and deficit-specific recovery in the acute and sub-acute phases, but far less
research has been performed regarding these measures and their relationship to
behavioral deficits in the chronic phase of recovery, or their sensitivity to measuring
response to treatment. There is some evidence that sEEG differences observed in the
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acute and sub-acute phases are maintained into the chronic phase. For example, a study
examining the relationship between perceived daytime sleepiness and sEEG in patients
with chronic left or right hemisphere stroke revealed greater power in delta and theta
bands compared to healthy controls which was not related to perceived sleepiness
(Herron et al., 2014). Similarly, Spironelli, Manfredi, and Angrilli (2013) found in a
sample of 11 individuals with chronic nonfluent aphasia that the strength of high beta
band activity (21-28Hz) during language tasks was greater in right hemisphere central
electrodes than left hemisphere central electrodes, a reversal of the pattern seen in healthy
controls. Additionally, reduced beta activity was observed in posterior left hemisphere
electrodes. Unlike controls, individuals with aphasia demonstrated greater high beta
activity in left hemisphere frontal electrodes, suggesting that reorganization of language
processing relies greatly on anterior regions, at least in individuals with mild nonfluent
aphasia. Given the differences in spectral power and coherence observed in the acute and
sub-acute phase, and that these measures are related to functional recovery, it is
reasonable to suspect that sEEG in the chronic phase could prove useful as a diagnostic
tool or as a biomarker of treatment response.
sEEG to Measure Treatment Response
Some researchers have examined sEEG before and after rehabilitation, either in
the sub-acute or chronic phase (Rozelle & Budzynksi, 1995; Stojanovic et al., 2013; Wu
et al., 2015). An early single case study of an individual with chronic post-stroke aphasia
investigated the use of sEEG as a biofeedback method and examined its impact on
functional outcomes (Rozelle & Budzynski, 1995). Following biofeedback training, the
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participant showed significantly less slow wave activity, and improvements were
observed in speech, language, motor, mood, and cognitive domains.
More recently, two studies have investigated treatment response; one in a sample
of individuals with motor deficits (Wu et al., 2015), and one in a sample of individuals
with aphasia (Stojanovic et al., 2013). In a study of 12 individuals with upper limb motor
weakness following stroke, Wu and colleagues (2015) found that prior to treatment,
connectivity of the primary motor cortex in the lesioned hemisphere accounted for 78%
of the variance in functional outcomes. Participants completed a course of 28 days of
intensive motor rehabilitation, and the connectivity of primary motor cortex was a good
measure of gains, accounting for ~60% of the variance. Stojanovic and colleagues (2013)
compared the hemispheric and regional symmetry in 32 individuals with aphasia before
and after treatment. Prior to treatment, hemispheric and regional asymmetry were
increased, and variability was decreased, compared to healthy controls. Following
treatment the differences between groups was significantly decreased, but only for
individuals who demonstrated good recovery. Taken together, these studies provide
preliminary evidence that sEEG variables may be useful in prognosis and measuring
treatment response. However, these studies were completed in the sub-acute phase, when
spontaneous recovery may still be ongoing. Therefore, it is possible that the sEEG
variables measured here were tracking spontaneous rather than treatment-induced
recovery.
Clinical Utility of Biomarkers
An important step in the translation of sEEG measures from research to clinical
practice is ensuring they possess adequate psychometric properties. Key psychometric
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features for EEG normative data development include selecting an appropriate control
sample and establishing the reliability of measures over time (Gordon et al., 2005;
Prichep, 2005). In addition, normative data must be reported with sufficient detail to fully
describe the sample (Mitrushina, Boone, Razani, D’Elia, 2005). Despite the large number
of studies that report analyses with sEEG variables, few report the descriptive features of
the data with enough detail for readers to judge the adequacy of the data.
However, there is a long history of investigating variability in EEG and sEEG,
with the majority of research focusing on variability in children, since maturation causes
significant changes in brain function (e.g., Fein et al., 1983; Fein et al., 1984; Gasser,
Bacher, & Steinberg, 1985; Matousek & Peterson, 1973a, b; van Dis et al., 1979).
Investigations into sEEG variability in adults have also been conducted, and generally
reveal good stability for healthy populations, with greater reliability for spectral power
measures than coherence measures (Corsi-Cabrera, Solis-Ortiz, & Guevara, 1997;
Gudmundsson et al., 2007; Kondacs & Szabo, 1999; Oken & Chiappa, 1988; Salinsky,
Oken, & Morehead, 1991; Suarez-Revelo et al., 2015). The electrode montage (i.e.,
combination of electrodes) can have a significant impact on reliability, especially for
coherence measures. These results are promising as they indicate that reliable norms can
be established for sEEG measures. However, for these measures to be clinically useful,
acceptable specificity and test-retest reliability must be demonstrated for specific patient
populations. Despite the fact that no information regarding test-retest reliability is
available for individuals post-stroke in any recovery phase, several studies have
compared sEEG measures across time (e.g., Rozelle & Budzynksi, 1995; Stojanovic et
al., 2013; Wu et al., 2015). Defining specificity and reliability of sEEG measures post-
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stroke is critical to ensuring appropriate application of these measures and preventing
research waste (for a discussion of research waste see Ioannidis et al., 2014).
Purpose of the Study
The long-term goal of this research is to establish a sensitive biomarker that
would allow targeted pairing of rehabilitation to deficits and would improve diagnosis
and prognosis of chronic stroke-induced deficits. Currently, there are several barriers
preventing the translation of sEEG from research to clinical practice. First, despite the
existence of large databases of sEEG measures in controls and the utilization of these
databases for comparisons with other neurologically disordered populations (e.g.,
ADHD/ADD, mental health disorders, traumatic brain injury), comparisons of healthy
controls and individuals chronically post-stroke are lacking. Furthermore, there is limited
evidence regarding the reliability and stability of sEEG measures in older controls and
individuals in the chronic phase post-stroke. The current study aims to address these
barriers by pursuing the following specific aims:
1.

Identify differences in spectral power and coherence between individuals in the

chronic phase post-stroke and neurologically healthy controls.
2.

Define intra- and inter-individual variability of spectral power and coherence

measures in individuals in the chronic phase post-stroke and neurologically healthy
controls.
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Methods
Participants
Healthy Controls
Twenty-seven (17 female, 10 male) healthy individuals participated in this study
(Table 1). Participants were screened to ensure no history of neurological disease or
injury that might affect brain function. Potential participants with a diagnosis of
significant psychiatric mood disorders were excluded, but individuals with mild
depression and anxiety were allowed to participate, as many individuals with chronic
stroke also experience depression and anxiety. Participants completed the Edinburgh
Handedness Inventory (EHI; Oldfield, 1971), and if bi- or multi-lingual, the Language
Experience and Proficiency Questionnaire (LEAP-Q; Marian, Blumenfeld, &
Kaushanskaya, 2007). All healthy control participants were right-handed. Seven reported
speaking at least one other language, including French, Spanish, Italian, and German. No
control participants reported learning another language prior to English, and all reported
English as their primary language at the time of participation. The average age of
participants was 63 years (SD = 13.2 years). Control participant ages ranged from 22 to
88 and were selected to match persons with stroke. The average education was 16.9 years
(SD = 2.6). Participants completed the Repeatable Battery for the Assessment of
Neuropsychological Status (RBANS; Randolph, 1998), Wechsler Adult Intelligence
Scales - Picture Completion subtest (WAIS-PC; Wechsler, Coalson, & Raiford, 2008),
Discourse Production Test (DPT; MacWhinney, Fromm, Forbes, & Holland, 2011),
aprosodia battery (AB; based on Ross & Monnot, 2011), subtests of the Apraxia Battery
for Adults - 2 (ABA-2; Dabul, 2000), and an in-house sensorimotor assessment including
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Table 1. Demographics for neurologically healthy controls and persons with stroke.
Healthy Controls
17
Female; 10 Male
Sex
63 (±13)
Age (years)
Range: 22-88
17 (±3)
Education (years)
Range: 12 - 22
27 Right; 0 Left
Handedness
7
Bi/Multilingual
Persons with Stroke
10 Female; 17 Male
Sex
57 (±14)
Age (years)
Range: 25-87
15 (±3)
Education (years)
Range: 7 - 22
27 Right; 0 Left*
Handedness
3
Bi/Multilingual
1.4 (±1)
Number of Strokes
Range: 1 - 5
Time post onset in months
72 (±71)
(since most recent stroke)
Range: 12 - 275
20 Left; 7 Right
Lesioned Hemisphere
13
Aphasia Diagnosis
†
14
Cognitive Deficit
20
Sensorimotor Deficit
*All PWS were right-handed prior to their stroke. Due to motor impairment, some participants used their
left hand at the time of the study.
†
Two participants did not complete cognitive testing due to withdrawing from the study and fatigue.
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sensory perception, proprioception, range of motion, and muscle tone (Table 2). Testing
was completed to ensure participants’ performance was within the range of
neurologically typical individuals. Participants completed two sessions of EEG recording,
approximately one month apart. Three participants were unable to complete the follow-up
EEG due to changes in schedules; these participants are included in the normative data
set and comparison with participants with stroke but are not included in the reliability
analysis.
Persons with Chronic Stroke
Twenty-seven (10 female, 17 male) persons who had experienced one or more
strokes also participated in this study (Table 1; referred to as persons with chronic stroke,
PWCS). We included participants with multiple strokes to ensure that our results are
maximally applicable to the general rehabilitation population served by practicing
therapists, as one of the strongest risk factors for stroke is a history of prior stroke.
Seventeen individuals experienced left hemisphere stroke, 7 experienced right
hemisphere stroke, and 3 experienced left and right hemisphere strokes. (Participant
reporting of stroke location was confirmed via medical records, CT, or MRI scans when
available). Thirteen individuals were diagnosed with aphasia, 14 had cognitive
impairment, and 20 had sensory and/or motor deficits (Table 2). All participants were at
least one-year post-stroke to ensure that spontaneous recovery was not a factor in the
reliability analysis. Participants completed the Edinburgh Handedness Inventory (EHI;
Oldfield, 1971), and if bi- or multi-lingual, the Language Experience and Proficiency
Questionnaire (LEAP-Q; Marian, Blumenfeld, & Kaushanskaya, 2007). All stroke
participants were right-handed prior to their stroke, although many individuals relied on
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the left hand after their stroke due to motor impairments. Three participants with stroke
reported speaking more than one language (Spanish and Azteca) and one participant
reported Spanish as their first language, although English was the primary language for
all participants at the time of testing and had been for many years. The average age of
PWCS was 56.6 (SD = 14.2 years). PWCS ages ranged from 25 to 87. Average education
was 15.2 years (SD = 3.3 years). PWCS completed the same assessments as healthy
controls in addition to the Western Aphasia Battery - Revised (WAB-R; Kertesz, 2006),
Boston Naming Test (BNT; Kaplan, Goodglass & Weintraub, 2001), and Discourse
Comprehension Test (DCT; Brookshire & Nicholas, 1997). Participants completed two
sessions of EEG recording, approximately one month apart. One participant was unable
to complete the follow up EEG recording due to a change in schedule. As with controls,
this participant is included in all analyses except reliability.
EEG Recording
EEG data was recorded from 64 active electrodes placed in an elastic cap
according to the 10-10 International system of classification. The ground electrode was
located at Fpz with the reference electrode at CPz. Eye movement was recorded via
vertical electro-oculography using paired electrodes placed above and below the left eye,
while heart rate was recorded via electrodes placed on the left and right collarbones. Data
were recorded on a BrainVision actiCHamp system with a 500Hz sampling rate and
online bandpass filtering from .01 - 100Hz. Participants were seated in front of a
computer in a dimly lit room. Resting-state EEG was recorded for two minutes with eyes
open (eyes open rest) and two minutes with eyes closed (eyes closed rest). During the
eyes-open recording, participants were asked to fixate on a white cross presented on a
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Table 2. Test scores for healthy controls and persons with chronic stroke
Control

PWCS

Palm Sensation (2)
Proprioception (11)
Left Hand Function (6)
Range of
Right Hand Function (6)
Motion (ROM); Left ROM (199)
Strength
Right ROM (199)
Left Index Finger Tap
SensoriRight Index Finger Tap
Motor
L Index/Middle Finger Tap
Fine Motor; R Index/Middle Finger Tap
Coordination L/R Index Finger Tap
L Foot Tap
R Foot Tap
L/R Foot Tap
RBANS
Cognitive
WAIS - PC

2 (+/- 0)
1.7 (+/- 0.6)
10.9 (+/- 0.2)
9 (+/- 3.3)
6 (+/- 0)
5.8 (+/- 0.7)
6 (+/- 0)
5.1 (+/- 1.7)
197.2 (+/- 3) 150 (+/- 72.4)
197.5 (+/- 1.9) 137.7 (+/- .72.3)
49.3 (+/- 8.3) 40.8 (+/- 14.5)
53.2 (+/- 8.8) 36.5 (+/- 20.2)
45.5 (+/- 18.2) 31.5 (+/- 15.9)
49.5 (+/- 15.9) 26.7 (+/- 21.9)
59.1 (+/- 15.1) 30.5 (+/- 26.6)
27.6 (+/- 8.7) 29.6 (+/- 7.5)
36.4 (+/- 7.5) 27.5 (+/- 11.3)
47.8 (+/- 10) 37..4 (+/- 17.3)
97.3 (+/- 13) 71.5 (+/- 19.2)
13 (+/- 3.1)
9.6 (+/- 4)
Word ID (12)
10.88 (+/- 1.2) 8.7 (+/- 2.8)
Monosyllabic ID (12)
10.2 (+/- 1.1)
8.1 (+/- 2.1)
Aprosodia Asyllabic ID (12)
9.16 (+/- 2.1)
6.6 (+/- 2.9)
Battery
Facial Expression (14)
12.6 (+/- 1.22) 10.8 (+/- 2.2)
Emotion
- Reception
Verbal Scenario (14)
12.5 (+/- 1.3) 10.6 (+/- 2.8)
Attitude (20)
16.2 (+/- 2.2)
15 (+/- 2.5)
- Expression Emotion Semantics (20)
19.8 (+/- 0.4)
18 (+/- 2.2)
MC Composite (216)
127.5 (+/- 20.5) 87.7 (+/- 49.8)
Accurate/Complete (72)
35 (+/- 7.2)
22.4 (+/- 14.9)
4.5 (+/- 2.5)
4.6 (+/- 2.9)
Main Concept Accurate/Incomplete (72)
(MC) Analysis Inaccurate/Complete (72)
6.5 (+/- 3.3)
5.1 (+/- 3.3)
Inaccurate/Incomplete (72)
0.5 (+/- 0.9)
0.8 (+/- 1.2)
Absent (72)
25 (+/- 7.3)
33.6 (+/- 17.6)
Increasing length
Language
.1 (+/- 0.2)
2.52 (+/- 2.9)
Motor Speech Limb/oral apraxia (50)
50 (+/- 0)
47.9 (+/- 2.9)
Multiple Repetition (30)
29.8 (+/- 0.7) 26.3 (+/- 7.1)
WAB-R-AQ (100)
84.9 (+/- 17.9)
BNT (60)
45.2 (+/- 15.7)
Main
Idea
–
Total
(12)
10.9 (+/- 1.73)
Discourse
Comprehension Detail – Total (12)
9.3 (+/- 2.2)
Sensory

RBANS – Repeatable Battery for the Assessment of Neuropsychological Status; WAIS-PC – Weschler
Adult Intelligence Scales – Picture Completion; WAB-R-AQ – Western Aphasia Battery - Revised –
Aphasia Quotient; BNT – Boston Naming Test
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black background to limit eye movement artifacts. Participants also completed cognitive,
language, and motor tasks, but the discussion here is limited to the resting state data.
Data Processing
Standard offline pre-processing (see Figure 2) using BrainVision Analyzer 2.1
was conducted to ensure adequate data quality. First, noisy channels were identified and
discarded through visual inspection. Specifically, electrodes were examined for spike
Figure 2. Pre-processing steps carried out in BrainVision Analyzer 2.1.

artifacts and high frequency electrical noise which is often due to poor contact between
the electrode and scalp (e.g., Finnigan et al., 2007). The following data processing steps
were conducted as described by Finnigan, Wong, and Read (2016). Next, data were high
(.5Hz) and low (40Hz) pass filtered using infinite impulse response zero-phase shift
Butterworth filters to minimize distortion and preserve phase information (Hamming,
1998; Oppenheim, 1999). After filtering, bad segments (i.e., muscle activity) were
manually rejected and independent components analysis was conducted to remove eye
movement artifacts (Makeig, Bell, & Jung, 1996). Data were then epoched into 2048ms
bins and epochs with data values greater than +/-100 microvolts and/or changes in value
greater than +/-25 microvolts were rejected. For both neurologically healthy controls and
PWCS, no more than 20% of data in a given channel was rejected. Data were then
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subjected to a fast Fourier transform (FFT) with Hanning window and tapering at the
beginning and end of the window totaling 10% of the epoch length.
Following processing, the absolute sum of spectral power in the four classic
frequency bands (delta: 1-4Hz; theta: 4.5-7.5Hz; alpha: 8-13Hz; beta: 13.5-30Hz) was
calculated, as well as the absolute sum of total spectral power from 1-30Hz. Relative
power was then calculated as absolute power in each frequency band divided by absolute
power in the full spectrum (as in Finnigan et al., 2016). Commonly reported ratios were
calculated, including delta/alpha ratio (DAR; Claassen et al., 2004),
delta+theta/alpha+beta ratio (DTABR; Sheorajpanday et al., 2011), and delta+theta/total
spectral power (QSlowing; Finnigan et al., 2016; Lodder & Van Putten, 2013). All measures
were calculated for each electrode separately, then averaged across electrodes.
Calculations were performed for the following electrode montages: whole brain (all 64
electrodes), clinical (19 electrodes corresponding to 10-20 International system
locations), left hemisphere (excluding midline electrodes), right hemisphere (excluding
midline electrodes), anterior (excluding all Cn electrodes), posterior (excluding all Cn
electrodes), left hemisphere language (including F7, FT7, FC5, T7, C5,TP7, CP5, P5),
right hemisphere language (including F8, FT8, FC6, T8, C6,TP8, CP6, P6), motor
(including FC5, FC3, FC1,FCz, FC2, FC4, FC6, C1, Cz, C2), and cognitive (including
Fp1, AF3, AF7, F7, AFz, Fpz, AF4, AF8, F8). See Figure 3 for electrode locations and
labels. These montages have been previously reported in the literature or were of interest
because they correspond to common chronic post-stroke deficits. Electrodes for the
language, motor, and cognitive networks were selected as the electrodes that overlay
brain regions implicated in each behavior based on Koessler and colleagues’ findings
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(2009). Inter-hemispheric coherence was calculated for the following pairs: 1) left
hemisphere - right hemisphere, 2) left hemisphere language - right hemisphere language,
3) anterior left hemisphere – anterior
Figure 3. Electrode locations and labels, as viewed from above the head.

right hemisphere (excluding midline and Cn electrodes), and 4) posterior left hemisphere
- posterior right hemisphere (excluding midline and Cn electrodes). Intra-hemispheric
coherence was calculated for the following pairs: 1) anterior left hemisphere - posterior
left hemisphere (excluding Cn electrodes), and 2) anterior right hemisphere - posterior
right hemisphere (excluding Cn electrodes).
Data Analysis
All statistical analyses were conducted using SPSS. First, descriptive statistics
(mean, median, standard deviation, range, skew, and kurtosis) were calculated for the
control and stroke participant groups and normality was assessed using skew and
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kurtosis. Student’s t-tests to compare differences between groups were planned. While
many variables reported here violate the assumption of normality, previous research has
shown parametric statistics such as the t-test to be robust to violations of normality (using
Bradley’s definition of robustness where deviation from p = .05 is £ ±.005; 1978).
Simulation studies have demonstrated the robustness of the t-test in the face of nonnormal distributions when the absolute value of skew (the spread of the data) is less than
2, and the absolute value of kurtosis (the “peakiness” of the data) is less than 9 (Boneau,
1960; Bradley, 1982; Posten, 1978; Schmider et al., 2010). Data with skew or kurtosis
outside the range for which t-tests are robust were assessed using the Mann-Whitney U
test. Several comparisons with and without acceptable skew and kurtosis values were
calculated with both t-tests and Mann-Whitney U tests. Results showed that the statistical
significance of comparisons was dependent on the use of the most appropriate statistical
test, so we did not default to the use of a single test with our data. This is consistent with
previous research (Herron et al., 2014; Sheorajpanday et al., 2009; Hensel et al., 2004;
Nolfe et al., 2006). Homogeneity of variance was assessed using the Levene’s test. For
variables that violated the homogeneity of variance assumption, Welch’s t-tests were
used (Ruxton, 2006). Between-group comparisons were conducted using the data from
the first recording session. Effect size calculations (Cohen’s d for t-tests and h2 for
Mann-Whitney U-tests) were conducted for all comparisons, and medium to large effects
are reported as they are likely to correspond to behaviorally relevant between-group
differences. Cohen’s d and h2 have a different range of possible values, so for ease of
interpretation, both the numeric value and commonly accepted estimates of effect size
(small, medium, or large) are reported (Cohen, 1988). Holm-Bonferroni correction for
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multiple comparisons (Holm, 1979) was used to reduce the chance of spurious significant
differences. Coherence was calculated using Pearson correlations.
Finally, the reliability of measures for which statistically significant group
differences were observed was calculated between sessions one and two via intra-class
correlations (ICC; Koo & Li, 2016). ICCs are widely used to evaluate the psychometric
properties of newly developed assessment instruments, as well as intra- and inter-rater
reliability, depending on the specific test parameters selected. The interpretation of the
ICCs conducted for this study differ from the more commonly known Spearman and
Pearson correlations. A Spearman or Pearson correlation is used to assess how strongly
related two variables are with each other. This does not require that the variables be
similar in value, only that the values change together in a predictable, linear manner.
However, the ICCs conducted here assessed the exactness of the match between, for
example, whole brain relative delta power at session one and whole brain relative delta
power at session two during eyes closed rest. The closer these values are to each other,
the stronger the correlation, and the more stable the measure over time. For readability,
only the point estimates are reported in the text; however, 95% confidence intervals are
reported in tables to allow readers a more nuanced interpretation of reliability.
Results
Eyes Open Rest
Descriptive Statistics
Full descriptive statistics for each sEEG measure and montage of interest are
reported in Appendix A (Tables A1-A2). For descriptive statistics only, the whole brain
montage is the only montage reported in the text in order to improve readability. The
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whole brain montage was chosen since whole brain values are most frequently reported
in the literature. Mean relative delta power was 0.386 (SD = .092) in controls and 0.354
(SD = 0.115) in PWCS. Mean relative theta power was 0.114 (SD = 0.025) in controls
and 0.168 (SD = .094) in PWCS. Mean relative alpha power was 0.151 (SD = 0.054) in
controls and 0.185 (SD = 0.098) in PWCS. Mean relative beta power was 0.285 (SD =
.089) in controls and 0.218 (SD = .098) in PWCS. Mean DAR was 3.236 (SD = 1.321) in
controls and 3.05 (SD = 2.118) in PWCS. Mean DTABR was 1.399 (SD = 0.601) in
controls and 1.897 (SD = 1.386) in PWCS. Mean Qslowing was 0.491 (SD = 0.106) in
controls and 0.515 (SD = 0.141) in PWCS.
Between-Group Comparison
Inspection of skew and kurtosis revealed skew values greater than +/-2 for all
relative theta power montages, so Mann-Whitney U tests were used for theta power rather
than t-tests. Consistent with the mean and standard deviations reported above, no
significant differences were observed between neurologically healthy controls and PWCS
for relative delta power, relative alpha power, delta/alpha ratio, delta+theta/alpha+beta
ratio, and Qslowing (see Figure 4; Table 3). After correcting for multiple comparisons,
Figure 4. Time frequency plot displaying delta, theta, alpha and beta power for
neurologically healthy controls (left) and persons with chronic stroke (right) during eyes
open rest.
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Table 3. Test statistic, p-value, and effect size for between group comparisons during
eyes open rest. Comparisons that survived correction for multiple comparisons are
bolded. Comparisons that were not statistically significant but showed a medium or large
effect size are italicized.
Delta
t = 1.121
Whole Brain p = 0.267
d = 0.307
t = 1.017
Left
p = 0.314
Hemisphere
d = 0.279
t = 0.970
Right
p = 0.337
Hemisphere
d = 0.266
t =1.222
Anterior
p = .227
d = 0.335
t = 1.157
Posterior
p = 0.253
d = 0.317
t = 0.925
LH –
p = 0.359
Language
d = 0.254
t = 0.583
RH –
p = 0.562
Language
d = 0.160
t = 1.523
Motor
p = 0.134
d = 0.418
t = 0.941
Cognitive
p = 0.351
d = 0.258
t = 0.867
Clinical
p = 0.390
d = 0.238

Theta

Alpha

Beta

DAR

DTABR

Qslowing

U = 211
p = 0.013
η2 = 0.119
U = 204
p = 0.009
η2 = 0.132
U = 241
p = 0.05
η2 = 0.074
U = 228
p = 0.029
η2 = 0.092
U = 189
p = 0.004
η2 = 0.160
U = 241
p = 0.05
η2 = 0.074
U = 255
p = 0.088
η2 = 0.074
U = 229
p = 0.03
η2 = 0.091
U = 243
p = 0.055
η2 = 0.074
U = 217
p = 0.017
η2 = 0.109

t = -1.543
p = 0.131
d = 0.426
t = -1.456
p = 0.153
d = 0.402
t = -1.583
p = 0.122
d = 0.437
t = -1.307
p = 0.199
d = 0.361
t = -1.627
p = 0.112
d = 0.449
t = -1.343
p = 0.185
d = 0.368
t = -1.395
p = 0.170
d = 0.385
t = -1.732
p = 0.092
d = 0.479
t = -0.819
p = 0.418
d = 0.226
t = -1.344
p = 0.187
d = 0.371

t = 2.625
p = 0.011
d = 0.721
t = 2.604
p = 0.012
d = 0.715
t = 2.289
p = 0.026
d = 0.628
t = 1.588
p = 0.118
d = 0.335
t = 3.329
p = 0.002
d = 0.915
t = 1.862
p = 0.069
d = 0.254
t = 1.949
p = 0.057
d = 0.160
t = 2.018
p = 0.049
d = 0.553
t = 0.922
p = 0.361
d = 0.258
t = 2.702
p = 0.009
d = 0.742

t = 0.385
p = 0.702
d = 0.105
t = 0.416
p = 0.679
d = 0.114
t = 0.175
p = 0.862
d = 0.048
t = 0.200
p = 0.842
d = 0.055
t = 0.432
p = 0.668
d = 0.118
t = 0.291
p = 0.772
d = 0.080
t = -0.141
p = 0.889
d = 0.039
t = 1.043
p = 0.302
d = 0.286
t = -0.338
p = 0.737
d = 0.093
t = 0.198
p = 0.844
d = 0.054

t = -1.685
p = 0.101
d = 0.466
t = -1.783
p = 0.083
d = 0.493
t = -1.458
p = 0.154
d = 0.403
t = -1.434
p = 0.160
d = 0.396
t = -1.794
p = 0.082
d = 0.496
t = -1.521
p = 0.137
d = 0.421
t = -1.279
p = 0.210
d = 0.354
t = -1.488
p = 0.146
d = 0.412
t = -1.228
p = 0.226
d = 0.339
t = -1.814
p = 0.079
d = 0.502

t = -0.626
p = 0.534
d = 0.171
t = -0.746
p = 0.459
d = 0.206
t = -0.503
p = 0.617
d = 0.138
t = -0.298
p = 0.767
d = 0.082
t = -0.771
p = 0.444
d = 0.211
t = -0.568
p = 0573
d = 0.157
t = -0.670
p = 0.506
d = 0.184
t = -0.374
p = 0.710
d = 0.103
t = -0.107
p = 0.915
d = 0.029
t = -0.773
p = 0.443
d = 0.212
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relative theta and relative beta power were significantly different between groups for the
posterior montage, and effect size calculations showed large effects for both (theta: U =
189, p = .004, eta2 = .16; beta: t = 3.329, p = .002, d = .915). Non-significant comparisons
with medium effect sizes for relative theta power were observed in the whole brain (eta2
= .12), left hemisphere (eta2 = .13), right hemisphere (eta2 = .07), anterior (eta2 = .09), left
hemisphere language (eta2 = .07), motor (eta2 = .09), and clinical (eta2 = .11) montages.
Non-significant comparisons with medium effect sizes were also observed for relative
beta power in whole brain (d = .72), left hemisphere (d = .72), right hemisphere (d =
.63), motor (d = .55), and clinical (d = .74) montages. Finally, a medium effect size was
seen for DTABR in the clinical montage (d = .50). For all reported comparisons, relative
theta power and DTABR values were higher in PWCS than controls, while relative beta
power values were higher in controls than PWCS.
Coherence
Inter- and intra-hemispheric coherence during eyes open rest is reported in Table
4. For inter-hemispheric coherence, all correlations were statistically significant and
strong in both groups. Inter-hemispheric coherence in controls was generally strongest
between either the whole left and right hemispheres (r = .886 to .965) or between the left
and right posterior regions (r = .692 to .967), depending on sEEG measure. Strong
correlations were observed for intra-hemispheric coherence in controls for all measures
and locations except theta coherence between left anterior and posterior regions (r =
.469).
Inter- and intra-hemispheric coherence was generally strong for PWCS. Interhemispheric coherence between left and right hemispheres in PWCS showed the
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Table 4. Inter- and intra-hemispheric coherence as measured by Pearson correlations for
neurologically healthy controls and persons with stroke for sEEG measures during eyes
open rest. All correlations were statistically significant.
Controls
Inter-hemispheric Coherence
Delta Theta Alpha Beta DAR DTABR Qslowing
Left vs. Right
.923
.955
.965 .886 .920
.936
.934
Anterior Left vs. Right
.824
.843
.794 .757 .837
.871
.835
Posterior Left vs. Right
.922
.692
.967 .914 .906
.935
.948
Language Left vs. Right .800
.688
.843 .733 .862
.828
.836
Intra-hemispheric Coherence
Delta Theta Alpha Beta DAR DTABR Qslowing
Left Anterior vs.
.827
.469
.780 .735 .806
.784
.801
Posterior
Right Anterior vs.
.890
.692
.803 .752 .875
.882
.875
Posterior
PWS
Inter-hemispheric Coherence
Delta Theta Alpha Beta DAR DTABR Qslowing
Left vs. Right
.927
.971
.968 .878 .924
.889
.931
Anterior Left vs. Right
.834
.924
.889 .870 .756
.853
.887
Posterior Left vs. Right
.753
.937
.892 .826 .702
.710
.835
Language Left vs. Right .822
.924
.872 .753 .775
.695
.857
Intra-hemispheric Coherence
Delta Theta Alpha Beta DAR DTABR Qslowing
Left Anterior vs.
.746
.924
.769 .492 .821
.776
.829
Posterior
Right Anterior vs.
.820
.922
.934 .737 .676
.863
.852
Posterior
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strongest correlation for all sEEG measures (r = .878 to .971). Similarly, intrahemispheric coherence was significant across all locations and measures. Strong
correlations were seen for PWCS for all measures except beta coherence between left
anterior and right regions (r = .492).
Reliability
Test-retest reliability of all sEEG measures for healthy controls during eyes open
rest ranged from poor to good (Table 5). Reliability was poor for theta in the left
hemisphere, right hemisphere, posterior, left hemisphere language, right hemisphere
language, and cognitive montages (ICCs between .327 and .494); and for delta in the
right hemisphere language montage (ICC = .496). All other montages and sEEG
measures demonstrated moderate (39/70 correlations) to good (24/70 correlations)
reliability in healthy controls. The montages with highest reliability in controls were the
clinical, left hemisphere, whole brain, and motor (no single montage showed better
reliability than all others for all sEEG measures).
PWCS in general demonstrated better reliability than healthy controls. All
correlations ranged from moderate to excellent in terms of the degree of reliability. For
PWCS, moderate reliability was observed in six out of 70 correlations (for theta and
DAR only), good reliability was observed in 46 of 70 correlations (across all measures),
and excellent reliability was observed in 17 of 70 correlations (for alpha, beta, DAR, and
DTABR). In PWCS, the montages with the highest reliability were posterior, whole
brain, right hemisphere, and clinical.
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Table 5. Intra-class correlation coefficients for neurologically healthy controls and
persons with stroke during eyes open rest. Moderate, good, and excellent reliability are
shown.
Control
Delta
Theta
Alpha
Beta
DAR DTABR Qslowing
.601
0.534
.769
0.692
.812
.741
.874
Whole Brain
Left
Hemisphere
Right
Hemisphere
Anterior
Posterior
LH –
Language
RH –
Language
Motor
Cognitive
Clinical

Whole Brain
Left
Hemisphere
Right
Hemisphere
Anterior
Posterior
LH –
Language
RH –
Language
Motor
Cognitive
Clinical

.277-.804

.174-.768

.534-.893

.403-.854

.599-.915

.491-.879

.571

0.441

.810

0.650

.803

.718

.733-.943

.859

.232-.788

.057-.712

.609-.913

.336-.833

.598-.91

.448-.868

.705-.936

.553

0.494

.703

0.678

.792

.723

.846

.211-.777

.116-.745

.431-.859

.381-.847

.563-.906

.461-.870

.679-.93

.566

0.629

.718

0.712

.770

.663

.815

.231-.784

.312-.820

.457-.867

.438-.865

.531-.894

.362-.839

.623-.915

.584

0.460

.737

0.622

.742

.759

.863

.252-.795

.072-.725

.484-.877

.294-.818

.496-.879

.521-.888

.713-.938

.547

0.460

.743

0.586

.712

.751

.841

.203-.773

.089-.722

.43-.887

.244-.798

.363-.874

.51-.884

.672-.928

.496

0.327

.696

0.604

.761

.676

.791

.12-.747

0-.642

.42-.855

.275-.806

.525-.889

.38-.846

.575-.904

.593

0.770

.760

0.755

.714

.650

.851

.261-.8

.539-.893

.52-.888

.509-.886

.448-.864

.336-.832

.69-.933

.564

0.442

.724

0.649

.706

.595

.719

.229-.782

.059-.713

.461-.87

.341-.831

.433-.861

.262-.802

.458-.867

.621

0.512

.801

0.671

.839

.757

.868

.303-.815

.141-.756

.597-.908

.37-.844

.66-.927

.516-.887

.723-.94

DAR
.884

DTABR
.932

Qslowing
.919

.754-.948

.85-.97

.823-.964

Delta
.868

Theta
0.813

PWS
Alpha
Beta
.933
0.894

.718-.941

.62-.914

.852-.97

.771-.953

.854

0.856

.936

0.873

.826

.895

.917

.692-.934

.697-.935

.859-.972

.729-.943

.639-.921

.776-.953

.818-.963

.829

0.728

.908

0.877

.862

.957

.898

.646-.922

.471-.872

.793-.959

.737-.945

.71-.937

.904-.981

.781-.954

.827

0.763

.900

0.828

.818

.895

.883

.641-.921

.53-.89

.785-.955

.644-.922

.627-.916

.773-.953

.752-.948

.872

0.810

.942

0.911

.916

.943

.902

.728-.942

.614-.913

.872-.974

.807-.96

.816-.963

.875-.975

.786-.956

.774

0.717

.889

0.791

.743

.774

.883

.542-.896

.445-.867

.761-.951

.572-.904

.49-.88

.548-.895

.749-.948

.812

0.728

.829

0.854

.869

.895

.882

.615-.914

.467-.872

.648-.922

.692-.934

.72-.941

.774-.953

.749-.947

.799

0.750

.900

0.778

.789

.893

.855

.587-.908

.504-.883

.770-.957

.549-.898

.571-.903

.768-.952

.697-.934

.763

0.748

.887

0.759

.705

.858

.835

.524-.89

.499-.883

.759-.949

.519-.888

.43-.861

.703-.935

.656-.925

.866

0.758

.939

0.883

.893

.928

.923

.715-.94

.523-.887

.867-.973

.751-.948

.77-.952

.841-.968

.832-.966
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Eyes Closed Rest
Descriptive Statistics
Descriptive statistics for the whole brain montage are reported here (see Appendix
A, Tables A3-A4 for full descriptive statistics). Mean relative delta power was 0.271
(SD = .117) in controls and 0.284 (SD = 0.124) in PWCS. Mean relative theta power was
0.104 (SD = 0.028) in controls and 0.171 (SD = .099) in PWCS. Mean relative alpha
power was 0.271 (SD = 0.117) in controls and 0.284 (SD = 0.124) in PWCS. Mean
relative beta power was 0.244 (SD = .071) in controls and 0.176 (SD = .066) in PWCS.
Mean DAR was 1.863 (SD = 1.431) in controls and 2.084 (SD = 1.824) in PWCS. Mean
DTABR was 1.044 (SD = 0.654) in controls and 1.765 (SD = 1.565) in PWCS. Mean
Qslowing was 0.420 (SD = 0.126) in controls and 0.488 (SD = 0.155) in PWCS.
Between-Group Comparison
Again, no significant differences were observed between individuals with stroke
and neurologically healthy controls for relative delta power, relative alpha power,
delta/alpha ratio, delta+theta/alpha+beta ratio, or Qslowing (Figure 5; Table 6). After
correcting for multiple comparisons, relative theta power was significantly different
between groups for all montages. Mann-Whitney U tests were used with relative theta
power for the right hemisphere language (U = 210, p = .012, eta2 = .12) and cognitive (U
= 203, p = .008, eta2 = .13) montages as unacceptably large skew and kurtosis values
were observed. For these montages, effect size calculations indicated a medium effect.
For the montages with acceptable skew and kurtosis, t-values ranged from t = 3.712 (p =
.001, d = 1.03; motor montage) to t = 3.061 (p = .005, d = .85; right hemisphere
montage), all with corresponding large effect sizes. Relative beta power was also
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Figure 5. Time frequency plot displaying delta, theta, alpha and beta power for
neurologically healthy controls (left) and persons with chronic stroke (right) during eyes
closed rest.

significantly different between groups for all montages (from t = 3.912, p <.001 for the
posterior montage to t = 2.32, p = .024 for the right hemisphere language montage).
Effect size calculations for relative beta power showed large effects for whole brain (d =
.98), left hemisphere (d = 1.07), posterior (d = 1.08), and clinical (d = .97) montages and
medium effects for right hemisphere (d = .77), anterior (d = .78), left hemisphere
language (d = .7), right hemisphere language (d = .64), motor (d = .8), and cognitive (d =
.68) montages. Non-significant between-group differences with medium effect sizes for
DTABR were observed in whole brain (d = .60), left hemisphere (d = .68), anterior (d =
.59), posterior (d = .61), left hemisphere language (d = .61), cognitive (d = .64), and
clinical montages (d = .62). Finally, for Qslowing, three non-significant difference with
medium effect sizes were observed in the left hemisphere (d = .57), posterior (d = .52)
and clinical (d = .51) montages. Relative beta power was higher in healthy controls than
PWCS for all montages; however, PWCS had larger relative theta power, DTABR, and
Qslowing than healthy controls.
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Table 6. Test statistic, p-value, and effect size for between group comparisons during
eyes closed rest. Comparisons that survived correction for multiple comparisons are
bolded and comparisons not statistically significant but with a medium or large effect size
are italicized.
Delta
t = -0.16
Whole Brain p = 0.987
d = 0.004
t = -0.448
Left
p = 0.656
Hemisphere
d = 0.123
t = 0.245
Right
p = 0.808
Hemisphere
d = 0.067
t = 0.064
Anterior
p = 0.950
d = 0.017
t = -0.182
Posterior
p = 0.856
d = 0.050
t = -0.127
LH –
p = 0.900
Language
d = 0.035
t = 0.002
RH –
p = 0.998
Language
d = 0.001
t = 0.594
Motor
p = 0.555
d = 0.163
t = -0.372
Cognitive
p = 0.711
d = 0.102
t = -0.143
Clinical
p = 0.887
d = 0.039

Theta

Alpha

Beta

DAR

DTABR

Qslowing

t = -3.317
p = 0.002
d = 0.919
t = -3.411
p = 0.002
d = 0.944
t = -3.061
p = 0.005
d = 0.848
t = -3.342
p = 0.002
d = 0.926
t = -3.197
p = 0.003
d = 0.885
t = -3.449
p = 0.002
d = 0.956
U = 210
p = 0.012
η2 = 0.121
t = -3.712
p = 0.001
d = 1.027
U = 203
p = 0.008
η2 = 0.133
t = -3.356
p = 0.002
d = 0.929

t = -0.391
p = 0.697
d = 0.107
t = -0.251
p = 0.802
d = 0.069
t = -0.494
p = 0.624
d = 0.136
t = -0.261
p = 0.795
d = 0.072
t = -0.270
p = 0.788
d = 0.074
t = -0.205
p = 0.838
d = 0.056
t = -0.676
p = 0.502
d = 0.186
t = -0.752
p = 0.456
d = 0.206
t = 0.149
p = 0.882
d = 0.041
t = -0.293
p = 0.771
d = 0.080

t = 3.559
p = 0.001
0.979
t = 3.876
p < 0.001
1.065
t = 2.814
p = 0.007
0.773
t = 2.829
p = 0.007
0.778
t = 3.912
p < 0.001
1.075
t = 2.535
p = 0.014
0.696
t = 2.320
p = 0.024
0.637
t = 2.893
p = 0.006
0.796
t = 2.454
p = 0.018
0.675
t = 3.515
p = 0.001
0.966

t = -0.493
p = 0.624
d = 0.135
t = -0.766
p = 0.447
d = 0.210
t = -0.377
p = 0.708
d = 0.103
t = -0.501
p = 0.619
d = 0.137
t = -0.653
p = 0.516
d = 0.179
t = -0.681
p = 0.499
d = 0.187
t = -0.692
p = 0.492
d = 0.189
t = 0.126
p = 0.900
d = 0.035
t = -0.982
p = 0.331
d = 0.269
t = -0.619
p = 0.538
d = 0.170

t = -2.173
p = 0.037
d = 0.601
t = -2.460
p = 0.019
d = 0.680
t = -1.827
p =0.081
d = 0.498
t = -2.145
p = 0.039
d = 0.593
t = -2.193
p = 0.036
d = 0.607
t = -2.203
p = 0.035
d = 0.609
t = -1.715
p = 0.097
d = 0.475
t = -1.941
p = 0.060
d = 0.536
t = -2.306
p = 0.027
d = 0.638
t = -2.236
p = 0.032
d = 0.619

t = -1.749
p = 0.086
d = 0.480
t = -2.095
p = 0.041
d = 0.574
t = -1.380
p = 0.174
d = 0.378
t = -1.638
p = 0.108
d = 0.449
t = -1.912
p = 0.062
d = 0.524
t = -1.736
p = 0.089
d = 0.476
t = -1.394
p = 0.169
d = 0.382
t = -1.403
p = 0.167
d = 0.385
t = -1.806
p = 0.077
d = 0.495
t = -1.872
p = 0.067
d = 0.513
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Coherence
Inter- and intra-hemispheric coherence during eyes closed rest is reported in
Table 7. Similar to eyes open rest, all correlations for inter-hemispheric coherence were
statistically significant and ranged from moderate to strong for both groups. Interhemispheric coherence in controls was highest between left and right hemispheres for all
sEEG measures (r = .927 to .986). In addition, relative alpha power had the largest
correlations for each inter-hemispheric coherence calculation (r = .946 to .986) than other
sEEG measures (r = .720 to .963). For healthy controls, all intra-hemispheric coherence
correlations were strong, but there was no consistent pattern.
For PWCS, inter-hemispheric coherence was highest between anterior left and right
hemisphere regions, except for relative theta power (r = .777 to .948). Relative theta
power (r = .901 to .959) had the largest correlations for each inter-hemispheric coherence
calculation than any other sEEG measure. A single moderate correlation was observed
for PWCS in DAR (r = .475) between posterior left and right hemispheres. Unlike
controls, intra-hemispheric coherence in PWCS showed a consistent pattern, with
correlations for intra-hemispheric left hemisphere anterior and posterior regions
consistently smaller than correlations between right hemisphere regions. Lowest
coherence (and the only moderate correlation) was seen in the left hemisphere for relative
beta power.
Reliability
Test-retest reliability of all measures for healthy controls during eyes closed rest
ranged from poor to excellent (Table 8). Control reliability was poor for relative delta in
the right hemisphere (ICC = .488), anterior (ICC = .478), left hemisphere language
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Table 7. Inter- and intra-hemispheric coherence as measured by Pearson correlations for
neurologically healthy controls and persons with stroke for sEEG measures during eyes
closed rest. All correlations were statistically significant.
Controls
Inter-hemispheric Coherence
Delta Theta Alpha Beta DAR DTABR Qslowing
Left vs. Right
.957
.938
.986 .927 .963
.963
.960
Anterior Left vs. Right
.946
.835
.962 .883 .954
.942
.951
Posterior Left vs. Right
.921
.864
.946 .891 .931
.940
.932
Language Left vs. Right .893
.768
.929 .729 .912
.910
.893
Intra-hemispheric Coherence
Delta Theta Alpha Beta DAR DTABR Qslowing
Left Anterior vs.
.938
.661
.926 .742 .936
.911
.928
Posterior
Right Anterior vs.
.873
.795
.925 .821 .893
.907
.894
Posterior
PWS
Inter-hemispheric Coherence
Delta Theta Alpha Beta DAR DTABR Qslowing
Left vs. Right
.902
.959
.905 .769 .881
.817
.908
Anterior Left vs. Right
.920
.948
.930 .777 .918
.895
.937
Posterior Left vs. Right
.639
.901
.624 .672 .475
.551
.720
Language Left vs. Right .778
.915
.817 .675 .768
.718
.826
Intra-hemispheric Coherence
Delta Theta Alpha Beta DAR DTABR Qslowing
Left Anterior vs.
.727
.905
.809 .454 .741
.797
.822
Posterior
Right Anterior vs.
.782
.950
.818 .739 .801
.881
.847
Posterior
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Table 8. Intra-class correlation coefficients for neurologically healthy controls and
persons with stroke during eyes closed rest. Moderate, good, and excellent reliability are
shown.
Control
Delta
Theta
Alpha
Beta
DAR DTABR Qslowing
.518
0.865
.515
0.782
.932
.827
.848
Whole Brain
Left
Hemisphere
Right
Hemisphere
Anterior
Posterior
LH –
Language
RH –
Language
Motor
Cognitive
Clinical

Whole Brain
Left
Hemisphere
Right
Hemisphere
Anterior
Posterior
LH –
Language
RH –
Language
Motor
Cognitive
Clinical

.153-.758

.712-.939

.148-.757

.56-.899

.85-.97

.644-.921

.516

0.814

.506

0.753

.895

.801

.681-.931

.833

.146-.759

.616-.915

.13-.753

.507-.885

.776-.953

.596-.908

.651-.924

.488

0.824

.529

0.747

.957

.812

.846

.118-.74

.636-.92

.169-.765

.501-.882

.904-.981

.616-.914

.678-.93

.478

0.748

.476

0.781

.895

.759

.815

.096-.736

.504-.882

.095-.735

.556-.899

.773-.953

.518-.888

.617-.915

.533

0.868

.522

0.789

.943

.846

.860

.175-.767

.718-.941

.155-.761

.574-.903

.875-.975

.68-.93

.704-.937

.478

0.539

.514

0.535

.774

.676

.737

.101-.735

.182-.771

.143-.757

.173-.769

.548-.895

.389-.844

.482-.877

.367

0.698

.580

0.575

.895

.743

.805

0-.668

.413-.858

.239-.794

.224-.792

.774-.953

.49-.88

.599-.911

.559

0.841

.442

0.818

.893

.866

.850

.217-.78

.665-.928

.064-.711

.623-.917

.768-.952

.715-.94

.687-.932

.517

0.607

.480

0.685

.858

.675

.737

.144-.76

.274-.809

.093-.738

.396-.851

.703-.935

.377-.846

.48-.878

.499

0.856

.506

0.745

.928

.831

.826

.124-.748

.694-.935

.135-.752

.494-.881

.841-.968

.649-.923

.639-.921

DAR
.873

DTABR
.932

Qslowing
.926

.731-.943

.85-.97

.836-.967

Delta
.868

Theta
0.858

.722-.941

.691-.937

PWS
Alpha
Beta
.871
0.879
.725-.942

.737-.946

.838

0.874

.867

0.853

.788

.895

.907

.664-.926

.734-.943

.718-.94

.691-.933

.574-.902

.776-.953

.797-.959

.878

0.833

.862

0.885

.918

.957

.930

.74-.945

.634-.926

.707-.938

.754-.949

.819-.964

.904-.981

.847-.969

.805

0.782

.782

0.765

.817

.895

.888

.599-.911

.545-.901

.558-.9

.51-.893

.623-.917

.773-.953

.762-.95

.898

0.906

.908

0.940

.903

.943

.942

.766-.955

.788-.959

.799-.959

.867-.974

.792-.957

.875-.975

.872-.974

.765

0.742

.765

0.733

.709

.774

.820

.534-.891

.494-.879

.53-.891

.472-.875

.442-.862

.548-.895

.629-.918

.839

0.799

.783

0.797

.889

.895

.893

.663-.927

.589-.908

.559-.9

.587-.907

.76-.95

.774-.953

.771-.952

.801

0.812

.863

0.741

.813

.893

.884

.597-.908

.581-.917

.709-.938

.493-.878

.619-.914

.768-.952

.751-.948

.758

0.625

.670

0.749

.774

.858

.855

.519-.888

.306-.818

.373-.842

.422-.892

.543-.896

.703-.935

.687-.935

.862

0.850

.865

0.871

.879

.928

.912

.707-.938

.655-.935

.713-.939

.715-.943

.742-.946

.841-.968

.808-.961
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(ICC = .478), right hemisphere language (ICC = .367), and clinical (ICC = .499)
montages as well as for relative alpha in the anterior (ICC = .474), motor (ICC = .442),
and cognitive (ICC = .480) montages. All other montages and sEEG measures
demonstrated moderate (27/70 correlations), good (32/70 correlations), or excellent (4/70
correlations) reliability in healthy controls.
PWCS in general demonstrated better reliability than healthy controls. All
correlations ranged from moderate to excellent in terms of the degree of reliability. For
PWCS, moderate reliability was observed in seven out of 70 correlations (for theta, alpha,
beta, and DAR), good reliability was observed in 49 of 70 correlations (across all
measures), and excellent reliability was observed in 14 of 70 correlations (for theta,
alpha, beta, DAR, and DTABR). In PWCS, the montage with the most consistent
reliability was the posterior montage, as it showed excellent reliability for all sEEG
measures except relative data power, which demonstrated good reliability.
Discussion
In this sample of 27 healthy controls and 27 persons with chronic stroke, we
found no significant between-group differences during eyes open rest for relative delta
and alpha power, delta/alpha ratio, delta+theta/alpha+beta ratio, or quantitative slowing.
However, significant differences were observed in relative theta and beta power during
eyes open rest in the posterior montage. Significant differences were also observed
during eyes closed rest for all montages of interest in relative theta and beta power.
Importantly, we reported acceptable stability of all sEEG measures over time, depending
on electrode montage. Better stability was observed for all measures in the eyes closed
rest condition, which is unsurprising since it is less prone to artifactual noise like eye
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movements or other muscle activation. In particular, during eyes closed rest the posterior
montage consistently had the best reliability.
Comparison with Previous Literature
Much of the previous literature investigating sEEG in individuals who have
experienced a stroke is limited to the acute and sub-acute phases of recovery. These
studies have generally reported significant differences between PWCS and neurologically
healthy controls, with the most consistent results reported for relative delta power and
delta/alpha ratio. In contrast, no significant differences were found for these measures
here (and in fact, healthy controls had numerically higher delta and DAR values than our
chronic PWCS). As a check, we examined previously published research to determine if
our values for relative delta, relative alpha, DAR, and DTABR had been previously
reported in the literature. While many studies have investigated these variables, relatively
few report descriptive statistics adequate to determine the observed range. Nevertheless,
examination of three articles (Finnigan et al., 2007; Leon-Carrion et al., 2009;
Sheorajpanday et al., 2011) showed the values observed here have been reported
previously (although not within a single study). Two acute studies (Finnigan et al., 2007;
Sheorajpanday et al., 2011) reported values matching and exceeding our largest observed
data points, but no values matching the lower end of those we observed. In contrast,
Leon-Carrion and colleagues (2009) included non-acute participants and reported values
matching our smallest observed data points, but no values matching the higher end.
Importantly, Leon-Carrion and colleagues reported values of a mixed group of
individuals with stroke and traumatic brain injury, and only included 5 participants with
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stroke. Given this limited sample, it is perhaps unsurprising they did not report the full
range of values found here.
We also examined the prior research for a range of values reported for
neurologically healthy controls. Again, although multiple studies include a healthy
control comparison group, descriptive statistics were reported in such a way that only a
single comparison can be made. Finnigan and colleagues (2016) reported that no healthy
controls in their sample of 28 individuals had a DAR above 3.56, which is lower than the
highest DAR observed in our sample (5.69). However, the authors specifically stated that
further research was needed to determine whether their values were confirmed in a
different sample. One possible explanation for the difference is our use of less stringent
inclusion criteria than Finnigan and colleagues. For example, we did not exclude
individuals who were diagnosed with mild depression or anxiety, or individuals who
scored in the borderline or low average range on the RBANS. Our rationale for including
controls with mild depression or anxiety is the high prevalence of depression and anxiety
in both the general population, and more importantly, in individuals who have
experienced a stroke. Excluding controls with depression and/or anxiety might artificially
limit the range of “normal” DAR that could be observed in neurologically intact
individuals and would also make the samples less comparable, potentially leading to
confounds. Similarly, individuals with borderline or low average RBANS scores were
included because they had not been diagnosed with any developmental or learning
disorder and did not have a history of any kind of neurological disease. Individuals with
these cognitive profiles undeniably represent one facet of neurologically “normal”
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performance, and to exclude them would artificially limit the variability seen in
neurologically healthy controls.
Few studies have examined sEEG in persons with stroke in the chronic phase. In
contrast to studies completed during the acute and sub-acute phases where EEG is
exclusively recorded during eyes closed rest or eyes open rest, studies in the chronic
phase have recorded EEG during completion of motor, cognitive, and language tasks
(Herron et al., 2009; Spironelli & Angrilli, 2009; Spironelli et al., 2013). These studies
have reported statistically significant differences between controls and persons with
stroke in delta, theta, and beta power. To our knowledge, this is the first study to examine
sEEG in individuals with chronic stroke at rest. Our results confirm the observation in the
acute and sub-acute phases that changes in delta and alpha immediately post-stroke tend
to normalize over time (e.g., Hensel et al., 2004). We are also the first to demonstrate that
previously reported differences in theta and beta at rest (Assenza et al., 2014; Cuspineda
et al., 2007; Finnigan et al., 2016; Gorisek et al., 2016; Song et al., 2015; Spironelli et al.,
2013) persist into the chronic phase indefinitely. The differences between our resting
state power results and previously reported task-based power results suggest that
engaging in a task may trigger a paradoxical slowing of overall brain activity for
individuals who have experienced a stroke. Although outside the scope of the current
investigation, this will be the focus of future research, as we currently possess a dataset of
task-based EEG recordings in this sample of participants, allowing for direct
investigation of the effect of task engagement on the speed of brain activity.

48
sEEG for Outcome Measurement
Some studies have examined changes in sEEG over time as a response to
treatment (e.g., Rozelle & Budzynksi, 1995; Stojanovic et al., 2013; Wu et al., 2015).
However, to date there has been no evidence that sEEG measures in PWS are stable over
time and therefore appropriate for use as repeated measures. This study is the first to
report on the stability of sEEG measures over one month. This time period was selected
as many research studies involving a treatment component last approximately one month
from pre-treatment assessment to post-treatment assessment. Our results suggest that
sEEG measures, particularly during eyes closed rest, demonstrate appropriate stability to
be used to track changes over time. Interestingly, we found the best reliability, the largest
magnitude differences, and the most reliably significant between-group differences in the
posterior montage. A prior study also reported that the largest between-group differences
observed in their sample of controls and PWS occurred in a set of posterior left
hemisphere electrodes (Hensel et al., 2004). This suggests that a posterior montage may
be most amenable to measuring treatment response or other change over time.
Correlation with Function
Although not the focus of the current study, an exploratory analysis investigating
the correlation between sEEG measures and performance on behavioral tasks was
conducted, as this result has been frequently reported in the literature. Due to its
exploratory nature, only eyes closed rest data in the whole brain, clinical and posterior
montages for relative theta and beta power was examined due to the significant
differences with large effect sizes observed for these. Pearson correlations were
conducted between relative theta or beta power and performance on motor (contralesional
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index finger tapping), cognitive (RBANS index score), and language (production of main
concepts during story-telling) assessments. For all measures, a lower score represents
worse behavioral performance. Negative correlations were observed between relative
theta power and main concept production in whole brain (r = -.684), clinical (r = -.678),
and posterior left hemisphere (r = -.679) montages. A negative correlation was also
observed for the RBANS (r = -.411) in the posterior left hemisphere. Positive correlations
were observed between relative beta power and main concept production in whole brain
(r = .569), clinical (r = .563), and posterior left hemisphere (r = .516) montages. Positive
correlations were also observed between the RBANS and clinical (r = .413) and posterior
left hemisphere (r = .516) montages. The negative correlations between theta power and
behavioral measures mean that as theta power increases, discourse and cognitive
performance decreases. The positive correlations between beta and behavioral measures
mean that as beta power increases, discourse and cognitive performance also increases.
These results provide an important assurance that the between-group differences
observed are functionally relevant. They also provide additional support for a continued
relationship between sEEG and behavioral function in the chronic phase of stroke
recovery.
These results additionally highlight the importance of the behavioral measures
selected to quantify functional abilities. No significant correlations were observed for
contralesional index finger tapping despite a large number of participants exhibiting
motor deficits. While this lack of significant correlation is possibly a reflection of no
relationship between motor function and sEEG measures, it is more likely that
contralesional index finger tapping was not sensitive enough to detect the relationship,
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especially given the significant correlations for language and cognitive tasks. Indeed, not
all participants with motor deficits demonstrated slowed finger tapping. A more global
measure of function, or perhaps a combination of multiple measures, might be required to
more sensitively quantify sensorimotor deficits.
In addition, the main concept score was selected as the measure of language
function because the WAB-R aphasia quotient (one of the most widely used standardized
aphasia assessments) did not demonstrate a linear relationship with theta and beta power,
due in large part to ceiling effects. The WAB-R is scored out of 100 points, and the cutoff of performance that distinguishes individuals with aphasia from those without is 93.8.
This means that the entire range of “normal” performance is constrained to less than
seven points in comparison to the range of 93 points to quantify aphasic performance. In
contrast, the main concept composite score, which quantifies the accuracy and
completeness of story retelling, has demonstrated sufficient sensitivity to describe both
impaired and control discourse across a wide range of performance (Dalton &
Richardson, 2019). Within the field of aphasiology, there have been calls to utilize
functional communication measures, such as discourse performance, as primary outcome
measures in treatment studies, since these changes correspond more directly to outcomes
desired by persons with aphasia (Brady et al., 2016). This exploratory analysis provides
further support for those calls. This result also provides continued evidence for the
sensitivity of posterior brain regions to changes following stroke, highlighting the need
for more research into the features of posterior brain structure and connectivity which
may contribute to these findings.

51
Future Directions
Future research should examine changes in sEEG before and after treatment of
chronic, stroke-induced deficits to determine if these measures are sensitive to changes in
response to treatment, and to determine if baseline sEEG measures are able to predict
treatment response. To date only a single treatment case study has been published
examining this topic, and the treatment was a biofeedback protocol with unknown
efficacy (Rozelle & Budzynski, 1995) rather than a more commonly used and potentially
more efficacious behavioral therapy. Additionally, as a field, improvements in reporting
methodology and basic descriptive statistical information regarding data are needed, even
if only in supplemental materials. By providing this information to readers, we can
increase the confidence in reported results and strengthen the inferences that can be
drawn from published findings. Ideally, a database, such as those already established for
healthy controls and some populations with disorders (e.g., Brain Research and
Integrative Neuroscience Network, http://www.brainnet.net; Patient Repository for EEG
Data + Computational Tools; http://predict.cs.unm.edu), would be established to allow
for sharing of data and use of big data analytics that are currently unavailable for
individuals with stroke.
Finally, research into the mechanisms behind increased slow wave and decreased
fast wave activity in chronic stroke should be investigated. There is evidence
demonstrating that theta band synchrony is associated with cognitive control in healthy
adults (Cavanagh & Frank, 2014), and is altered in some disordered populations (e.g.,
Cavanagh, Meyers, & Hajcak, 2017). If, for example, increased theta post-stroke is
related to increased cognitive control effort required to navigate everyday life, this could
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contribute to patient reported experiences of fatigue and increased effort. On the other
hand, if increased theta is a result of the cognitive control network being co-opted to
participate in non-standard tasks, this could indicate that there is less capacity for
cognitive control mechanisms to be engaged, which would have implications for
rehabilitation success.
Conclusion
Within the field of stroke rehabilitation, and especially within the field of
aphasiology, there is great need for improved individualization of rehabilitation. One of
the primary limiting factors in achieving this goal is the lack of sensitive measures that
can predict treatment response. Simply looking at an individual’s behavioral profile has
proven to be insufficient to determine the most appropriate treatment course that will
result in greatest functional recovery. This is especially critical for adults engaging in
rehabilitation, as insurance companies impose annual limits on total therapy hours (often
forcing individuals to choose between occupational, physical, and speech therapy). By
improving individualization of treatment and thereby maximizing outcomes, individuals
post-stroke will be more likely to experience meaningful improvements in everyday
living. Given the persistence of stroke-induced changes into the chronic phase as
demonstrated here and elsewhere, as well as the stability of these measures, sEEG shows
great potential to be one such measure.
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Chapter 3
Introduction
Event-Related Potentials
Perhaps the most widely utilized methodology in EEG research is the eventrelated potential (ERP) analysis. ERPs take advantage of the fact that the brain
automatically processes information as it is presented. By marking the time at which a
specific stimulus is presented to participants (typically auditorily or visually) and
recording brain activation following stimulus presentation, ERPs allow inferences to be
made regarding the timing and general location of processing. While activation for any
given trial may be variable, averaging across many trials and many participants cancels
out activity that is random and unrelated to stimulus processing, revealing a clear timeline
of activation related to stimulus response. Of particular interest in ERP analysis is
identification of ERP “components” corresponding to positive or negative peaks in the
electrical signals recorded from the brain. Generally, early ERP components (occurring
prior to ~150ms after stimulus onset) are associated with basic sensory (e.g., color, shape,
brightness, tone frequency, loudness) processing of stimuli, while later components are
associated with cognitive processing (e.g., attention, memory, language, executive). For
example, the N400 is a cognitive-linguistic ERP component comprised of a typically
negative-going peak that occurs around 400ms after stimulus presentation. It was first
described by Kutas and Hillyard (1980) and was elicited in response to an unexpected
word occurring at the end of a sentence (for example, “He cut his food with a
toothbrush.”). Since that time there have been hundreds of investigations of the N400 in
healthy control and clinical populations that indicate it is involved in processing semantic
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meaning, among other tasks (for discussion see Kutas & Federmeier, 2011; Lau, Phillips,
& Poeppel, 2008). Researchers have identified numerous other ERP components
corresponding to different aspects of sensory and cognitive processing in healthy controls
(for an excellent tutorial see Luck & Kappenman, 2012). These components have been
leveraged to better understand how the brain processes incoming information in healthy
controls. ERP analysis has also been widely used to understand how brain processing is
changed following a range of diseases and disabilities.
ERPs in Individuals Post-Stroke
Examination of ERPs in individuals who have had a stroke provides insight into
neural adaptation when structural and functional connectivity is altered. Many such
studies have been conducted (for a review see Hernandez, 2015; Monge-Pereira et al.,
2017). These investigations encompass a wide range of tasks and behaviors, including:
auditory processing, emotion processing, memory, language, motor imagery, motor
planning, and movement execution (e.g., Daly et al., 2006; Dejanovic et al., 2015;
Ilvonen et al., 2003; Kohlmetz et al., 2001; Laganaro, Python, & Toepel, 2013; Li, Yan,
& Wei, 2013; Ofek et al., 2013; Sheppard et al., 2017; Stahlhut, Grotemeyer, Husstedt,
Evers, 2014). Overall, studies report differences in the latency, amplitude, and
topographic distribution of ERP components for persons with chronic stroke (PWCS)
compared to neurologically healthy controls. Some studies have investigated stroke
recovery broadly, while others have focused on specific stroke-induced deficits. While
many investigations of cognitive ERPs include broadly defined stroke populations,
cognitive-linguistic ERP investigations have generally constrained criteria to include
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populations with specific features (for example, only individuals with post-stroke
aphasia, or only individuals with mild stroke).
Measuring Cognition with ERP Post-Stroke
Attention
Many stroke researchers have investigated attention using the P300 (or P3)
component (e.g., Dejanovic et al., 2015; Ehlers, Herrero, Kastrup, & Hildebrandt, 2015;
Korpelainen et al., 2000; Molnar, Osman-Sagi, Nagy, & Kenez, 1999; Nolfe, Cobianchi,
Mossuto-Agatiello, & Giaquinto, 2006). The P300 is a typically positive going peak
occurring around 300ms after stimulus onset. It is centered over the midline and posterior
to the midpoint of the skull (referred to as the vertex). It is elicited by presenting a
commonly occurring “standard” stimulus, an infrequently occurring “target” stimulus,
and (optional) infrequently occurring “novel” stimuli that differ from both the standard
and target. The P300 can be elicited in response to either visual or auditory stimuli and
differs in a well-described manner according to gender and age. There are two distinct
constituents, the P3a and P3b. The P3a occurs slightly earlier than the P3b and is stronger
in response to novel than target stimuli. It is thought to correspond to involuntary
attentional processes (e.g., Picton, 1992), or stimulus processing and inhibition (Linden,
2005). The P3a also has a more fronto-medial, rather than posterior, distribution. In
contrast, the P3b occurs slightly later, across a larger time window, and is more posterior
in distribution than the P3a. It is more strongly elicited in response to the target stimulus,
which highlights its involvement in conscious attentional and memory processes, because
the stimulus must be attended to and then compared to a target exemplar stored in
memory.
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Because the P300 indexes conscious and unconscious attentional processes, can
be elicited in a non-linguistic manner, and can be elicited without a behavioral task that
requires an overt response, it is useful for examining recovery post-stroke when cognitive
and/or language deficits may be present. Research has shown smaller P300 amplitude and
longer latency following stroke (Figure 6; e.g., Dejanovic et al., 2014). Additional
examination of changes in the P300 indicates that lesion location (e.g., temporal, parietal,
frontal) also affects amplitude (Picton, 1992). Furthermore, the P300 shows a welldescribed pattern of age-related change, with longer latencies observed as age increases.
This is an important consideration when studying diseases, such as stroke, that tend to
occur in a more elderly population.
Figure 6. Example of the P300 response in an auditory oddball paradigm. The black trace
corresponds to activation in response to the frequently occurring tone. The red trace
corresponds to activation in response to novel sounds. The blue trace corresponds to
activation in response to the target tone.
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Language
Another important aspect of cognition is language production and processing.
Language abilities can be directly disrupted by damage to language dominant areas in the
brain, or indirectly through damage to areas of the brain responsible for cognitive
processes that underlie language abilities, such as memory and attention. Research with
individuals post-stroke has sought not only to describe how language processing changes
following stroke (e.g., Angrilli & Spironelli, 2005; Angrilli et al., 2015; Chang et al.,
2016; D’Arcy et al., 2003; Dobel et al., 2002; Friederici et al., 1999; Hagoort et al., 1996;
Hagoort et al., 2003; Kawohl, Bunse, & Willmes, 2010; Kielar, Meltzer-Asscher, &
Thompson, 2012; Kojima & Kaga, 2003; Laganaro et al., 2013; Robson, et al., 2017;
Pulvermuller et al., 2004; Sheppard et al., 2017; Swaab et al., 1997; ter Keurs et al., 1999;
Wilson et al., 2012), but also how language recovery manifests in the brain (e.g.,
Cobianchi & Giaquinto, 2000), and whether ERP analyses can be used to inform
treatment response or predict treatment recovery (e.g., Barbancho et al., 2015; D’Arcy et
al., 2003; Laganaro et al., 2008). These studies almost exclusively limit inclusion criteria
to individuals who have been diagnosed with aphasia. While this has provided important
and useful information regarding aphasia specifically, limiting inclusion/exclusion
criteria in this manner prevents us from characterizing the contribution of other cognitive
processes, such as working memory and attention, to language production and
processing.
The N150 and N350 are ERP components that can be elicited in response to
presentation of single words (Spironelli & Angrilli, 2015). The N150 is a negative-going
peak that occurs posteriorly and is left-lateralized. It is related to early word recognition
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(supported by the visual word form area discussed in chapter 1). Unlike controls, when
completing orthographic, rhyme, and semantic relatedness judgment tasks, persons with
post-stroke aphasia demonstrated an N150 that was either bilaterally distributed or
lateralized to the right hemisphere (Spironelli & Angrilli, 2015). The N350 is also a
negative-going peak that is left-lateralized, but its distribution is more frontal than the
N150. The N350 is related to processing word-specific phonological features (Spironelli
& Angrilli, 2015). Again, in contrast to controls, individuals with post-stroke aphasia
demonstrated an N350 that was centered over spared anterior and posterior left
hemisphere language areas. For both components, individuals with post-stroke aphasia
also demonstrated decreased amplitude compared to healthy controls.
Predicting recovery post-stroke.
P300. Investigations of attentional and linguistic ERPs during stroke recovery, or
in response to therapy, are promising with regards to their use as biomarkers of treatment
response and general recovery. In one study, amplitude and latency immediately
following a stroke were significantly different from healthy controls and showed a
divergence during the first year of stroke recovery, such that latency became more
normalized while amplitude showed no significant normalization (Dejanovic et al.,
2015). In contrast, Korpelainen and colleagues (2000) found only a latency change in the
P300 in the acute phase post-stroke, which was related to the severity of post-stroke
depression. However, Korpelainen and colleagues only included individuals with minor
strokes (i.e., small lesions, mild deficits), while Dejanovic and colleagues enrolled a
consecutive sample regardless of severity, potentially accounting for these different
findings. Yamagata and colleagues (2004) investigated the P300 in individuals with
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subcortical strokes and found significant differences in P300 amplitude between
participants with and without apathy. However, no control group was enrolled in this
study, so it is unclear if differences existed between the individuals with stroke and
healthy controls. A study examining whether the P300 indexed recovery in individuals
with global aphasia (and therefore persons with larger lesions and more severe
symptoms) found that presence of the P300 at stroke onset corresponded with better
recovery at six months (Nolfe et al., 2006). The authors also reported that the P300 in this
population of individuals with severe strokes was not stable over the first sixth months of
recovery. Participants might show a P300 response in one month, but not the next. If this
finding of instability holds for all individuals it might explain some of the variability in
P300 changes following stroke, as individuals in the acute and subacute phases of
recovery were included in the studies reviewed above.
The P300 is also associated with functional recovery and positive outcomes in
response to treatment. In their study, Ehlers and colleagues (2015) found that larger P300
amplitude at frontal locations (P3a) corresponded with better recovery (e.g., discharge
from acute care to sub-acute rehabilitation versus discharge to a nursing home). P300
amplitude was also correlated with improvement on a measure of activities of daily
living. Based on their results, the authors suggested that degree of impairment in
attention, as indexed by P3a amplitude, predicted poor versus good rehabilitation
outcomes. Finally, the P300 can be directly altered through administration of
pharmacological agents (Yamaguchi, Matsubara, & Kobayashi, 2004), which indicates
that it may also be amenable to alterations induced by neurorehabilitation. Taken
together, the body of work on P300 in PWS in early phases of recovery demonstrates that
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ERP measures offer a fruitful avenue for understanding cognitive recovery after a stroke,
and perhaps more importantly, improving prognosis and individualization of
rehabilitation.
N150 and N350. Language ERPs have also been examined during recovery and
in response to treatment, although participants were limited to individuals with poststroke aphasia. In persons with very mild nonfluent aphasia, behavioral recovery as
measured by the Aachen Aphasia Test (AAT; Huber, Poek, & Willmes, 1984) correlated
with a return of left lateralization during language processing (e.g., Spironelli et al.,
2008). One study reported that behavioral language improvements measured during
recovery were indexed by both a return to the “normal” pattern of ERPs shown by
controls in some participants, and emergence of ERP components with divergent
topography and amplitude compared to controls in other participants (Laganaro et al.,
2008). This study only included four PWAs (two conduction, one transcortical sensory,
one unclassified), which did not allow for an investigation of possible patient factors that
contribute to normalized versus divergent patterns of recovery. However, these findings
have been replicated in additional research. For example, Wilson and colleagues (2012)
reported that following therapy, the topography of the N400 shifted in a group of chronic,
primarily fluent PWAs, from right-lateralized towards a more left-lateralized component,
which the authors attributed to compensatory recovery mechanisms, and not
normalization. Finally, Barbancho and colleagues (2015) administered the drug
memantine to individuals with fluent and nonfluent chronic aphasia both alone and in
conjunction with aphasia therapy. When participants received the drug intervention only,
the ERP demonstrated reduced amplitude, and when participants received memantine
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plus therapy, the ERP amplitude increased. In both cases, changes in ERP amplitude were
correlated with improvements on behavioral measures of language. However, only
individuals who received both the drug and behavioral therapy intervention demonstrated
changes in ERP amplitude that persisted over time.
Purpose of the Study
The published literature on both cognitive and language ERPs supports their use
to elucidate changes in processing after stroke, to track recovery during the acute and
sub-acute phases, and to measure treatment response, whether it be pharmacological or
therapy-induced. The long-term goal of the current research is to establish sensitive
biomarkers that would allow targeted pairing of rehabilitation to deficits and would
improve diagnosis and prognosis of chronic stroke-induced deficits. However, the P300
is not well-characterized in individuals with chronic stroke, and the N150 and N350 have
not been investigated in samples that also include individuals without chronic strokeinduced aphasia to determine if they are sensitive to non-linguistic cognitive changes.
Further, there is limited evidence regarding the reliability and stability of cognitive and
linguistic ERP components in individuals with chronic stroke.
We will characterize the P300, N150, and N350 in a mixed population of
individuals with left and right hemisphere strokes and a variety of post-stroke deficits.
Our rationale for doing so here is two-fold. First, improved normative information
regarding ERP changes in chronic post-stroke is needed. The most efficient way to
develop norms is through databases to which many individuals can contribute. Guidelines
for the development of such databases suggest that it is important to maximize the
variability of participants who are included, in order to have robust generalizability and
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reduce the chance of statistically significant, but clinically insignificant, differences
(Prichep, 2005). This paper represents the first step in developing robust norms by
pairing assessment of chronic stroke deficits in multiple behavioral domains with
cognitive ERPs. Future research will then be able to use this well-characterized
population, and its planned expansion, to investigate the impact of specific or cooccurring deficits on a variety of ERP components. Second, behavioral assessments are
often insensitive to mild but functionally debilitating changes in cognition (for an
example in persons with post-stroke aphasia, see Fromm et al., 2017). By selecting only
individuals who score beyond a certain cut-off on standardized assessments, we limit our
ability to learn about the full range of behavioral impairments experienced by individuals
with chronic stroke, and potentially mischaracterize individuals as unimpaired when they
are in fact experiencing functional difficulties. The aim of the current study is to address
these gaps in the literature by pursuing the following specific aims:
1. Characterize the mean amplitude in attention and language ERPs in an Englishspeaking control population.
2. Characterize the mean amplitude in attention and language ERPs in an Englishspeaking PWCS population of mixed stroke hemisphericity and impairments.
3. Identify differences in mean amplitude in cognitive and language ERPs between
controls and PWCS.
4. Report reliability of mean amplitude in cognitive and language ERPs in controls
and PWCS.

63
Methods
Participants
Healthy Controls
Twenty-seven (17 female, 10 male) healthy individuals participated in this study
(Table 1). Participants were screened to ensure no history of neurological disease or
injury that might affect brain function. Potential participants with a diagnosis of
significant psychiatric mood disorders were excluded, but individuals with mild
depression and anxiety were allowed to participate, as many individuals with chronic
stroke suffer from depression and anxiety. Participants completed the Edinburgh
Handedness Inventory (EHI; Oldfield, 1971), and if bi- or multi-lingual, the Language
Experience and Proficiency Questionnaire (LEAP-Q; Marian, Blumenfeld, &
Kaushanskaya, 2007). All healthy control participants were right-handed, and seven
reported speaking at least one other language, including French, Spanish, Italian, and
German. No control participants reported learning another language prior to English, and
all reported English as their primary language at the time of participation. The average
age of participants was 63 years (SD = 13.2 years). Control participant ages ranged from
22 to 88 and were selected to match persons with stroke. Average education was 16.9
years (SD = 2.6). Participants completed the Repeatable Battery for the Assessment of
Neuropsychological Status (RBANS; Randolph, 1998), Wechsler Adult Intelligence
Scales - Picture Completion subtest (WAIS-PC; Wechsler, Coalson, & Raiford, 2008),
Discourse Production Test (DPT; MacWhinney, Fromm, Forbes, & Holland, 2011),
aprosodia battery (AB; based off of Ross & Monnot, 2011), subtests of the Apraxia
Battery for Adults - 2 (ABA-2; Dabul, 2000), and an in-house sensorimotor assessment
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including sensory perception, proprioception, range of motion, and muscle tone (Table
2). Testing was conducted to ensure participants’ performance was within the range of
neurologically typical individuals. Participants completed two sessions of EEG recording,
approximately one month apart. Three participants were unable to complete the follow-up
EEG due to changes in schedules, these participants are included in the normative data
set and comparison with participants with stroke but are not included in the reliability
analysis. Please see for complete demographics for each group.
Persons with Stroke
Twenty-seven (10 female, 17 male) persons who had experienced one or more
strokes also participated in this study (Table 1). We included participants with multiple
strokes to ensure that our results are maximally applicable to the general rehabilitation
population served by practicing therapists, since one of the strongest risk factors for
stroke is a history of prior stroke. Seventeen individuals experienced left hemisphere
stroke, 7 experienced right hemisphere stroke, and 3 experienced left and right
hemisphere strokes (participant reporting of stroke location was confirmed via medical
records, CT, or MRI scans when available). Thirteen individuals were diagnosed with
aphasia, 14 had cognitive impairment, and 20 had sensory and/or motor deficits (Table
2). All participants were in the chronic phase (greater than one-year post-stroke) to ensure
that spontaneous recovery was not a factor in change over time. Participants completed
the Edinburgh Handedness Inventory (EHI; Oldfield, 1971), and if bi- or multi-lingual,
the Language Experience and Proficiency Questionnaire (LEAP-Q; Marian, Blumenfeld,
& Kaushanskaya, 2007). All stroke participants were right-handed prior to their stroke.
Three participants with stroke reported speaking more than one language (Spanish and/or
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Azteca) and one participant reported Spanish as their first language, although English
was the primary language for all participants at the time of testing and had been for many
years. The average age of PWCS was 56.6 years (SD = 14.2 years). PWCS ages ranged
from 25 to 87. Average education was 15.2 years (SD = 3.3 years). PWCS completed the
same assessments as healthy controls, as well as the Western Aphasia Battery - Revised
(WAB-R; Kertesz, 2006), Boston Naming Test (BNT; Kaplan, Goodglass & Weintraub,
2001), and Discourse Comprehension Test (DCT; Brookshire & Nicholas, 1997).
Participants completed two sessions of EEG recording, approximately one month apart.
One participant was unable to complete the follow up EEG recording due to a change in
schedule. As above, this participant is included in all analyses except reliability.
EEG Recording
EEG data was recorded from 64 active electrodes in an elastic cap placed
according to the 10-10 International system of classification. The ground electrode was
located at Fpz with the reference electrode at CPz. Eye movement was recorded via
vertical electrooculography using paired electrodes placed above and below the left eye,
while heart rate was recorded via electrodes placed on the left and right collarbones. Data
were recorded on a BrainVision actiCHamp system with a 500Hz sampling rate and
online bandpass filtering from .01 - 100Hz.
Behavioral Tasks
Participants were seated in front of a computer in a dimly lit room while
completing the EEG recording. The sequence of tasks during recording was: rest,
auditory oddball task, lexical decision task, semantic relatedness task, orthographic
matching task, rhyme judgment task, emotion recognition task, motor imagery task, and
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go/no-go task. We will limit our discussion to one cognitive task (auditory oddball) and
three language tasks (orthographic matching, rhyme judgment, and semantic relatedness).
During the auditory oddball task (Polich, 1998), individuals heard a commonly occurring
low frequency tone (standard) which was interspersed with a rarely occurring high
frequency tone (target) and oddball noises (novel) consisting of short segments of
environmental or non-speech sounds (e.g., bark, meow, cough, laugh, sigh) as described
by Cavanagh and colleagues (Cavanagh et al., 2018). Participants were asked to count the
number of high tones they heard but were not required to make any behavioral responses
while the sounds were presented. This task was used to investigate the P3a and P3b
components. One hundred and twenty standard tones, 30 target tones, and 30 novel
sounds were presented across two approximately 5-minute blocks.
During the language tasks (which we will refer to as orthographic, phonological,
and semantic), word pairs were presented on the screen one at a time for one second to
ensure participants with aphasia would be able to successfully process the stimuli.
Participants were instructed to push one keyboard button if the words were related in
meaning (semantic), rhymed (phonological), or matched in case (orthographic) and were
instructed to push a different keyboard button if the words were not related in meaning,
did not rhyme, or the case did not match (see Figure 7; Spironelli & Angrilli, 2015).
Words were presented in white text on a black background to reduce visual fatigue. Word
pairs were separated by a green plus sign, which helped visually cue participants with
stroke that they should compare the two words according to the directions for that
particular task. In the present study, only brain activity to the first word in each pair is
evaluated, consistent with investigation of the N150 and N350 as reported by Spironelli
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Figure 7. Examples of the orthographic, phonological, and semantic tasks completed by
participants.

and Angrilli (2015). This also has the benefit of providing a larger dataset for averaging
because no trials have to be discarded for incorrect or missing behavioral responses. Sixty
word-pairs were included in each task, 30 matched and 30 non-matched, lasting
approximately ten minutes.
Data Processing
Standard offline pre-processing (see Figure 2) using BrainVision Analyzer 2.1
was conducted to ensure adequate data quality. First, noisy channels were identified and
discarded through visual inspection. Specifically, electrodes were examined for spike
artifacts and high frequency electrical noise which is often due to poor contact between
the electrode and scalp (e.g., Finnigan et al., 2007). The following data processing steps
were conducted as described by Finnigan, Wong, and Read (2016). Next, data were high
(.5Hz) and low (40Hz) pass filtered using infinite impulse response zero-phase shift
Butterworth filters to minimize distortion and preserve phase information (Hamming,
1998; Oppenheim, 1999). After filtering, bad segments (i.e., muscle activity) were
manually rejected and independent components analysis was conducted to remove eye
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movement artifacts (Makeig, Bell, & Jung, 1996). Data were then epoched into 2048ms
bins and epochs with data values greater than +/-100 microvolts and/or changes in value
greater than +/-25 microvolts were rejected. For both neurologically healthy controls and
PWCS, no more than 20% of data in a given channel was rejected. For the oddball task,
epochs were calculated 1024 ms before and after sound presentation separately for the
standard, novel, and target stimuli. For the language tasks, epochs were calculated
1024ms before and after the first word in a pair appeared on screen. Epochs were
calculated separately for orthographic, phonological, and semantic tasks.
For these six datasets (orthographic, phonological, semantic, standard, novel, and
target), the mean activation was calculated for each electrode by participant, and then
averaged across participants to yield mean control and mean PWCS activation. The mean
control waveform for the novel and target datasets were visually examined to identify the
time windows for statistical comparison, taking into account previously published
research. When identifying time windows of interest for each component, only peaks in
the healthy control waveforms were examined in order to protect against experimenter
bias (e.g., not selecting time windows with apparent visual differences between controls
and PWCS to maximize likelihood of significant differences). Mean amplitude and
standard deviation were calculated at each electrode. While previous literature has
primarily reported on peak amplitude or peak latency, we chose mean amplitude as it is a
less biased measure of activation (Clayson, Baldwin, & Larson, 2013) and is more robust
to the presence of high frequency noise in the signal (Luck, 2014). Recent texts have
therefore encouraged the use of mean amplitude to reduce the risk of bias and improve
validity of reported findings (Luck & Gaspelin, 2017).
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P3a and P3b
P3a and P3b times were selected based on a symmetric window around the largest
positive peak in Fz (for P3a) and Pz (for P3b) occurring between 300-800ms (e.g.,
Conroy & Polich, 2007). Mean amplitude was calculated between 375-450ms for P3a and
between 440-480ms for P3b. In order to compare our results with previously published
findings in stroke (e.g., Dejanovic et al., 2015; Ehlers et al, 2015; Korpelainen et al.,
2000; Nolfe et al, 2006; Stahlhut et al, 2014; Yamagata, Yamaguchi, & Kobayashi,
2004), we first examined mean amplitude in Fz, Cz, and Pz (for results reporting we will
refer to these as historical). An additional set of electrodes were selected to examine
activation away from the midline (referred to as expanded electrodes) due to the mixed
hemisphericity of strokes in our PWCS group, and to leverage the density of our
recording array. This expanded set of electrodes include F3, F4, C3, C4, P3, and P4.
N150 and N350
For the language tasks, mean amplitude of the N150 was calculated between 130150ms and mean amplitude of the N350 was calculated between 300-500ms (based on
Spironelli & Angrilli, 2015). In order to evaluate between-group differences, electrodes
were assigned to regions of interest (ROIs). One set of ROIs were chosen to closely
match ROIs reported by Spironelli and Angrilli (2015) to allow comparison of our results
with previously published literature. These ROIs are: 1) left anterior (Fp1, AF7, F7); 2)
left posterior (P3, P7, O1); 3) right anterior (Fp2, AF8, F8); and 4) right posterior (P4, P8,
O2). We were able to use the Spironelli and Angrilli ROIs exactly for the posterior
regions. However, the montage used by Spironelli and Angrilli included electrodes F9
and F10 in the anterior ROIs, which were not present in our electrode montage.
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Therefore, we used Fp1 and Fp2 rather than F9 and F10 for calculation of the anterior
ROIs. A second set of ROIs were also selected in order to leverage the granularity of the
relatively dense electrode array used in this study. These expanded ROIs are: 1) left
orbito-frontal (Fp1, AF3, AF7); 2) left antero-medial (F1, F3, FC1, FC3); 3) left anterolateral (F5, F7, FC5, FT7); 4) left postero-medial (CP1, CP3, P1, P3); 5) left posterolateral (CP5, TP7, P5, P7); 6) left occipital (PO3, PO7, O1); 7) right orbito-frontal (Fp2,
AF4, AF8); 8) right antero-medial (F2, F4, FC2, FC4); 9) right antero-lateral (F6, F8,
FC6, FT8); 10) right postero-medial (CP2, CP4, P2, P4); 11) right postero-lateral (CP6,
TP8, P6, P8); 12); and right occipital (PO4, PO8, O2).
Data Analysis
All statistical analyses were conducted using SPSS. First, descriptive statistics
(mean, median, standard deviation, range, skew, and kurtosis) were calculated for the
control and stroke participant groups, and normality of MA distributions was assessed
using skew and kurtosis for each ROI. Student’s t-tests to compare differences between
groups were planned. While many variables reported here violate the assumption of
normality for use of t-tests, previous research has shown parametric statistics such as the
t-test to be robust to violations of normality (using Bradley’s definition of robustness
where deviation from p = .05 is £ ±.005; 1978). Simulation studies have demonstrated
such robustness when the absolute value of skew (the spread of the data) is less than 2,
and the absolute value of kurtosis (the “peakiness” of the data) is less than 9 (Boneau,
1960; Bradley, 1982; Posten, 1978; Schmider et al., 2010). Data with skew or kurtosis
outside the range for which t-tests are robust were assessed using the Mann-Whitney U
test. Homogeneity of variance was assessed using the Levene’s test. For variables that
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violated this assumption, Welch’s t-tests were used (Ruxton, 2006). Between-group
comparisons were conducted using data from the first recording session. Examination of
skew and kurtosis revealed that the distribution of mean amplitude was generally
amenable to use of the t-test. Effect size calculations (Cohen’s d for t-tests and h2 for
Mann-Whitney U-tests) were conducted for all comparisons that were statistically
significant prior to correcting for multiple comparisons. Cohen’s d and h2 have a
different range of possible values, so for ease of interpretation, both are reported with an
estimate of the size of the effect: small, medium, or large (Cohen, 1988). HolmBonferroni correction for multiple comparisons were used to reduce the chance of
spurious significant differences (Holm, 1979).
For the N150 and N350, effect sizes for all individual electrodes were calculated
to determine which electrode(s) might be powering group differences. Additionally,
while averaging across electrodes helps reduce the number of variables entered into
analysis, it may also conceal differences among electrodes within a single ROI. Given the
large number of comparisons and experimental nature of this analysis, results are
reported via effect sizes, rather than test statistics and p-values. It is hoped that this
method will allow identification of electrodes that maximally contribute to betweengroup differences and could help reduce dimensions of comparison in future research,
while improving specificity (such as is available for the P300 components).
Finally, reliability of mean amplitude for each electrode or ROI was calculated
between sessions one and two using intra-class correlation (ICC) coefficients (Koo & Li,
2016). ICCs are widely used to evaluate the psychometric properties of newly developed
assessment instruments, as well as intra- and inter-rater reliability, depending on the
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specific test parameters selected. The interpretation of the ICCs conducted for this study
differ from the more commonly known Spearman and Pearson correlations. A Spearman
or Pearson correlation is used to assess how strongly related two variables are with each
other. This does not require that the variables be similar in value, only that the values
change together in a predictable, linear manner. However, the ICCs conducted here
assessed the exactness of the match between, for example, the value of mean amplitude at
AFz in session one and the value of mean amplitude at AFz in session two in response to
target tones. The closer these values are to each other, the stronger the correlation, and
the more stable the measure over time. For readability, only the point estimate of the ICC
is reported in the text, but 95% confidence intervals are reported in the tables to allow for
more nuanced interpretations of reliability.
Results
P3a
Descriptive statistics in healthy controls
Historical. See Appendix B (Table B1-B4) for full P3a descriptive statistics. For
healthy controls, positive mean amplitude was observed in response to target (M =
2.016µV, SD = 2.211) and novel sounds for Fz (M = 23.359µV, SD = 1.756), target (M =
1.679µV, SD = 2.478) and novel (M = 1.661µV, SD = 2.393) sounds for Cz, and target
sounds for Pz (M = 1.734µV, SD = 2.068). A negative mean amplitude was observed to
novel sounds in Pz (M = -0.471µV, SD = 1.978).
Expanded. When examining the expanded electrodes, controls demonstrated
positive mean amplitude in response to target sounds for all electrodes, ranging from
0.596µV (SD = 1.186) in electrode P3 to 1.357µV (SD = 1.921) in F3. In response to
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novel sounds, controls demonstrated positive amplitudes in F3, F4, C3, and C4 (ranging
from 0.809µV, SD = 0.809 to 2.513µV, SD = 1.504). Negative mean amplitudes were
observed to novel sounds in P3 (-1.436µV, SD = 1.294) and P4 (-1.229µV, SD = 1.753).
Descriptive statistics in PWCS
Historical. Positive mean amplitude in response to target and novel stimuli was
also observed for PWCS in Fz (1.281µV, SD = 1.552 and 2.017µV, SD = 1.850,
respectively), Cz (1.254µV, SD = 1.328 and 1.442µV, SD = 1.445, respectively), and Pz
(.953µV, SD = 1.378; target only). Again, negative mean amplitude was observed in
response to novel sounds in Pz (-0.273µV, SD = 1.478).
Expanded. Following the same pattern as seen above in controls, PWCS showed
positive mean amplitude in response to target sounds for all expanded electrodes (ranging
from 0.036µV, SD = 1.237 to 1.199, SD = 1.822µV), except P3 (-0.407µV, SD = 1.883).
Positive mean amplitude in response to novel sounds was observed in F3, F4, C3, and
C4, ranging from 0.539µV (SD = 1.470) to 1.588µV (SD = 1.598). Mean amplitude for
PWCS in response to novel tones was negative for P3 (-1.234µV, SD = 1.866) and P4 (0.501µV, SD = 1.207).
Between group comparisons
Historical. Overall, healthy controls had a larger, more positive mean amplitude than
PWCS (Table 9). A statistically significant difference with medium effect size in mean
amplitude was observed in electrode Fz in response to novel sounds (t = 2.733, p = .009,
d = .744).
Expanded. When examining the expanded set of electrodes, none reached
statistical significance for mean amplitude after correcting for multiple comparisons.
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Table 9. Test statistic, p-value, and effect size for between group comparisons during
P3a. Comparisons that survived correction for multiple comparisons are bolded.
Comparisons that were not statistically significant but showed a medium or large effect
size are italicized.
Target
Novel
Historical
t = 1.414
t = 2.733
Fz
p = 0.164
p = 0.009
d = 0.385
d = 0.744
t = 0.786
t = 0.406
Cz
p = 0.436
p = 0.687
d = 0.214
d = 0.111
t = 1.634
t = -0.418
Pz
p = 0.108
p = 0.678
d = 0.445
d = 0.114
Expanded
t = 1.545
t = 2.167
F3
p = 0.129
p = 0.035
d = 0.424
d = 0.596
t = -0.318
t = 1.826
F4
p = 0.752
p = 0.075
d = 0.087
d = 0.497
t = 1.748
t = 1.513
C3
p = 0.086
p = 0.136
d = 0.476
d = 0.412
t = 1.256
t = 0.112
C4
p = 0.215
p = 0.911
d = 0.110
d = 0.031
t = 1.994
t = -0.464
P3
p = 0.051
p = 0.645
d = 0.543
d = 0.126
t = 0.801
t = -1.777
P4
p = 0.427
p = 0.081
d = 0.218
d = 0.484
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Several electrodes exhibited medium effects sizes and may be of interest for future
research. In particular, mean amplitude in P3 showed a medium effect in response to
target sounds (t = 1.994, p = .051, d = .543) and in F3 showed a medium effect in
response to novel sounds (U = 244, p = .057, η2 = .070). For both electrodes mean
amplitude was larger in healthy controls than PWCS (and in fact PWCS showed negative
mean amplitude in P3).
Reliability in healthy controls
Historical. When examining the reliability of electrodes Fz, Cz, and Pz,
inadequate reliability was observed for all electrodes and variables in response to target
tones (Table 10). In contrast, moderate to good reliability for controls was observed in
response to novel tones. Moderate reliability of mean amplitude (ICC = .678) was seen
for Fz and good reliability was seen for Cz (ICC = .848) and Pz (ICC = .846).
Expanded. Similar to the historical electrodes, no electrodes in the expanded set
showed adequate reliability in response to target sounds. Moderate reliability was seen
for controls to novel sounds in F4 (ICC = .542), C4 (ICC = .675), P3 (ICC = .649), and
P4 (ICC = .610). Inadequate reliability was observed for controls in response to novel
tones in F3 and C3.
Reliability in PWCS
Historical. When examining the reliability of electrodes Fz, Cz, and Pz,
inadequate reliability was observed for all electrodes and variables in response to target
tones. For PWCS, moderate reliability in response to novel sounds was seen only for Fz
(ICC = .709) and Cz (ICC = .731).
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Table 10. Intra-class correlation coefficients for neurologically healthy controls and
persons with stroke during P3a. Moderate, good, and excellent reliability are shown.
Target
Novel
PWS
Con
PWS
Historical
.031
.678
.709
0-.347
.388-.846 .429-.864
.011
.848
.731
0-.376
.681-.931 .46-.877
.055
.846
.413
0-.41
.68-.93
.016-.697
Expanded
.006
.497
.775
0-.374
.128-.748 .551-.895
.012
.542
.721
0-.28
.199-.77 .386-.877
.410
.041
.415
.723
0-.701
0-.365
.021-.697 .464-.87
.023
.675
.763
0-.341
.388-.844 .518-.892
.005
.649
.820
0-.306
.349-.83 .632-.917
.031
.011
.610
.593
0-.302
0-.306
.276-.811 .258-.801
Con

Fz
Cz
Pz

F3
F4
C3
C4
P3
P4
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Expanded. PWCS demonstrated moderate to good reliability in all expanded
electrodes. Moderate reliability was demonstrated for F4 (ICC = .721), C3 (ICC = .723),
and P4 (ICC = .593). Good reliability was demonstrated for F3 (ICC = .775), C4 (ICC =
.763), and P3 (ICC = .820).
P3b
Descriptive statistics in healthy controls
Historical. See Appendix B (Tables B5-B8) for full P3b descriptive statistics.
For healthy controls, positive mean amplitude was observed in response to target and
novel sounds for Fz (1.334µV and 2.877µV, respectively), Cz (1.466µV and 1.265µV,
respectively), and Pz (2.72µV and .402µV, respectively).
Expanded. Controls demonstrated positive mean amplitude in response to target
sounds for all electrodes, ranging from 0.228µV (SD = 1.912) in F4 to 1.634µV (SD =
1.903) in P3. In response to novel sounds, controls demonstrated positive amplitudes in
F3, F4, C3, and C4 (ranging from 0.668µV, SD = 1.242 to 1.942µV, SD = 1.277).
Negative mean amplitudes were observed to novel sounds in P3 (-0.65µV, SD = 1.524)
and P4 (-0.403µV, SD = 1.512).
Descriptive statistics in PWCS
Historical. Positive mean amplitude in response to target and novel stimuli was
also observed for PWCS in Fz (1.044µV, SD = 1.850 and 1.891µV, SD = 2.215,
respectively), Cz (1.240µV, SD = 1.487 and 1.463, SD = 1.869µV, respectively), and Pz
(1.449µV, SD = 1.809 and 0.344µV, SD = 1.610, respectively).
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Expanded. Following the same pattern, positive mean amplitude in response to
target sounds was observed for all expanded electrodes and ranged from 0.135µV (SD =
2.238) to 0.885µV (SD = 1.950) in PWCS. Positive mean amplitude in response to novel
sounds was observed in all but one electrode, ranging from 0.018µV (SD = 1.462) in P4
to 1.606µV (SD = 1.829) in F3. A negative mean amplitude was observed in P3 (0.987µV, SD = 2.633).
Between group comparisons
Historical. No significant differences in mean amplitude survived correction for
multiple comparisons (Table 11). However, medium effects in mean amplitude were
seen in Pz (t = 2.404, p = .020, d = .654) to target tones and Fz (t = 1.918, p = .061, d =
.522) to novel tones. For both, healthy controls had a larger, positive mean amplitude
than PWCS.
Expanded. No significant differences in mean amplitude survived correction for
multiple comparisons in the expanded set. A medium effect was observed in P3 (t =
2.651, p = .011, d = .722) in response to target tones, and mean amplitude in P3 was
larger for healthy control than PWCS. No significant differences or medium to large
effect sizes were observed in response to novel sounds for mean amplitude.
Reliability in healthy controls
Historical. Cz and Pz demonstrated moderate reliability (Table 12) in response
to target and novel sounds (Cz: ICC = .538 and .588, respectively; Pz: ICC = .653 and
ICC = .635, respectively), while Fz demonstrated good reliability in response to target
tones only (ICC = .753).
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Table 11. Test statistic, p-value, and effect size for between group comparisons during
P3b. Comparisons that survived correction for multiple comparisons are bolded.
Comparisons that were not statistically significant but showed a medium or large effect
size are italicized.
Target
Novel
Historical
t = 0.524
t = 1.918
Fz
p = 0.603
p = 0.061
d = 0.143
d = 0.522
t = -0.091
t = -0.409
Cz
p = 0.928
p = 0.684
d = 0.025
d = 0.111
t = 2.404
t = 0.123
Pz
p = 0.020
p = 0.902
d = 0.654
d = 0.034
Expanded
t = 0.551
t = 0.773
F3
p = 0.584
p = 0.443
d = 0.151
d = 0.213
t = -0.973
t = 1.342
F4
p = 0.335
p = 0.185
d = 0.340
d = 0.365
t = 1.476
t = 0.541
C3
p = 0.146
p = 0.591
d = 0.402
d = 0.147
t = -1.488
t = 0.021
C4
p = 0.143
p = 0.983
d = 0.405
d = 0.006
t = 2.651
t = 0.575
P3
p = 0.011
p = 0.567
d = 0.722
d = 0.157
t = 1.531
t = -1.040
P4
p = 0.132
p = 0.303
d = 0.417
d = 0.283
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Table 12. Intra-class correlation coefficients for neurologically healthy controls and
persons with stroke during P3b. Moderate, good, and excellent reliability are shown.

Fz
Cz
Pz

Target
Novel
Con
PWS
Con
PWS
Historical
.753
.425
.497
.686
.510-.885

.056-.698

.132-.744

.395-.851

.538

.554

.588

.709

.187-.769

.187-.784

.249-.798

.442-.862

.653

.447

.635

.428

.343-.834

.063-.716

.317-.824

.04-.704

Expanded
F3
F4

.587

.661

-

-

.632

.605

.143

.711

.323-.82

.136-.829

0-.517

.445-.863

.247-.8

.355-.838

C3

.622

.389

.531

.504

.293-.818

0-.68

.163-.768

.135-.75

C4

.189

.525

.539

.592

0-.527

.169-.764

.185-.77

.259-.8

P3

.806

.390

.581

.837

.602-.911

.011-.676

.245-.794

.661-.926

P4

.575

.266

.470

.482

.24-.79

0-.601

.083-.732

.103-.738
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Expanded. Mean amplitude reliability in response to target tones was moderate to
good in all electrodes (ICC from .575 to .806) except C4 (ICC = .189). In contrast, only
moderate reliability of mean amplitude in response to novel tones was seen for C3 (ICC
=.531), C4 (ICC = .539), and P3 (ICC = .581).
Reliability in PWCS
Historical. PWCS demonstrated moderate reliability in Fz to novel sounds and
Cz to both target (ICC = .554) and novel sounds (ICC = .709).
Expanded. For PWCS, moderate reliability in response to target sounds was seen
in F4 (ICC = .605) and C4 (ICC = .525). Reliability was stronger for PWCS in response
to novel sounds, as moderate reliability was observed for F3 (ICC = .661), F4 (ICC =
.711), C3 (ICC = .504), and C4 (ICC = .592) and good reliability was observed for P3
(ICC = .837).
N150
Descriptive statistics in healthy controls
Spironelli and Angrilli. See Appendix B (Table B9-B14) for full N150
descriptive statistics. For healthy controls, negative mean amplitude was seen in the left
anterior (-0.459µV, SD = 1.429) and right anterior (-0.033µV, SD = 1.396) ROIs during
the orthographic task. During the phonological task, negative mean amplitude was also
seen for left anterior (-0.517µV, SD = 1.582) and right anterior (-0.265µV, SD = 1.627)
ROIs. The semantic task also showed negative mean amplitude in left anterior (-0.760µV,
SD = 1.488) and right anterior (-0.311µV, SD = 1.332) ROIs. Positive mean amplitude
was measured in left and right posterior ROIs, ranging from .164µV (SD = 2.020) in
orthographic to 3.676µV (SD = 2.256) in phonological.
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Expanded. When examining the expanded set of ROIs, healthy controls showed
negative mean amplitude during the orthographic task in left orbito-frontal, left anteromedial, left antero-lateral, right orbito-frontal, right antero-medial, and right anterolateral ROIs, ranging from -0.182µV (SD = 1.269) to -0.482µV (SD = 1.555). During the
phonological task, negative mean amplitude was observed in left and right orbito-frontal,
antero-medial, and antero-lateral ROIs, ranging from -0.327µV (SD = 1.080) to -0.606µV
(SD = 1.648). During the semantic task, negative mean amplitude followed the same
pattern as orthographic and phonological, with amplitude ranging from -0.265µV (SD =
1.162) to -0.732µV (SD = 1.570). Positive mean amplitude during the orthographic task
was seen in left postero-medial, left postero-lateral, left occipital, right postero-medial,
right postero-lateral, and right occipital ROIs ranging from 0.065µV (SD = 0.835) to
1.579µV (SD = 1.140). Positive mean amplitude during the phonological task was
observed in the same ROIs as in the orthographic, with amplitude ranging from 0.205µV
(SD = 0.841) to 1.759µV (SD = 1.269). Again, positive mean amplitude was observed in
the posterior left and right ROIs during the semantic task, ranging from 0.221µV (SD =
0.732) to 1.640µV (SD = 1.142).
Descriptive statistics in PWCS
Spironelli and Angrilli. In PWCS, negative mean amplitude was observed in left
anterior (-0.128µV, SD = 1.693) and right anterior (-0.279µV, SD = 1.427) ROIs during
the orthographic tasks. During the phonological task, negative amplitude was only seen
in left anterior (-0.593µV, SD = 1.838) and right anterior (-0.762µV, SD = 1.324) ROIs.
Again, for the semantic task, negative mean amplitude was seen only in the left (0.581µV, SD = 2.065) and right (-0.451µV, SD = 1.426) anterior ROIs. For PWCS,
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positive mean amplitudes ranged from 0.049µV (SD = 1.991) in orthographic to
4.289µV (SD = 1.775) in phonological.
Expanded. During the orthographic task in PWCS, negative mean amplitude was
observed for the left orbito-frontal, left antero-medial, left antero-lateral, right orbitofrontal, right antero-medial, and right antero-lateral ROIs, ranging from -0.044µV (SD =
1.374) to -0.357µV (SD = 1.569). During the phonological task, negative mean amplitude
in PWCS followed the same pattern as in controls - left and right orbito-frontal, anteromedial, and antero-lateral ROIs, although PWCS amplitude ranged from -0.441µV (SD =
1.179) to -0.967µV (SD = 1.445). During the semantic task, negative mean amplitude
was observed in left and right orbito-frontal, left and right antero-lateral, and left anteromedial ROIs, ranging from -0.109µV (SD = 1.212) to -0.619µV (SD = 1.859). Positive
mean amplitude ranging from .032µV (SD = 1.004) to 2.223µV (SD = 1.082) during the
orthographic task was seen in left antero-medial, left postero-medial, left postero-lateral,
left occipital, right postero-medial, right postero-lateral, and right occipital ROIs. Positive
mean amplitude during the phonological task ranged from 0.231µV (SD = 0.837) to
2.631µV (SD = 1.071) in left and right postero-medial, left and right postero-lateral, and
left and right occipital ROIs. Finally, during the semantic task, positive mean amplitude
was seen in right antero-medial, left and right postero-medial, left and right posterolateral, and left and right occipital ROIs, ranging from 0.005µV (SD = 1.515) to 2.149µV
(SD = 1.284).
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Between group comparisons
Spironelli and Angrilli. No significant differences in mean amplitude between
controls and PWCS were observed for the left and right anterior and posterior ROIs
(Table 13). Further, no comparisons had moderate or large effect sizes.
Expanded. No significant differences survived correction for multiple
comparisons in the expanded ROI set. However, the left postero-lateral ROI
demonstrated medium effects during the orthographic (t = -2.112, p = 0.040, d = 0.580)
and semantic tasks (t = -2.708, p = .009, d = .743). Investigation of descriptive statistics
revealed that for both ROIs, PWCS had larger, positive mean amplitudes than healthy
controls.
Single electrodes. Effect sizes for the between-group comparison were calculated
for each electrode and task separately. No medium or large effect sizes were observed in
single electrodes during the orthographic and phonological tasks. Medium effect sizes
were observed in F3 (d = .711), FC5 (d = .509), F1 (d = .553), F5 (d = .515), and FC3 (d
= .573) during the semantic task.
Reliability in healthy controls
Spironelli and Angrilli. In healthy controls, during the orthographic task (Table
14), moderate reliability was seen in the left anterior (ICC = .661), right anterior (ICC =
.762), and right posterior (ICC = .589) ROIs. Excellent reliability was seen in the left
posterior ROI (ICC = .907). During the phonological task, moderate reliability was
observed in the right anterior (ICC = .655) and posterior (ICC = .525) ROIs, with good
reliability in the left posterior (ICC = .837) ROI. During the semantic task, moderate
reliability was again observed in the right hemisphere ROIs (ICC = .623, anterior;
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Table 13. Test statistic, p-value, and effect size for between group comparisons during
N150. Comparisons that survived correction for multiple comparisons are bolded.
Comparisons that were not statistically significant but showed a medium or large effect
size are italicized.
Orthographic Phonological
Spironelli & Angrilli ROIs

Left Anterior
Left Posterior
Right Anterior
Right Posterior

t = -0.748
p = 0.458
d = 0.211
t = 0.208
p = 0.836
d = 0.057
t = 0.615
p = 0.541
d = 0.174
t = -0.924
p = 0.360
d = 0.253

Semantic

t = -0.353
p = 0.726
d = 0.099
t = 0.338
p = 0.736
d = 0.093
t = 0.359
p = 0.721
d = 0.101
t = -0.365
p = 0.716
d = 0.100

t = 0.157
p = 0.876
d = 0.044
t = -0.314
p = 0.755
d = 0.086
t = 1.184
p = 0.242
d = 0.335
t = -1.103
p = 0.275
d = 0.302

t = -0.238
p = 0.813
d = 0.066
t = -1.051
p = 0.298
d = 0.289
t = -0.917
p = 0.365
d = 0.251
t = 0.824
p = 0.414
d = 0.227
t = -1.523
p = 0.134
d = 0.419
t = 0.543
p = 0.590
d = 0.150
t = 0.420
p = 0.677
d = 0.116
t = -0.725
p = 0.472
d = 0.200
t = -0.939
p = 0.352
d = 0.259
t = 1.137
p = 0.261
d = 0.314
t = 0.199
p = 0.843
d = 0.055
t = 0.538
p = 0.593
d = 0.147

t = 0.508
p = 0.613
d = 0.141
t = -0.030
p = 0.976
d = 0.008
t = -0.149
p = 0.882
d = 0.041
t = -0.111
p = 0.912
d = 0.030
t = -2.708
p = 0.009
d = 0.743
t = -0.115
p = 0.909
d = 0.032
t = 1.258
p = 0.214
d = 0.349
t = -0.023
p = 0.982
d = 0.006
t = 0.551
p = 0.584
d = 0.152
t = 0.069
p = 0.946
d = 0.019
t = -0.200
p = 0.842
d = 0.055
t = -0.139
p = 0.890
d = 0.038

Granular ROIs

Left Orbito-Frontal
Left Antero-Medial
Left Antero-Lateral
Left Postero-Medial
Left Postero-Lateral
Left Occipital
Right Orbito-Frontal
Right Antero-Medial
Right Antero-Lateral
Right Postero-Medial
Right Postero-Lateral
Right Occipital

t = -0.289
p = 0.774
d = 0.080
t = 0.112
p = 0.911
d = 0.031
t = -0.769
p = 0.445
d = 0.212
t = 0.131
p = 0.896
d = 0.036
t = -2.112
p = 0.040
d = 0.580
t = 0.106
p = 0.916
d = 0.029
t = 0.262
p = 0.794
d = 0.073
t = -0.009
p = 0.993
d = 0.002
t = -0.176
p = 0.861
d = 0.048
t = 0.978
p = 0.333
d = 0.269
t = -0.132
p = 0.895
d = 0.036
t = 0.089
p = 0.929
d = 0.024
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Table 14. Intra-class correlation coefficients for neurologically healthy controls and
persons with stroke during N150. Moderate, good, and excellent reliability are shown.
Orthographic
Phonological
Semantic
Control PWCS Control PWCS Control PWCS
Spironelli & Angrilli ROIs
Left Anterior
.661
.378
.433
.292
.798
.356-.84
0-.687
.033-.713
0-.641
.582-.909
Left Posterior
Right Anterior
Right Posterior
Left Orbito-Frontal

.907

.703

.837

.762

.887

.621

.795-.96

.422-.86

.658-.927

.529-.889

.752-.95

.292-.817

.762

.344

.655

.069

.623

.432

.509-.894

0-.664

.316-.845

0-.638

.267-.829

.039-.714

.589

.674

.525

.365

.583

.696

.225-.805

.376-.845

.168-.764

0-.664

.246-.797

.417-.856

.742
.485-.881

Left Antero-Medial
Left Antero-Lateral
Left Postero-Medial
Left Postero-Lateral
Left Occipital
Right Orbito-Frontal
Right Antero-Medial
Right Antero-Lateral
Right Postero-Medial
Right Postero-Lateral
Right Occipital

Granular ROIs
.401
.618
0-.694

.284-.818

.481

.831

.364

.09-.742

.644-.924

0-.671

.759

.736

.593

.499

.747

.573

.515-.89

.476-.877

.257-.803

.141-.745

.488-.885

.229-.79

.661

.413

.601

.196

.638

.424

.329-.844

.011-.697

.262-.809

0-.547

.308-.829

.052-.698

.758

.351

.613

.687

.372

.509-.89

0-.658

.279-.815

.4-.853

0-.672

-

.778

.614

.614

.556

.534

.496

.55-.899

.294-.811

.277-.816

.218-.778

.156-.773

.116-.747

.889

.757

.833

.818

.894

.728

.757-.952

.515-.887

.646-.926

.627-.916

.766-.953

.464-.873

.828

.266

.798

.194

.734

.479

.641-.923

0-.609

.583-.909

0-.552

.467-.878

.109-.737

.751

.636

.763

.458

.718

.653

.494-.887

.315-.825

.522-.892

.097-.718

.439-.871

.345-.834

.733

.341

.670

.466-.878

0-.652

.36-.846

-

.582

.441

.241-.797

.057-.712

.731

.571

.704

.463

.768

.465

.466-.876

.22-.79

.424-.862

.1-.722

.527-.895

.08-.728

.826

.758

.736

.764

.715

.718

.637-.922

.514-.888

.469-.879

.534-.89

.435-.869

.455-.866

.907

.720

.874

.681

.836

.759

.787-.96

.458-.868

.725-.944

.397-.847

.655-.927

.523-.887

87
ICC = .583, posterior), while good reliability was observed in the left hemisphere ROIs
(ICC = .798, anterior; ICC = .887, posterior). Overall, the left posterior ROI showed the
strongest reliability.
Expanded. During the orthographic task, moderate reliability (ICC ranging from
.661 to .742) was observed in left orbito-frontal, left antero-lateral, right antero-lateral,
and right postero-medial ROIs. Good reliability (ICC ranging from .751 to .889) was
observed in left antero-medial, left postero-medial, left postero-lateral, left occipital, right
orbito-frontal, right antero-medial, and right postero-lateral ROIs. Finally, excellent
reliability (ICC = .907) was observed in the right occipital ROI. During the phonological
task, moderate reliability (ICC ranging from .601 to .736) was observed in the left orbitofrontal, left antero-medial, left antero-lateral, left postero-medial, left postero-lateral,
right antero-lateral, right postero-medial, and right postero-lateral ROIs. Good reliability
(ICC ranging from .763 to .874) was observed in left occipital, right orbito-frontal, right
antero-medial and right occipital ROIs. During the semantic task, moderate reliability
(ICC ranging from .534 to .747) was observed in left antero-medial, left antero-lateral,
left postero-medial, left postero-lateral, right orbito-frontal, right antero-medial, right
anter-lateral, and right postero-lateral ROIs. Good reliability (ICC ranging from .768 to
.894) was observed in left orbito-frontal, left occipital, right postero-medial, and right
occipital ROIs. Across all tasks, the right occipital ROI, followed by the left posterolateral ROI, showed the strongest reliability.
Reliability in PWCS
Spironelli and Angrilli. During the orthographic task, PWCS demonstrated
moderate reliability in the left (ICC = .703) and right (ICC = .674) posterior ROIs.
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During the phonological task, good reliability was seen only for the left posterior ROI
(ICC = .762). During the semantic task, moderate reliability was observed for the left
(ICC = .621) and right (ICC = .696) posterior ROIs. Similar to controls, the left posterior
ROI showed the strongest reliability for PWCS.
Expanded. During the orthographic task, moderate reliability (ICC ranging from
.571 to .736) was observed in the left antero-medial, left postero-lateral, right anteromedial, right postero-medial, and right occipital ROIs. Good reliability was observed
only in the right postero-lateral ROI (ICC = .758). During the phonological task,
moderate reliability was observed in the left postero-lateral (ICC = .556) and right
occipital (ICC = .681) ROIs. Good reliability was observed in the left occipital (ICC =
.818) and right postero-lateral (ICC = .764) ROIs. During the semantic task, moderate
reliability (ICC ranging from .573 to .728) was observed in left antero-medial, left
occipital, right antero-medial, and right postero-lateral ROIs.
N350
Descriptive statistics in healthy controls
Spironelli and Angrilli. See Appendix B (Table B15-B20) for full N350
descriptive statistics. In healthy controls during the orthographic task, mean amplitude
was negative in the left anterior (-0.539µV, SD = 1.398) and right anterior (-0.653µV, SD
= 1.229) ROIs and positive in the left posterior (0.070µV, SD = 1.286) and right posterior
(2.992µV, SD = 1.787) ROIs. During the phonological task, negative mean amplitude
was observed in left anterior (-0.660µV, SD = 1.154) and right anterior (-0.883µV, SD =
1.178) ROIs, while positive mean amplitude was observed in left posterior (0.240µV, SD
= 1.139) and right posterior (3.380µV, SD = 1.648) ROIs. The semantic task has the
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same pattern, where left anterior (-0.561µV, SD = 0.857) and right anterior (-0.721µV,
SD = 0.939) ROIs showed negative and left posterior (0.094µV, SD = 1.236) and right
posterior (3.362µV, SD = 1.691) ROIs showed positive mean amplitude.
Expanded. For healthy controls, negative mean amplitude was observed during
the orthographic task in left orbito-frontal, left occipital, right orbito-frontal, right anteromedial, right antero-lateral, right postero-lateral, and right occipital ROIs with values
ranging from -0.134µV (SD = 1.672) to -.773µV (SD = 1.293). During the orthographic
task, mean amplitude was positive in left antero-medial, left antero-lateral, left posteromedial, left postero-lateral, and right postero-medial with values ranging from 0.008µV
(SD = 0.766) and 1.625µV (SD = 0.954). During the phonological task, negative mean
amplitude was observed in left orbito-frontal, left antero-medial, left antero-lateral, right
orbito-frontal, right antero-medial, and right antero-lateral ROIs (from -0.118µV, SD =
0.812 to -1.023µV, SD = 1.160) while positive mean amplitude was observed in left
postero-medial, left postero-lateral, left occipital, right postero-medial, right posterolateral, and right occipital ROIs ranging from 0.110µV (SD = 0.924) to 1.586µV (SD =
0.934). During the semantic task, negative mean amplitude ranged from -0.026µV (SD =
1.572) to -0.874µV (SD = 0.922) in left orbito-frontal, left antero-medial, left anterolateral, left occipital, right orbito-frontal, right antero-medial, and right antero-lateral.
Positive mean amplitude during the semantic task, ranging from 0.058µV (SD = 0.966) to
1.481µV (SD = 1.067), was observed in left postero-medial, left postero-lateral, right
postero-medial, right postero-lateral, and right occipital.
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Descriptive statistics in PWCS
Spironelli and Angrilli. In PWCS during the orthographic task, mean amplitude
was negative in the left anterior (-0.039µV, SD = 1.149) and right anterior (-0.667µV, SD
= 1.493) ROIs while mean amplitude was positive in left posterior (0.324µV, SD =
1.572) and right posterior (3.905µV, SD = 1.167) ROIs. During the phonological task,
mean amplitude was negative only in the left posterior ROI (-0.676µV, SD = 2.113).
Positive mean amplitude in left anterior, right anterior and right posterior ROIs during the
phonological task ranged from 0.200µV, (SD = 1.334) to 3.275µV (SD = 1.558). Mean
amplitude during the semantic task was negative in left (-0.559µV, SD = 1.597) and right
(-0.745µV, SD = 1.108) anterior ROIs and positive in left (0.584µV, SD = 1.551) and
right (4.122µV, SD = 1.242) posterior ROIs.
Expanded. For PWCS, negative mean amplitude was observed during the
orthographic task in left orbito-frontal, left antero-medial, right orbito-frontal, right
antero-medial, and right antero-lateral ROIs ranging from -0.168µV (SD = 0.895) to 0.517µV (SD = 1.533). Positive mean amplitude during the orthographic task was seen
in left antero-lateral, left postero-medial, left postero-lateral, left occipital, right posteromedial, right postero-lateral, and right occipital ROIs ranging from 0.148µV (SD =
1.136) to 2.212µV (SD = 1.636). During the phonological task, negative mean amplitude
ranged from -0.055µV (SD = 1.308) to -0.721µV (SD = 2.442) in left orbito-frontal, left
occipital, right orbito-frontal, right postero-latral, and right occipital ROIs while positive
amplitude ranged from 0.033µV (SD = 1.220) to 1.785µV (SD = 1.266) in left anteromedial, left antero-lateral, left postero-medial, left postero-lateral, right antero-medial,
right antero-lateral, and right postero-medial. Finally, during the semantic task, negative
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mean amplitude ranged from -0.229µV (SD = 1.452) to -0.897µV (SD = 1.219) in left
orbito-frontal, left antero-medial, left antero-lateral, right orbito-frontal, right anteromedial, and right antero-lateral ROIs while positive mean amplitude ranged from
0.238µV (SD = 0.791) to 2.234µV (SD = 1.642) in left postero-medial, left posterolateral, left occipital, right postero-medial, right postero-lateral, and right occipital.
Between group comparisons
Spironelli and Angrilli. No significant differences in mean amplitude were
observed between controls and PWCS (Table 15). Additionally, no comparisons
exhibited medium to large effect sizes.
Expanded. Again, no significant differences were observed between controls and
PWCS in the expanded ROI list. Comparisons with medium effect sizes were observed in
orthographic left orbito-frontal (t = 2.183, p = .034, d = 0.601) and phonological left
postero-medial (t = 2.279, p = .027, d = .627) mean amplitude. Inspection of descriptive
statistics revealed that controls had a more negative mean amplitude in the left orbitofrontal ROI and a more positive mean amplitude in the left postero-medial ROI than
PWCS.
Single electrodes. A large effect was observed during the orthographic task in
C3 (d = .954). In addition, medium effects were observed during the orthographic task in
CP1 (d = .614), O2 (d = .524), P8 (d = .613), CP2 (d = .564), C1 (d = .582), CP3 (d =
.739), P1 (d = .504), PO8 (d = .516). During the phonological task, medium effects in
single electrodes were seen in CP1 (d = .611), P1 (d = .501), P2 (d = .526), POz (d =
.513), and CPz (d = .506). During the semantic task, a single medium effect was observed
in O2 (d = .5).
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Table 15. Test statistic, p-value, and effect size for between group comparisons during
N350. Comparisons that survived correction for multiple comparisons are bolded.
Comparisons that were not statistically significant but showed a medium or large effect
size are italicized.

Left Anterior
Left Posterior
Right Anterior
Right Posterior

Left Orbito-Frontal
Left Antero-Medial
Left Antero-Lateral
Left Postero-Medial
Left Postero-Lateral
Left Occipital
Right Orbito-Frontal
Right Antero-Medial
Right Antero-Lateral
Right Postero-Medial
Right Postero-Lateral
Right Occipital

Orthographic
Phonological
Spironelli & Angrilli ROIs
t = 0.767
t = -1.378
p = 0.447
p = 0.175
d = 0.211
d = 0.388
t = -0.283
t = -0.712
p = 0.779
p = 0.480
d = 0.078
d = 0.196
t = 0.734
t = -0.552
p = 0.466
p = 0.583
d = 0.203
d = 0.156
U = 316
U = 314
p = 0.533
p = 0.510
η2 = 0.007
η2 = 0.008
Granular ROIs
t = 2.183
t = -0.691
p = 0.034
p = 0.493
d = 0.601
d = 0.192
t = 0.226
t = 0.675
p = 0.822
p = 0.503
d = 0.062
d = 0.186
t = -1.178
t = -0.412
p = 0.244
p = 0.682
d = 0.324
d = 0.114
t = -0.044
t = 2.279
p = 0.965
p = 0.027
d = 0.012
d = 0.627
U = 339
t = -0.054
p = 0.831
p = 0.957
η2 = 0.001
d = 0.015
t = -0.633
t = -1.412
p = 0.529
p = 0.164
d = 0.174
d = 0.389
t = -0.034
t = -0.930
p = 0.973
p = 0.357
d = 0.009
d = 0.258
t = -1.481
t = 1.193
p = 0.145
p = 0.239
d = 0.408
d = 0.329
t = -1.744
t = 0.664
p = 0.087
p = 0.510
d = 0.479
d = 0.183
t = -0.269
t = -0.269
p = 0.789
p = 0.789
d = 0.074
d = 0.074
t = 0.352
t = -1.047
p = 0.726
p = 0.300
d = 0.289
d = 0.289
t = 0.441
t = -1.694
p = 0.661
p = 0.096
d = 0.465
d = 0.465

Semantic
t = -0.007
p = 0.994
d = 0.002
t = -1.269
p = 0.210
d = 0.349
t = 0.081
p = 0.936
d = 0.023
U = 278
p = 0.194
η2 = 0.032
t = 0.667
p = 0.508
d = 0.185
t = 0.981
p = 0.331
d = 0.270
U = 275
p = 0.176
η2 = 0.035
t = 0.849
p = 0.400
d = 0.233
t = -0.484
p = 0.631
d = 0.134
t = -1.426
p = 0.160
d = 0.392
t = 0.075
p = 0.940
d = 0.021
t = 1.301
p = 0.199
d = 0.358
t = 0.621
p = 0.538
d = 0.171
t = -0.031
p = 0.975
d = 0.008
t = -1.077
p = 0.287
d = 0.297
t = -1.495
p = 0.141
d =0.411
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Reliability in healthy controls
Spironelli and Angrilli. In healthy controls, moderate-good reliability (Table 16)
was observed for mean amplitude in left anterior (orthographic and phonological tasks),
left posterior (all tasks), and right anterior (semantic task) ROIs.
Expanded. Test-retest reliability of mean amplitude in all ROIs for healthy
controls during orthographic, phonological, and semantic tasks ranged from poor to
good. Moderate reliability was most frequently observed (18/36 correlations), ranging
from .503 in semantic right postero-lateral ROI to .745 in orthographic left antero-medial
ROI. Fifteen out of 36 correlations for mean amplitude showed good reliability, ranging
from .754 (semantic left occipital) to .866 (semantic left postero-lateral). The ROI with
the strongest reliability for mean amplitude was left postero-medial.
Reliability in PWCS
Spironelli and Angrilli. Adequate reliability was only seen in the left and right
posterior ROI for PWCS. Moderate reliability was observed during the phonological task
(ICC = .731) in the left posterior ROI. Good reliability was seen during the orthographic
task in left posterior (ICC = .887) semantic task in left posterior (ICC = .772), and
semantic task in right posterior (ICC = .755) ROIs.
Expanded. PWCS in general demonstrated poorer reliability of mean amplitude
than healthy controls. Two correlations (phonological left orbito-frontal and phonological
right antero-lateral) were not significant, and an additional nine correlations demonstrated
poor reliability. Moderate reliability was observed for 11 correlations (ranging from .511
in semantic right orbito-frontal to .71 in semantic right antero-medial). Good reliability
was observed for 13 correlations, ranging from .762 (phonological right occipital) to .89
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Table 16. Intra-class correlation coefficients for neurologically healthy controls and
persons with stroke during N350. Moderate, good, and excellent reliability are shown.
Orthographic
Phonological
Semantic
Control PWS Control PWS Control PWS
Spironelli & Angrilli ROIs
.518
.089
.505
.232
.486
.254
Left Anterior
.159-.757
0-.507
.146-.749
0-.587
.107-.741
0-.624
Left Posterior

.721

.887

.875

.731

.752

.772

.453-.869

.755-.95

.733-.944

.464-.876

.51-.884

.538-.896

Right Anterior

.408

.354

.462

.253

.555

.266

0-.702

0-.679

.056-.736

0-.616

.193-.786

0-.621

Right Posterior

0-.413

-

0-.475

-

-

.506-.888

.032

.470

.102

Granular ROIs
.540
.530

.755

.329

.434

.461

0-.65

.053-.707

.05-.736

Left Orbito-Frontal

.083-.732

Left Antero-Medial

.745

.773

.828

.662

.820

.756

.5-.881

.535-.897

.644-.922

.351-.841

.632-.918

.503-.889

Left Antero-Lateral

.755

.356

.581

.477

.713

.436

.517-.885

0-.666

.252-.792

.094-.738

.441-.865

.037-.715

Left Postero-Medial

.853

.598

.836

.426

.866

.675

.692-.934

.25-.808

.656-.926

.039-.705

.713-.94

.369-.848

Left Postero-Lateral

.773

.857

.861

.858

.680

.839

.542-.896

.696-.937

.709-.937

.695-.937

.386-.849

.661-.928

.626

.890

.775

.556

.754

.655

.305-.819

.763-.952

.547-.896

.188-.785

.516-.885

.347-.836

Left Occipital
Right Orbito-Frontal
Right Antero-Medial
Right Antero-Lateral
Right Postero-Medial
Right Postero-Lateral
Right Occipital

.163-.78

.177-.764

.512

.550

.606

.461

.574

.511

.137-.757

.172-.786

.28-.808

.047-.737

.229-.791

.114-.765

.741

.667

.778

.498

.733

.710

.485-.88

.364-.843

.555-.897

.111-.752

.463-.877

.435-.865

.679

.462

.744

.260

.786

.408

.383-.848

.06-.732

.491-.881

0-.606

.56-.902

.001-.699

.851

.617

.557

.785

.717

.683

.672-.934

.278-.818

.22-.779

.554-.903

.448-.867

.389-.851

.407

.883

.717

.793

.503

.777

.018-.69

.744-.948

.447-.867

.57-.907

.136-.75

.545-.899

.599

.827

.787

.762

.820

.841

.265-.804

.625-.924

.567-.902

.52-.891

.609-.92

.661-.93
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(orthographic left occipital). Mean amplitude in the left postero-lateral ROI had the most
consistently high reliability. For PWCS, only a single correlation showed moderate
reliability - left occipital during the orthographic task.
Discussion
This study investigated changes in cognitive and language ERP components in
persons with chronic stroke of mixed hemisphericity and behavioral impairments. In our
sample of 27 healthy controls and 27 persons with chronic stroke, statistically significant
differences were observed in mean amplitude for the P3a component only. However,
comparisons with medium to large effects were seen in all four components. Acceptable
stability was found for mean amplitude in each component, although the specific
electrodes and ROIs varied.
Attention ERPs
In healthy controls in the P3a window, we found larger positive amplitudes in
frontal electrodes in response to novel sounds than in response to target sounds (Figure
8). Amplitude in frontal and central electrodes was highest in the midline. Amplitude
decreased compared to frontal electrodes, but was still positive in central electrodes, and
decreased and became negative in posterior electrodes. This distribution matches the
typical P3a reported in the literature and provides confirmation that healthy controls were
complying with the task. In PWCS, the same pattern of positive mean amplitude values
was observed in frontal electrodes, with greater amplitude in response to novel sounds
than target sounds. Mean amplitude was largest in midline electrodes and also
demonstrated decrements from frontal to central to posterior electrodes as described for
controls. The significant reduction in mean amplitude to novel sounds observed in Fz
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Figure 8. Topographic maps of activation during the P3a in healthy controls and PWCS.

confirms that PWCS continue to exhibit changes in the P3a well into the chronic phase of
recovery. Additionally, the medium effect in F3 suggests that the typically bilateral
activation observed in the P3a may continue to be altered in chronic stroke.

97
In healthy controls during the P3b window (Figure 9), we found larger positive
amplitudes in posterior electrodes in response to target sounds as compared to novel
sounds. Amplitude was greater in midline electrodes than left or right electrodes. In
addition, left hemisphere electrodes had numerically larger values than right hemisphere
values, although no comparisons were run to determine if these differences were
statistically significant. Amplitude was largest in posterior electrodes, then central
Figure 9. Topographic maps of activation during the P3b in healthy controls and PWCS.
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electrodes, with the smallest values observed in frontal electrodes, although mean
amplitude remained positive. These results are consistent with the typical P3b reported in
the literature. In PWCS, mean amplitude was larger in posterior electrodes in response to
target compared to novel sounds. Midline electrodes also displayed larger mean
amplitude than lateral electrodes. However, while mean amplitude in midline electrodes
decreased from posterior to anterior, the opposite pattern was observed in left and right
lateralized electrodes, with amplitude increasing posterior to anterior. Additionally, mean
amplitude in left hemisphere electrodes was numerically smaller than in right hemisphere
electrodes, although again no statistical comparisons were conducted. The reduction of
mean amplitude to target sounds observed in electrode Pz suggests that PWCS may
continue to exhibit changes in the P3b well into the chronic phase of recovery.
Additionally, the medium effect in electrode P3 suggests that PWCS also have a
reduction in posterior left hemisphere activation compared to controls.
Although our investigation did not yield a large number of statistically significant
results, those we did observe provide support for two major conclusions. First, use of a
three stimuli oddball paradigm is sufficiently sensitive to identify changes in individuals
post-stroke in a sample with varying stroke characteristics and behavioral impairments.
Second, the P300 ERP complex continues to be altered in individuals who are years, and
in some instances, decades post-stroke (consistent with Dejanovic et al., 2015). This
neurophysiological finding is also consistent with behavioral reports of chronic attention
deficits post-stroke (Barker-Collo et al., 2010; Hyndman & Ashburn, 2003) which
negatively impact function (McDowd et al., 2003). Future research should investigate
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whether ERP measurement of attention via the P300 component is more sensitive to
deficits than traditional behavioral measures.
Language ERPs
Examination of mean amplitude in healthy controls and PWCS in the N150
window (Figure 10) revealed negative amplitudes across anterior ROIs and positive
amplitudes across posterior ROIs in both the Spironelli and Angrilli and expanded set.
This is not consistent with previous research which has reported a posterior distribution
of the N150 (Spironelli & Angrilli, 2015). Although we selected the time window for
investigation in this study based on Spironelli and Angrilli’s report where N150 peaked
130-150ms after stimulus onset, peak latency can be unstable (Spencer, 2005), and this
window may not have adequately reflected the N150 latency of the populations included
here. Indeed, after examining the brain activation in healthy controls during the language
Figure 10. Topographic maps of activation during the N150 in healthy controls and
PWCS.
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tasks, it appears that the N150 peak in our population may appear slightly later: from
~140ms to ~170ms. Our results provide important evidence that the N150 may occur
across a wider timeframe in both controls and PWCS than was previously reported by
Spironelli and Angrilli.
In contrast to the N150 results, examination of mean amplitude in healthy controls
in the N350 window (Figure 11) did reflect the expected, generally anterior, distribution
of this component (Spironelli & Angrilli, 2015). Completion of the orthographic task
yielded a more distributed pattern of activation across anterior and posterior ROIs, with
numerically greater activation in right hemisphere ROIs than left. Both the phonological
and semantic tasks demonstrated similar patterns of activation, with negative mean
amplitudes restricted to right and left anterior ROIs (except the left occipital ROI in
semantic, which also had a negative mean amplitude). For both tasks, orbito-frontal ROIs
demonstrated the largest mean amplitudes (numerically larger on the left than right).
Figure 11. Topographic maps of activation during the N350 in healthy controls and
PWCS.
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Lateralization of activation in all three tasks differs from previously reported. We report
numerically larger mean amplitude in right hemisphere ROIs in healthy controls for all
tasks as opposed to the left. However, the topographic distribution of activation for the
orthographic and semantic tasks is generally consistent between the studies. Mean
amplitude of the N350 in PWCS during the orthographic task was negative in left and
right anterior ROIs, but not in right hemisphere posterior ROIs. During the phonological
task, PWCS had negative mean amplitudes in left and right orbito-frontal ROIs, and also
had negative mean amplitude in several left and right posterior ROIs. The largest
negative mean amplitudes were observed in the left and right posterior ROIs, rather than
the anterior ROIs. Finally, during the semantic task, PWCS demonstrated negative mean
amplitudes in left and right frontal ROIs, with amplitude larger in the right hemisphere
than left. Similar to healthy controls, our lateralization (and topographic distributions)
results differ from those previously reported.
There are some key differences between our study and Spironelli and Angrilli that
may contribute to our different findings. First, with regard to the lack of significant
differences between groups, and the descriptive differences in amplitude and distribution
for PWCS, the characteristics of our stroke population diverge sharply from that enrolled
in Spironelli and Angrilli’s study. We included individuals with left and right hemisphere
strokes and different behavioral deficits because we were interested in whether a
cognitive-linguistic task might be sensitive to changes in both language and underlying
cognitive processes. These results indicate that the N350 may be of marginal use in a
mixed sample and may only be appropriate when variability is reduced along some
factor. We also report findings for healthy controls that differ from previous reports. One
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possible explanation is that Spironelli and Angrilli studied these components in
individuals who are speakers of Italian. It is possible that differences in the transparency
of written linguistic features differs between the two languages. For example, English
orthography has a much more opaque mapping onto phonology than does Italian
orthography onto phonology (Seymour, Aro, & Erskine, 2003), which may result in
different patterns of neural activation for reading. In addition, participants in this study
viewed each word for a longer period of time, which may have changed the strategy by
which participants completed the task. Research in fMRI reveals that reading in English
speakers, and differential timing of stimulus presentation for reading, results in activation
of a wide array of bilateral areas, with some exhibiting sensitivity to differences in timing
(Mechelli, Friston, & Price, 2000).
Stability of Mean Amplitude
Investigation of the stability of mean amplitude over time in the selected cognitive
and language components revealed differing patterns of reliability. Historical and
expanded electrodes showed some evidence of a task-specific reliability response in P3a,
as adequate reliability for controls was observed in response to novel, but not target,
sounds in P3a. PWCS demonstrated this task specificity in the historical electrodes, but
not in the expanded set. In contrast, task specificity was not observed for either group for
the P3b. In the N150 window used here, controls generally demonstrated better reliability
than PWCS. However, given the uncertainty around whether this time frame actually
captured the N150 ERP component in our study, it is difficult to interpret this in a
meaningful way. Finally, during the N350 window, moderate to good reliability was
observed in many ROIs in both controls and PWCS. Our results indicate that mean
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amplitude exhibits adequate reliability for use over time in these components, although
care should be taken when selecting specific electrodes or ROIs.
Variability Post-Stroke
In this sample, we observed very large standard deviations relative to the mean
(often double or greater) for both healthy controls and PWCS. This within-group and
within-individual variability likely contributed greatly to the lack of statistically
significant differences in the study, and, in some instances, inadequate reliability. While
variability due to broad inclusion criteria reduced power here, it was necessary to include
individuals with a wide range of stroke deficits. Providing normative information
regarding the general stroke population allows future comparisons to be made when
investigations are limited to a single behavioral deficit, or when investigating the effects
of co-morbid impairments.
The variability observed in both individuals with aphasia and healthy controls
suggests that alternative analyses may need to be considered when investigating ERPs. In
particular, some method of quantifying variability, to see if it differs between groups and
could potentially identify group membership would be particularly useful (standard
deviation cannot be used in this manner, as it is dependent on the value of the mean). One
of the most commonly used measures of variability is the coefficient of variation;
however, it is not appropriate for use in data that contain both positive and negative
numbers, or for data that take values close to zero. There are several other measures of
variability currently available (e.g., median absolute deviation, maximum absolute
deviation, entropy) that may be more appropriate for ERP data and should be investigated
in future research. In fact, some recent investigations have posited that variability in
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neural activation indexes a system’s capacity for processing information, with greater
variability relating to greater capacity. A recent EEG study in traumatic brain injury
(TBI) reported reduced variability in comparison to controls (Beharelle, Kovacevic,
McIntosh, & Levine, 2012). This reduced variability was related to behavioral
performance on an attention task, where those with greater variability showed better
performance across both control and TBI groups. However, it is likely also the case that
once variability increases beyond a certain value, the positive relationship between
variability and behavioral performance fails to hold, after which point increasing
variability is maladaptive. Indeed, evidence for this switch is seen in individuals with
schizophrenia (e.g., Gallinat et al., 2003; Winterer et al., 2006). Further research is
needed to determine whether the increased variability reported in PWCS here is
consistent, varies with lesion severity, and/or corresponds to functional behavioral
performance. The P3a may be an ideal component for such investigations, as its
amplitude is strongly related to overall variability in the signal (e.g., Winterer et al.,
2003). This knowledge has the potential to greatly contribute to prognosis and treatment
prediction, as measuring frontal variability through P3a amplitude could be accomplished
in approximately 10 minutes with a small electrode montage that would be clinically
feasible.
Future Directions and Conclusion
The results and limitations reported here, combined with previous research,
suggest several avenues of exploration for the future. First, it may be valuable to
investigate the N150 at a later latency to see if it is able to capture cognitive processing
that the N350 was not able to. In addition, the data reported here only investigate
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activation in response to the first word in a pair. This did not require participants to make
any decisions regarding the stimuli, and it may be that a higher task demand is required
before underlying cognitive processes can be observed during language tasks to elicit
cognitive-linguistic ERPs. In addition, the method of stimulus presentation may have an
impact on participants’ success in completing the behavioral tasks. In this study, as in
previous research (Spironelli & Angrilli, 2015), written words were presented on the
computer screen. However, many individuals post-stroke have some degree of reading
difficulty (alexia), particularly if they experienced a more posterior stroke (and most
individuals in the Spironelli & Angrilli sample had frontal strokes). Research
investigating the effects of stimulus presentation modality could reveal cognitivelinguistic competencies that might otherwise be difficult to detect.
Second, an important feature of the P300 was not investigated in this study.
Previous research has reported a very clear age effect whereby P300 latency increases as
age increases. We did not consider age in this study because our participant groups were
matched on age, so any age-related pattern was expected be present in both groups and
therefore would be washed out during analysis. However, the wide age range included in
the study may have also contributed to our lack of significant findings. Including a large
age range would have a smearing effect on the distribution of the P3 peak, as some
healthy controls would be likely to have earlier peaks while others would be more likely
to display later peaks. The net effect would be a reduction in peak amplitude and a
widening of the tails of the distribution, thereby increasing standard deviation. Future
research may benefit from limiting inclusion criteria to a specific age range (although this
would also limit generalizability) or dividing participants into age bins. In addition,
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research in the future should examine whether individuals post-stroke demonstrate the
same pattern of age effects as healthy controls, or if the presence of stroke disrupts
amplitude and latency to such an extent that normal aging effects are no longer
observable.
Finally, and perhaps most importantly, our results provide a characterization of
the changes in cognitive ERPs in a broad stroke sample, which was previously lacking in
the chronic phase. This characterization will allow future studies to become progressively
more fine-grained by providing a stroke baseline for comparison. For example, much
research is needed to characterize changes as a result of single versus co-morbid deficits.
It is currently unknown how increasing numbers of deficits are reflected in the magnitude
of change in brain activation. These factors may be linearly related such that, as
successive impairments are loaded onto an individual, brain activation changes by a set
amount each time. However, and potentially more likely due to the complexity of the
neural system, brain activation may change in an exponential manner where each
additional deficit causes an increasingly large change in brain activation (these are not the
only possible relationships but are used as examples). Understanding how the presence,
number, and degree of impairment impacts brain activity, and therefore functional
performance, will be a critical step in improving rehabilitation. Combining this
information with current knowledge regarding lesion anatomy (such as site and size) will
also be valuable and may provide better insight into the intact brain’s role in recovery.
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Chapter 4
Shared Discussion
As discussed in Chapter 1, there is currently no consensus on the optimal pattern
of recovery following a stroke. Many studies have reported greater recovery and better
functional outcomes when perilesional regions responsible for processing specific
information prior to a stroke continue to be recruited for that processing after the stroke
(e.g., Burke Quinlan et al., 2014; Naeser et al., 2005; Postman-Caucheteux, 2010; Rosen
et al., 2000; Saur et al., 2006). However, some studies have also demonstrated better
recovery when contralesional areas, rather than perilesional, are recruited (e.g., Burke &
Cramer, 2013; Schlaug, Marchina, & Norton, 2008). Contributing to the lack of
consensus regarding optimal recovery is a dearth of sensitive measures that directly index
brain activation. While MRI can provide important information about the structure and
function of the brain, brain activation is inferred from changes in blood flow rather than
directly measured. This is warranted in healthy control populations, as the relationship
between oxygen and glucose consumption and resultant increases in blood flow are well
described. However, the canonical patterns of blood flow response are altered in
individuals with stroke, making inferences about brain activation less certain. EEG has
been widely used to investigate brain activation and changes after stroke, and as a direct
measure of the electrical activation of neural populations, it has great potential to serve as
a marker of biophysiological function. While previous research has demonstrated
changes in both sEEG and ERP in the acute and sub-acute phases following stroke
(Finnigan & van Putten, 2013; Hernandez, 2015; Monge-Pereira et al., 2017), relatively
few reports have investigated changes that persist into the chronic phase. The results
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reported here extend our understanding of how sEEG and ERP measures are altered in
the chronic phase following stroke and provide evidence that EEG variables may
continue to be potential biomarkers years and decades after a stroke.
Establishing Normative Data
One of the primary goals of this research was to establish preliminary normative
values for power and mean amplitude in healthy controls and a population of individuals
who exhibited a wide range of stroke and behavioral impairment characteristics. For both
manuscripts, we provide descriptive statistics that will allow readers to better evaluate the
raw data under analysis here and the appropriateness of the statistical methods utilized.
Previous research in both sEEG and ERP has generally lacked adequate reporting of
descriptive statistics, which makes it difficult to determine whether findings are
comparable across studies, and what the range of values for healthy controls or PWCS
might be for power and mean amplitude. We also report effect sizes in addition to test
statistics and p-values, in order to facilitate discussion of statistically significant versus
practically significant differences; keeping in mind that not all statistically significant
results equate to meaningful differences in performance or functional abilities. Finally,
we reported on the test-retest reliability, or stability, of sEEG and ERP measures over
time. Given that many researchers have used repeated sessions of sEEG or ERP to
evaluate functional recovery or assess response to treatment, the lack of reliability data on
these measures was a critical gap in the literature. For both EEG analyses we
demonstrated adequate reliability for use as repeated measures, although care must be
taken to ensure that the specific montages, electrodes, or ROIs of interest demonstrate
adequate reliability.
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In addition to facilitating comparisons with future research, we expect the
normative data reported for this broad stroke population will be used in investigations
that narrow the focus onto a specific deficit or constellation of deficits. To this end, we
also provided a detailed description of the number of motor, cognitive and language
impairments observed in our sample, as well as estimates of the severity of the various
impairments. Consistent with previous reports, most of our sample experienced deficits in
more than one domain, and several experienced deficits in all three domains. Given the
rich interconnectedness of the brain, it is important to consider how a lesion in one area
might impact multiple behavioral domains, and the data reported here provide a place to
start these investigations.
sEEG versus ERP Results
Significant differences in sEEG and ERP variables were observed in this sample.
During sEEG, relative delta and relative beta power showed clear patterns of difference
from healthy controls and moderate to excellent reliability, particularly for eyes closed
rest. During ERP, results of P300 also showed clear differences between PWCS and
healthy controls that was stimulus-specific and had moderate to good reliability. Results
for the N150 and N350 showed the fewest between-group differences, and generally
poorer reliability. Because power and mean amplitude of the P300 demonstrated more
consistent differences from controls, and also generally better reliability, they may be
more appropriate for investigations of biomarkers in the immediate future. However,
further research is needed to determine whether the N150, N350, or another ERP
component (or complex of components) might be able to measure different types of
cognitive ability in the same task (such as attention and language). Identifying a single
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paradigm that could provide useful information about multiple domains would decrease
the time required for assessment while potentially increasing prognostic accuracy.
EEG as a Marker of Target Engagement
One of the most frustrating aspects of neurorehabilitation for individuals, family
members, and therapists is the length of time required for significant gains to be
achieved. Interest in therapeutic adjuvants for post-stroke rehabilitation, such as noninvasive brain stimulation (e.g., Fridriksson et al., 2018) or pharmacology (e.g., Kessler,
Thiel, Karbe, & Heiss, 2000), to enhance recovery has gained ground due to the
intractable nature of chronic deficits. The goal of treatment adjuvants is to increase the
magnitude of behavioral treatments and/or reduce the time needed to achieve
improvements. Unfortunately, the limitations in our understanding of optimal recovery
patterns make it difficult to design theoretically motivated investigations. Additionally,
current studies have primarily used behavioral measures to determine the impact of
therapeutic adjuvants on functional outcomes. This is problematic given the host of
unanswered questions, particularly for non-invasive brain stimulation, regarding optimal
dosage parameters and targets. Without directly measuring how the brain is changing,
even or perhaps especially if those changes do not initially induce behavioral effects, it
will be difficult to determine appropriate dosing parameters and maximize the potential
benefits of adjuvants.
Identification of biomarkers may provide insights into the specific brain regions
that should be targeted for excitation or inhibition, which could then be applied generally
to behavioral rehabilitation strategies. For example, noninvasive brain stimulation has
been studied as a potential mechanism to improve aphasia rehabilitation (although we
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focus our discussion here on aphasia, this is also being studied in motor rehabilitation). In
these studies, excitatory transcranial direct current stimulation (tDCS) has almost
exclusively been applied to the left hemisphere. On the other hand, inhibitory transcranial
magnetic stimulation (TMS) is often applied to right hemisphere language homologues,
consistent with theories of interhemispheric inhibition. Results from these brain
stimulation studies are mixed. Inhibitory TMS to the right hemisphere consistently results
in language improvements (Otal et al., 2015), while a recent review of tDCS studies
determined there was no evidence of tDCS effectiveness beyond those seen with
behavioral therapy alone (Elsner et al., 2013; Sandars et al., 2015). Part of the divergence
in results is likely due to the mechanism of action of the two methods. TMS directly
activates the underlying cortex, inducing action potentials (or preventing action potentials
from firing). In contrast, tDCS alters the propensity of neurons to fire, but does not
actually cause them to fire directly (Nitsche & Paulus, 2000). For this reason, tDCS must
be paired with a behavioral task in order for long-term changes to be observed (e.g.,
Fritsch et al., 2010). Given the much subtler mechanism of tDCS action, biomarkers that
could identify positive changes in brain activation, such as sEEG power or ERP
amplitude, would provide researchers with measures to investigate the impact of dosage
parameters, while also assessing the engagement of hypothesized brain regions.
Currently, it is impossible to determine whether non-significant changes as a result of
tDCS are because it truly does not improve rehabilitation outcomes, because
inappropriate behavioral assessments are used to measure effects, and/or because the
targeted brain region has not been influenced. A handful of studies to date have utilized
EEG in this manner in healthy controls, individuals with stroke, and individuals with
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traumatic brain injury, to good effect (e.g., Barwood et al., 2011; Boonstra et al., 2016;
Ulam et al., 2015).
Conclusion
Millions of people around the world are living with chronic stroke-induced
impairments that negatively impact quality of life and life participation. While therapy
provided by speech-language pathologists, occupational therapists, and physical
therapists allow individuals to regain function following a stroke, recovery can be
painstakingly slow and frustrating, and complete restoration of abilities is rare. Advances
in neuroimaging techniques offer the promise of elucidating brain function and the neural
mechanisms behind observable behaviors. However, critical gaps in our understanding of
recovery following stroke persist. Each neuroimaging modality carries with it strengths
and weaknesses that limit the inferences we can draw. By combining multiple modalities
in research studies, we may be able to offset the technical weaknesses of each, allowing a
clearer picture of stroke recovery to emerge. To this end, EEG measures such as those
reported here should continue to be investigated and should be combined with other
frequently used imaging modalities such as MRI. Deepening our understanding of stroke
recovery has the potential to transform the way we provide rehabilitation services, with
the ultimate goal of helping more of our clients move even closer to pre-stroke levels of
functioning, participation, and life satisfaction.
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Appendix A
Table A1. Descriptive statistics for neurologically healthy controls during eyes open rest.
Mean
SD
Median
Range
Skew Kurtosis
Delta
Whole Brain
0.386
0.092
0.392
0.156 - 0.546 -0.617
0.587
Left Hemisphere
0.383
0.095
0.392
0.149 - 0.553 -0.534
0.922
Right Hemisphere
0.382
0.097
0.398
0.158 - 0.553 -0.441 -0.120
Anterior
0.405
0.096
0.395
0.186 - 0.626 -0.210
0.821
Posterior
0.372
0.095
0.387
0.140 - 0.519 -0.675
0.353
LH – Language
0.385
0.097
0.389
0.108 - 0.438 -0.770
1.455
RH – Language
0.372
0.101
0.388
0.165 - 0.557 -0.353 -0.665
Motor
0.395
0.094
0.413
0.140 - 0.627 -0.595
2.377
Cognitive
0.431
0.114
0.427
0.209 - 0.750 0.274
1.720
Clinical
0.380
0.090
0.392
0.153 - 0.515 -0.707
0.352
Theta
Whole Brain
0.114
0.025
0.119
0.062 - 0.149 -0.489 -0.656
Left Hemisphere
0.112
0.023
0.113
0.065 - 0.143 -0.421 -0.752
Right Hemisphere
0.113
0.027
0.116
0.057 - 0.152 -0.466 -0.801
Anterior
0.116
0.027
0.117
0.064 - 0.170 -0.306 -0.465
Posterior
0.113
0.026
0.112
0.062 - 0.169 -0.133 -0.245
LH – Language
0.105
0.024
0.116
0.055 - 0.152 -0.251 -0.444
RH – Language
0.106
0.028
0.106
0.061 - 0.150 -0.084 -1.129
Motor
0.125
0.033
0.130
0.063 - 0.189 -0.184 -0.130
Cognitive
0.110
0.029
0.113
0.045 - 0.153 -0.481 -0.491
Clinical
0.115
0.024
0.119
0.063 - 0.156 -0.261 -0.587
Alpha
Whole Brain
0.151
0.054
0.140
0.084 - 0.290 1.324
1.515
Left Hemisphere
0.151
0.055
0.139
0.086 - 0.297 1.332
1.718
Right Hemisphere
0.150
0.053
0.138
0.081 - 0.287 1.239
1.148
Anterior
0.137
0.045
0.127
0.082 - 0.179 1.152
1.076
Posterior
0.169
0.065
0.156
0.083 - 0.351 1.342
1.694
LH – Language
0.150
0.059
0.129
0.071 - 0.304 0.916
0.117
RH – Language
0.150
0.056
0.133
0.075 - 0.271 0.990
0.088
Motor
0.138
0.045
0.128
0.083 - 0.281 1.497
2.740
Cognitive
0.131
0.048
0.113
0.080 - 0.259 1.348
1.074
Clinical
0.154
0.057
0.138
0.082 - 0.293 1.348
1.204
Beta
Whole Brain
0.285
0.089
0.279
0.102 - 0.461 0.173
-0.476
Left Hemisphere
0.290
0.091
0.305
0.113 - 0.475 0.061
-0.505
Right Hemisphere
0.294
0.097
0.274
0.097 - 0.488 0.338
-0.365
Anterior
0.281
0.095
0.277
0.096 - 0.469 0.299
-0.489
Posterior
0.279
0.092
0.267
0.091 - 0.469 0.334
-0.131
LH – Language
0.295
0.086
0.316
0.145 - 0.333 0.080
-0.436
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RH – Language
Motor
Cognitive
Clinical

0.315
0.278
0.271
0.288

Whole Brain
Left Hemisphere
Right Hemisphere
Anterior
Posterior
LH – Language
RH – Language
Motor
Cognitive
Clinical

3.236
3.273
3.209
3.640
2.804
3.378
3.168
3.463
4.046
3.218

Whole Brain
Left Hemisphere
Right Hemisphere
Anterior
Posterior
LH – Language
RH – Language
Motor
Cognitive
Clinical

1.399
1.380
1.364
1.531
1.296
1.353
1.299
1.481
1.675
1.383

Whole Brain
Left Hemisphere
Right Hemisphere
Anterior
Posterior
LH – Language
RH – Language
Motor
Cognitive
Clinical

0.491
0.487
0.485
0.510
0.477
0.480
0.478
0.512
0.524
0.489

0.112
0.089
0.110
0.090

0.298
0.249
0.264
0.283
DAR
1.321
3.396
1.392
3.333
1.364
3.355
1.443
3.845
1.301
2.704
1.563
3.243
1.485
3.088
1.295
3.573
1.701
4.179
1.333
3.340
DTABR
0.601
1.338
0.633
1.238
0.604
1.344
0.700
1.373
0.573
1.318
0.629
1.250
0.624
1.251
0.587
1.517
0.911
1.516
0.592
1.300
Qslowing
0.106
0.510
0.105
0.488
0.112
0.501
0.112
0.523
0.109
0.479
0.107
0.493
0.115
0.498
0.108
0.542
0.124
0.535
0.106
0.512

0.124 - 0.570
0.074 - 0.506
0.069 - 0.557
0.119 - 0.459

0.468
0.495
0.562
0.236

-0.167
0.978
0.402
-0.657

0.701 - 5.503
0.589 - 6.263
0.852 - 5.531
0.856 - 6.362
0.568 - 5.929
0.498 - 6.482
0.901 - 6.428
0.763 - 5.832
1.011 - 7.817
0.692 - 5.457

-0.206
0.066
-0.251
-0.176
0.278
-0.068
0.131
-0.371
-0.078
-0.216

-0.614
-0.292
-0.970
-0.612
-0.034
-0.748
-0.685
-0.063
-0.425
-0.678

0.384 - 2.503
0.379 - 2.817
0.381 - 2.453
0.447 - 3.316
0.357 - 2.487
0.345 - 2.851
0.398 - 2.664
0.328 - 2.737
0.504 - 4.763
0.381 - 2.489

0.307
0.651
0.213
0.677
0.237
0.637
0.312
0.115
1.558
0.268

-0.653
-0.061
-0.897
0.256
-0.764
-0.215
-0.915
0.103
3.979
-0.738

0.218 - 0.659
0.227 - 0.684
0.198 - 0.654
0.28 - 0.700
0.212 - 0.661
0.229 - 0.685
0.182 - 0.662
0.216 - 0.692
0.253 - 0.796
0.221 - 0.653

-0.684
-0.555
-0.643
-0.585
-0.601
-0.367
-0.508
-1.035
-0.453
-0.638

0.129
0.177
-0.251
-0.169
-0.042
-0.198
-0.408
1.114
-0.108
-0.011
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Table A2. Descriptive statistics for persons with stroke during eyes open rest.
Mean
SD
Median
Range
Skew Kurtosis
Delta
Whole Brain
0.354 0.115
0.342
0.113 - 0.535
-0.213
-0.431
Left Hemisphere
0.353 0.118
0.340
0.092 - 0.545
-0.289
-0.391
Right Hemisphere
0.353 0.119
0.344
0.129 - 0.550
-0.069
-0.568
Anterior
0.369 0.118
0.363
0.122 - 0.578
-0.191
0.026
Posterior
0.338 0.116
0.338
0.106 - 0.517
-0.059
-0.779
LH – Language
0.357 0.123
0.348
0.091 - 0.549
-0.209
-0.408
RH – Language
0.353 0.128
0.342
0.149 - 0.618
0.386
-0.518
Motor
0.351 0.114
0.366
0.120 - 0.564
-0.371
-0.180
Cognitive
0.399 0.133
0.394
0.119 - 0.634
-0.261
-0.002
Clinical
0.356 0.114
0.351
0.111 - 0.542
-0.366
-0.334
Theta
Whole Brain
0.168 0.094
0.142
0.078 - 0.515
2.337
6.847
Left Hemisphere
0.169 0.095
0.138
0.074 - 0.514
2.199
6.221
Right Hemisphere
0.160 0.094
0.130
0.073 - 0.506
2.389
6.849
Anterior
0.163 0.086
0.144
0.067 - 0.464
2.019
5.365
Posterior
0.174 0.105
0.142
0.075 - 0.571
2.496
7.817
LH – Language
0.154 0.090
0.116
0.060 - 0.445
1.867
3.812
RH – Language
0.149 0.090
0.119
0.065 - 0.448
2.041
4.303
Motor
0.182 0.099
0.168
0.078 - 0.519
1.877
4.570
Cognitive
0.146 0.075
0.130
0.059 - 0.407
2.038
5.399
Clinical
0.167 0.094
0.138
0.079 - 0.519
2.479
7.481
Alpha
Whole Brain
0.185 0.098
0.164
0.070 - 0.414
1.209
0.543
Left Hemisphere
0.182 0.095
0.165
0.067 - 0.405
1.134
0.460
Right Hemisphere
0.185 0.100
0.154
0.069 - 0.423
1.214
0.550
Anterior
0.162 0.084
0.145
0.069 - 0.361
1.178
0.362
Posterior
0.211 0.118
0.187
0.064 - 0.516
1.313
1.121
LH – Language
0.177 0.087
0.163
0.061 - 0.372
0.720
-0.309
RH – Language
0.178 0.089
0.148
0.049 - 0.377
0.759
-0.216
Motor
0.173 0.093
0.149
0.080 - 0.381
1.243
0.281
Cognitive
0.146 0.076
0.123
0.063 - 0.333
1.192
0.572
Clinical
0.184 0.099
0.162
0.066 - 0.411
1.245
0.558
Beta
Whole Brain
0.218 0.098
0.209
0.037 - 0.465
0.315
0.253
Left Hemisphere
0.221 0.102
0.219
0.044 - 0.444
0.063
-0.377
Right Hemisphere
0.229 0.109
0.217
0.032 - 0.508
0.556
0.534
Anterior
0.234 0.120
0.222
0.041 - 0.491
0.529
-0.255
Posterior
0.194 0.093
0.195
0.030 - 0.442
0.586
0.843
LH – Language
0.241 0.122
0.247
0.046 - 0.394
-0.062
-1.116
RH – Language
0.252 0.122
0.236
0.029 - 0.533
0.377
-0.171
Motor
0.223 0.110
0.199
0.040 - 0.470
0.539
-0.251
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Cognitive
Clinical

0.239
0.219

0.141
0.097

Whole Brain
Left Hemisphere
Right Hemisphere
Anterior
Posterior
LH – Language
RH – Language
Motor
Cognitive
Clinical

3.050
3.068
3.117
3.532
2.603
3.217
3.258
2.997
4.272
3.121

2.118
2.143
2.331
2.379
2.034
2.399
2.924
1.909
2.975
2.139

Whole Brain
Left Hemisphere
Right Hemisphere
Anterior
Posterior
LH – Language
RH – Language
Motor
Cognitive
Clinical

1.897
1.926
1.815
1.973
1.836
1.792
1.770
1.931
2.086
1.918

1.386
1.434
1.460
1.412
1.428
1.335
1.772
1.431
1.453
1.386

Whole Brain
Left Hemisphere
Right Hemisphere
Anterior
Posterior
LH – Language
RH – Language
Motor
Cognitive
Clinical

0.515
0.519
0.501
0.522
0.509
0.509
0.492
0.524
0.536
0.515

0.141
0.148
0.144
0.150
0.138
0.156
0.151
0.151
0.158
0.140

0.227
0.212
DAR
2.387
2.724
2.509
3.065
2.002
2.479
2.364
2.794
3.265
2.792
DTABR
1.783
1.708
1.314
1.495
1.681
1.326
1.148
1.512
1.626
1.736
Qslowing
0.519
0.525
0.499
0.526
0.542
0.493
0.465
0.548
0.565
0.517

0.049 - 0.578
0.039 - 0.456

0.857
0.247

0.256
0.054

0.310 - 8.700
0.263 - 8.651
0.352 - 9.518
0.415 - 8.996
0.230 - 9.199
0.288 - 9.306
0.446 - 13.177
0.352 - 7.439
0.429 - 10.568
0.296 - 9.371

1.084
1.115
1.259
0.879
1.615
1.131
1.962
0.691
0.812
1.160

0.936
1.140
1.241
0.121
3.261
0.842
4.473
0.070
-0.246
1.779

0.267 - 6.720
0.222 - 6.275
0.299 - 7.297
0.279 - 6.434
0.267 - 7.047
0.198 - 5.263
0.339 - 9.211
0.266 - 6.835
0.251 - 5.828
0.262 - 6.695

1.812
1.419
2.339
1.506
2.093
1.209
3.216
1.740
0.993
1.767

4.746
2.178
7.346
2.782
6.184
0.881
12.689
4.325
0.418
4.504

0.192 - 0.793
0.166 - 0.780
0.209 - 0.811
0.160 - 0.777
0.191 - 0.807
0.152 - 0.785
0.219 - 0.845
0.185 - 0.798
0.169 - 0.765
0.190 - 0.790

-0.443
-0.438
-0.186
-0.539
-0.347
-0.185
0.213
-0.517
-0.734
-0.503

-0.228
-0.330
-0.264
-0.084
-0.387
-0.610
-0.477
-0.439
0.000
-0.133
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Table A3. Descriptive statistics for neurologically healthy controls during eyes closed
rest.
Mean
SD
Median
Range
Skew Kurtosis
Delta
Whole Brain
0.271
0.117
0.245
0.096 - 0.453 0.159
-1.443
Left Hemisphere
0.267
0.113
0.231
0.100 - 0.467 0.190
-1.331
Right Hemisphere 0.271
0.117
0.255
0.092 - 0.459 0.113
-1.465
Anterior
0.243
0.107
0.226
0.079 - 0.415 0.104
-1.557
Posterior
0.314
0.138
0.279
0.113 - 0.522 0.116
-1.401
LH – Language
0.249
0.104
0.250
0.094 - 0.465 0.237
-1.057
RH – Language
0.246
0.097
0.248
0.092 - 0.451 0.207
-0.936
Motor
0.238
0.109
0.207
0.090 - 0.414 0.412
-1.351
Cognitive
0.243
0.106
0.236
0.075 - 0.420 0.077
-1.269
Clinical
0.271
0.116
0.247
0.095 - 0.457 0.157
-1.446
Theta
Whole Brain
0.104
0.028
0.101
0.057 - 0.181 0.567
0.840
Left Hemisphere
0.105
0.030
0.102
0.058 - 0.191 0.773
1.305
Right Hemisphere 0.100
0.026
0.099
0.054 - 0.164 0.235
0.182
Anterior
0.109
0.025
0.111
0.061 - 0.169 0.362
0.361
Posterior
0.098
0.035
0.089
0.046 - 0.210 1.138
2.536
LH – Language
0.101
0.024
0.105
0.055 - 0.141 -0.185 -0.573
RH – Language
0.102
0.027
0.102
0.054 - 0.159 0.148
-0.151
Motor
0.116
0.033
0.111
0.063 - 0.197 0.577
0.155
Cognitive
0.103
0.026
0.098
0.060 - 0.170 0.838
1.141
Clinical
0.103
0.029
0.104
0.058 - 0.192 0.997
2.470
Alpha
Whole Brain
0.271
0.117
0.245
0.096 - 0.453 0.159
-1.443
Left Hemisphere
0.267
0.113
0.231
0.100 - 0.467 0.190
-1.331
Right Hemisphere 0.271
0.117
0.255
0.092 - 0.459 0.113
-1.465
Anterior
0.243
0.107
0.226
0.079 - 0.415 0.104
-1.557
Posterior
0.314
0.136
0.279
0.113 - 0.522 0.116
-1.401
LH – Language
0.249
0.104
0.250
0.094 - 0.465 0.237
-1.057
RH – Language
0.246
0.097
0.248
0.092 - 0.451 0.207
-0.936
Motor
0.238
0.109
0.207
0.090 - 0.414 0.412
-1.351
Cognitive
0.243
0.106
0.236
0.075 - 0.420 0.077
-1.269
Clinical
0.271
0.116
0.247
0.095 - 0.457 0.157
-1.446
Beta
Whole Brain
0.244
0.071
0.246
0.131 - 0.408 0.262
-0.464
Left Hemisphere
0.251
0.073
0.254
0.140 - 0.405 0.193
-0.889
Right Hemisphere 0.244
0.072
0.245
0.130 - 0.407 0.261
-0.489
Anterior
0.230
0.072
0.234
0.127 - 0.409 0.413
-0.171
Posterior
0.248
0.075
0.239
0.136 - 0.391 0.487
-0.698
LH – Language
0.250
0.079
0.245
0.142 - 0.426 0.641
-0.293
RH – Language
0.258
0.082
0.245
0.132 - 0.424 0.369
-0.672
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Motor
Cognitive
Clinical

0.245
0.214
0.246

0.078
0.071
0.073

Whole Brain
Left Hemisphere
Right Hemisphere
Anterior
Posterior
LH – Language
RH – Language
Motor
Cognitive
Clinical

1.863
1.837
1.913
2.215
1.427
2.014
2.026
2.065
2.365
1.860

1.431
1.398
1.524
1.763
1.169
1.461
1.525
1.504
1.971
1.393

Whole Brain
Left Hemisphere
Right Hemisphere
Anterior
Posterior
LH – Language
RH – Language
Motor
Cognitive
Clinical

1.044
1.036
1.045
1.221
0.843
1.111
1.091
1.148
1.301
1.034

0.654
0.666
0.654
0.753
0.586
0.638
0.639
0.686
0.830
0.623

Whole Brain
Left Hemisphere
Right Hemisphere
Anterior
Posterior
LH – Language
RH – Language
Motor
Cognitive
Clinical

0.420
0.418
0.420
0.463
0.373
0.436
0.432
0.449
0.480
0.418

0.126
0.127
0.126
0.119
0.134
0.126
0.117
0.131
0.116
0.123

0.240
0.224
0.250
DAR
1.366
1.432
1.428
1.726
1.037
1.537
1.524
2.007
1.764
1.535
DTABR
0.887
0.879
0.890
1.021
0.680
0.986
0.922
1.151
1.119
0.923
Qslowing
0.423
0.419
0.429
0.463
0.377
0.440
0.438
0.476
0.488
0.424

0.124 - 0.492
0.114 - 0.336
0.127 - 0.415

1.095
0.038
0.225

2.797
-1.211
-0.381

0.357 - 5.771
0.357 - 5.424
0.343 - 6.428
0.450 - 7.366
0.193 - 4.347
0.259 - 5.384
0.437 - 7.100
0.434 - 6.387
0.510 - 8.423
0.364 - 5.698

1.261
1.266
1.369
1.549
1.064
1.054
1.684
1.229
1.728
1.184

1.290
1.156
1.802
2.417
0.246
0.370
3.606
1.816
2.849
1.016

0.294 - 2.896
0.271 - 2.978
0.271 - 2.928
0.344 - 3.311
0.183 - 2.566
0.229 - 2.718
0.324 - 2.697
0.247 - 3.292
0.406 - 3.979
0.298 - 2.848

1.551
1.602
1.485
1.659
1.482
1.026
1.292
1.444
1.904
1.420

2.698
2.778
2.398
3.142
2.157
0.619
1.371
3.135
4.037
2.308

0.206 - 0.672
0.192 - 0.672
0.195 - 0.676
0.232 - 0.707
0.157 - 0.655
0.169 - 0.665
0.218 - 0.665
0.178 - 0.704
0.270 - 0.724
0.210 - 0.665

0.009
0.059
0.048
-0.087
0.209
-0.096
0.074
-0.441
0.162
-0.039

-0.265
-0.277
-0.325
-0.008
-0.527
-0.315
-0.188
-0.199
0.052
-0.393
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Table A4. Descriptive statistics for persons with stroke during eyes closed rest.
Mean
SD
Median
Range
Skew Kurtosis
Delta
Whole Brain
0.284
0.124
0.279
0.087 - 0.604 0.619
0.483
Left Hemisphere
0.275
0.123
0.285
0.098 - 0.552 0.450
-0.382
Right Hemisphere 0.287
0.124
0.271
0.074 - 0.622 0.650
0.902
Anterior
0.251
0.115
0.240
0.082 - 0.538 0.791
0.456
Posterior
0.324
0.138
0.326
0.098 - 0.675 0.370
0.264
LH – Language
0.255
0.108
0.268
0.086 - 0.494 0.487
-0.050
RH – Language
0.265
0.110
0.245
0.063 - 0.575 0.694
1.628
Motor
0.263
0.131
0.229
0.087 - 0.589 1.132
1.173
Cognitive
0.238
0.113
0.210
0.079 - 0.527 0.817
0.538
Clinical
0.281
0.125
0.276
0.083 - 0.596 0.601
0.331
Theta
Whole Brain
0.171
0.099
0.141
0.054 - 0.509 1.862
4.417
Left Hemisphere
0.175
0.100
0.147
0.055 - 0.510 1.718
3.967
Right Hemisphere 0.161
0.098
0.129
0.052 - 0.491 1.957
4.459
Anterior
0.173
0.094
0.150
0.062 - 0.480 1.638
3.431
Posterior
0.171
0.110
0.137
0.043 - 0.547 1.938
4.567
LH – Language
0.165
0.092
0.143
0.064 - 0.437 1.539
2.305
RH – Language
0.154
0.091
0.131
0.059 - 0.469 2.066
4.939
Motor
0.188
0.093
0.167
0.062 - 0.474 1.241
2.067
Cognitive
0.160
0.097
0.129
0.067 - 0.495 2.006
5.012
Clinical
0.170
0.098
0.139
0.057 - 0.511 1.948
4.927
Alpha
Whole Brain
0.284
0.124
0.279
0.087 - 0.604 0.619
0.483
Left Hemisphere
0.275
0.123
0.285
0.098 - 0.552 0.450
-0.382
Right Hemisphere 0.287
0.124
0.271
0.074 - 0.622 0.650
0.902
Anterior
0.251
0.115
0.240
0.082 - 0.538 0.791
0.456
Posterior
0.324
0.138
0.326
0.098 - 0.675 0.370
0.264
LH – Language
0.255
0.108
0.268
0.086 - 0.494 0.487
-0.050
RH – Language
0.265
0.110
0.245
0.063 - 0.575 0.694
1.628
Motor
0.263
0.131
0.229
0.087 - 0.589 1.132
1.173
Cognitive
0.238
0.113
0.210
0.079 - 0.527 0.817
0.538
Clinical
0.281
0.125
0.276
0.083 - 0.596 0.601
0.331
Beta
Whole Brain
0.176
0.066
0.177
0.038 - 0.286 -0.356 -0.502
Left Hemisphere
0.175
0.069
0.192
0.041 - 0.281 -0.497 -0.686
Right Hemisphere 0.186
0.076
0.183
0.036 - 0.337 -0.051 -0.492
Anterior
0.176
0.066
0.177
0.039 - 0.299 -0.248 -0.549
Posterior
0.165
0.078
0.162
0.032 - 0.309 0.204
-0.701
LH – Language
0.193
0.084
0.225
0.046 - 0.301 -0.646 -0.994
RH – Language
0.205
0.086
0.203
0.038 - 0.373 0.101
-0.517
Motor
0.187
0.067
0.182
0.042 - 0.287 -0.316 -0.628
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Cognitive
Clinical

0.167
0.178

0.068
0.068

Whole Brain
Left Hemisphere
Right Hemisphere
Anterior
Posterior
LH – Language
RH – Language
Motor
Cognitive
Clinical

2.084
2.168
2.105
2.482
1.683
2.319
2.431
2.011
2.991
2.139

1.824
1.742
2.146
2.103
1.655
1.783
2.624
1.612
2.640
1.861

Whole Brain
Left Hemisphere
Right Hemisphere
Anterior
Posterior
LH – Language
RH – Language
Motor
Cognitive
Clinical

1.765
1.830
1.709
1.959
1.613
1.827
1.780
1.709
2.202
1.781

1.565
1.511
1.771
1.598
1.694
1.535
1.951
1.311
1.800
1.591

Whole Brain
Left Hemisphere
Right Hemisphere
Anterior
Posterior
LH – Language
RH – Language
Motor
Cognitive
Clinical

0.488
0.501
0.474
0.525
0.451
0.504
0.484
0.503
0.549
0.490

0.155
0.160
0.156
0.155
0.162
0.157
0.152
0.151
0.159
0.153

0.164
0.179
DAR
1.510
1.533
1.496
1.840
1.129
1.803
1.644
1.608
2.390
1.535
DTABR
1.143
1.240
1.126
1.345
1.048
1.184
1.185
1.309
1.437
1.169
Qslowing
0.472
0.498
0.463
0.526
0.458
0.477
0.470
0.507
0.546
0.471

0.046 - 0.285
0.039 - 0.286

0.033
-0.356

-0.920
-0.606

0.255 - 7.864
0.224 - 6.539
0.254 - 9.964
0.252 - 8.792
0.182 - 7.009
0.260 - 6.833
0.364 - 12.294
0.260 - 6.028
0.260 - 10.232
0.265 - 8.457

1.725
1.260
2.375
1.626
1.854
1.128
2.581
1.421
1.613
1.903

3.027
1.074
6.514
2.342
3.464
0.784
7.591
1.587
1.911
4.349

0.326 - 7.290
0.269 - 6.605
0.319 - 7.759
0.302 - 7.022
0.268 - 8.101
0.321 - 6.183
0.370 - 9.035
0.338 - 5.703
0.258 - 7.502
0.339 - 7.420

2.115
1.631
2.532
1.738
2.582
1.531
2.785
1.511
1.597
2.149

5.439
2.886
6.587
3.308
8.131
1.912
8.205
2.283
2.484
5.580

0.220 - 0.803
0.192 - 0.795
0.216 - 0.810
0.215 - 0.804
0.189 - 0.820
0.219 - 0.787
0.246 - 0.842
0.230 - 0.753
0.196 - 0.817
0.225 - 0.803

0.019
-0.090
0.334
-0.285
0.310
0.042
0.526
-0.226
-0.458
0.045

-0.507
-0.614
-0.126
-0.275
-0.406
-0.781
0.058
-0.674
0.023
-0.524
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Appendix B
Table B1. Descriptive statistics during the P3a for neurologically healthy controls in
response to novel stimuli.
Mean
SD
Median
Range
Skew Kurtosis
Historical
Fz
3.359
1.756
3.410 -0.259 - 6.230
-0.425
-0.626
Cz
1.661
2.393
1.363 -2.292 - 7.336
0.235
-0.191
Pz
-0.471
1.978
-0.415 -4.945 - 2.830
-0.642
0.103
Expanded
F3
2.513
1.504
2.172 -0.316 - 5.660
0.328
-0.232
F4
2.471
1.418
2.487 -0.669 - 4.771
-0.462
-0.203
C3
1.117
1.333
0.915 -0.874 - 3.724
0.351
-0.887
C4
0.809
1.433
0.896 -0.762 - 5.071
1.234
1.840
P3
-1.436
1.294
-1.303 -5.217 - 0.500
-1.181
2.056
P4
-1.229
1.753
-0.604 -5.028 - 1.994
-0.367
-0.239
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Table B2. Descriptive statistics during the P3a for PWCS in response to novel stimuli.
Mean
SD
Median
Range
Skew Kurtosis
Historical
Fz
2.017
1.850
1.905 -1.887 - 6.360 0.112
0.882
Cz
1.442
1.445
1.534 -1.647 - 5.201 0.335
0.734
Pz
-0.273
1.478
-0.214 -3.117 - 3.794 0.663
0.756
Expanded
F3
1.588
1.598
1.418 -2.835 - 4.428 -0.395
0.899
F4
1.571
2.132
1.485 -2.755 - 6.221 0.148
0.250
C3
0.539
1.470
0.573 -2.771 - 4.019 0.162
0.911
C4
0.762
1.652
0.747 -4.992 - 3.227 -1.402
4.643
P3
-1.234
1.866
-1.316 -6.315 - 2.792 -0.106
1.669
P4
-0.501
1.207
-0.745 -3.076 - 1.656 0.031
-0.452
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Table B3. Descriptive statistics during the P3a for neurologically healthy controls in
response to target stimuli.
Mean
SD
Median
Range
Skew Kurtosis
Historical
Fz
2.016
2.211
1.966 -3.106 - 7.497
0.167
0.566
Cz
1.679
2.478
1.802 -3.312 - 8.328
0.315
1.205
Pz
1.734
2.068
1.561 -1.949 - 7.281
0.496
0.951
Expanded
F3
1.357
1.921
1.562 -3.239 - 4.346 -0.347
-0.368
F4
1.043
1.781
0.920 -1.853 - 4.278
0.158
-1.049
C3
0.700
1.538
0.862 -2.148 - 3.978
0.009
-0.458
C4
0.651
1.218
0.437 -1.128 - 4.751
1.379
3.624
P3
0.596
1.816
0.708 -3.044 - 3.787 -0.293
-0.554
P4
0.704
1.789
0.763 -2.974 - 4.386 -0.030
-0.080
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Table B4. Descriptive statistics during the P3a for PWCS in response to target stimuli.
Mean
SD
Median
Range
Skew Kurtosis
Historical
Fz
1.281
1.552
1.204 -2.365 - 5.891
0.566
2.513
Cz
1.254
1.328
1.279 -1.832 - 3.466 -0.241
-0.150
Pz
0.953
1.378
0.873 -1.084 - 4.043
0.652
0.122
Expanded
F3
0.627
1.498
0.547 -1.365 - 3.850
0.303
-1.035
F4
1.199
1.822
1.203 -4.033 - 4.319 -0.729
1.852
C3
0.036
1.237
0.136 -2.807 - 2.365 -0.302
-0.286
C4
0.791
1.312
1.031 -1.924 - 2.954 -0.561
-0.415
P3
-0.407
1.883
-0.232 -4.455 - 3.588
0.039
0.123
P4
0.380
1.108
0.199 -1.189 - 2.671
0.353
-0.967
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Table B5. Descriptive statistics during the P3b for neurologically healthy controls in
response to novel stimuli.
Mean
SD
Median
Range
Skew Kurtosis
Historical
Fz
2.877
1.492
2.829 -0.584 - 6.101 0.114
0.070
Cz
1.265
1.673
1.388 -1.870 - 4.137 -0.230
-0.553
Pz
0.402
1.885
0.358 -3.948 - 4.192 -0.395
0.243
Expanded
F3
1.942
1.277
1.681 -0.990 - 4.899 0.372
0.635
F4
1.833
1.321
2.069 -0.576 - 5.203 0.392
0.331
C3
0.789
1.041
0.488 -0.865 - 3.030 0.416
-0.578
C4
0.668
1.242
0.672 -1.374 - 3.355 0.184
-0.460
P3
-0.650
1.524
-0.530 -4.872 - 1.774 -0.891
1.109
P4
-0.403
1.512
-0.100 -3.672 - 2.323 -0.626
0.269
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Table B6. Descriptive statistics during the P3b for PWCS in response to novel stimuli.
Mean
SD
Median
Range
Skew Kurtosis
Historical
Fz
1.891
2.215
2.143
-4.408 - 7.199 -0.527
2.283
Cz
1.463
1.869
1.496
-2.642 - 6.743 0.632
1.651
Pz
0.344
1.610
0.417
-3.283 - 3.563 0.044
-0.049
Expanded
F3
1.606
1.829
1.783
-3.161 - 5.489 -0.243
1.027
F4
1.142
2.325
1.413
-3.875 - 7.081 -0.261
1.568
C3
0.572
1.804
0.847
-4.755 - 4.948 -0.528
2.625
C4
0.658
1.891
0.685
-6.059 - 4.108 -1.484
5.280
P3
-0.987
2.633
-1.028 -10.395 - 3.460 -1.597
5.723
P4
0.018
1.462
0.350
-2.802 - 2.835 -0.159
-0.828
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Table B7. Descriptive statistics during the P3b for neurologically healthy controls in
response to target stimuli.
Mean
SD
Median
Range
Skew Kurtosis
Historical
Fz
1.334
2.207
1.700 -3.520 - 5.459 -0.425
-0.235
Cz
1.466
1.831
1.289 -1.847 - 4.636 -0.049
-0.915
Pz
2.720
2.068
2.613 -0.716 - 8.854 0.908
1.550
Expanded
F3
0.794
2.048
1.320 -4.170 - 3.141 -0.975
0.062
F4
0.228
1.912
0.318 -3.175 - 3.707 -0.055
-0.996
C3
0.789
1.115
0.785 -1.197 - 2.576 -0.148
-1.055
C4
0.355
1.026
0.145 -1.388 - 2.714 0.249
-0.482
P3
1.634
1.903
1.862 -2.137 - 5.544 -0.123
-0.009
P4
1.331
1.848
1.650 -1.748 - 5.574 0.344
-0.145
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Table B8. Descriptive statistics during the P3b for PWCS in response to target stimuli.
Mean
SD
Median
Range
Skew Kurtosis
Historical
Fz
1.044
1.850
0.740 -3.998 - 6.284 0.289
2.995
Cz
1.240
1.487
0.927 -0.989 - 5.575 1.055
1.797
Pz
1.449
1.809
0.956 -1.347 - 5.612 0.587
-0.656
Expanded
F3
0.515
1.619
0.531 -2.903 - 3.747 -0.167
-0.319
F4
0.885
1.950
0.921 -5.298 - 4.377 -0.971
2.797
C3
0.323
1.202
0.211 -2.425 - 2.746 -0.004
-0.195
C4
0.869
1.470
0.769 -2.400 - 3.771 -0.055
-0.209
P3
0.135
2.238
0.107 -4.416 - 4.411 0.035
-0.532
P4
0.695
1.120
0.561 -1.026 - 2.743 0.410
-0.924
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Table B9. Descriptive statistics during the N150 for neurologically healthy controls
during the orthographic task.
Mean
SD Median
Range
Skew Kurtosis
Spironelli & Angrilli ROIs
Left Anterior
-0.459 1.429
-0.579 -3.470 - 2.799
0.020
0.563
Left Posterior
0.164 2.020
0.464 -5.932 - 3.580 -1.192
2.369
Right Anterior
-0.033 1.396
0.044 -3.126 - 4.074
0.639
2.467
Right Posterior
3.226 2.310
3.616 -2.297 - 7.652 -0.252
0.323
Expanded ROIs
Left Orbito-Frontal
-0.482 1.555
-0.491 -4.116 - 2.930 -0.204
0.913
Left Antero-Medial
-0.278 1.231
-0.440 -2.363 - 2.671
0.519
0.177
Left Antero-Lateral
-0.299 1.007
-0.328 -3.032 - 1.895 -0.475
1.247
Left Postero-Medial
0.065 0.835
0.001 -1.258 - 1.660
0.265
-0.665
Left Postero-Lateral
1.579 1.140
1.688 -0.948 - 3.532 -0.246
-0.305
Left Occipital
0.219 2.364
0.479 -7.283 - 3.607 -1.525
3.539
Right Orbito-Frontal
-0.221 1.591
-0.292 -3.643 - 4.212
0.461
1.461
Right Antero-Medial
-0.182 1.269
-0.400 -2.348 - 3.011
0.852
0.593
Right Antero-Lateral
-0.194 0.973
-0.089 -1.841 - 2.619
0.600
1.423
Right Postero-Medial
0.273 0.681
0.113 -0.492 - 2.668
1.885
5.097
Right Postero-Lateral
0.669 1.584
0.512 -2.049 - 5.173
0.903
1.442
Right Occipital
0.468 3.159
0.727 -9.620 - 7.569 -0.945
3.667
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Table B10. Descriptive statistics during the N150 for PWCS during the orthographic
task.
Mean
SD Median
Range
Skew Kurtosis
Spironelli & Angrilli ROIs
Left Anterior
-0.128 1.693
-0.229 -2.775 - 3.297 0.361
-0.431
Left Posterior
0.049 1.991
0.040 -5.278 - 5.267 -0.110
2.245
Right Anterior
-0.279 1.427
-0.424 -2.814 - 3.252 0.996
1.502
Right Posterior
3.755 1.837
3.630 -0.211 - 7.907 -0.243
0.292
Expanded ROIs
Left Orbito-Frontal
-0.357 1.569
-0.446 -3.194 - 3.359 0.497
0.330
Left Antero-Medial
-0.316 1.243
-0.498 -3.683 - 1.522 -0.528
0.391
Left Antero-Lateral
-0.044 1.374
0.039 -2.128 - 3.181 0.337
-0.099
Left Postero-Medial
0.032 1.004
-0.033 -1.991 - 2.304 0.188
-0.127
Left Postero-Lateral
2.223 1.082
2.216 -0.336 - 5.203 0.507
1.926
Left Occipital
0.147 2.545
0.303 -5.586 - 7.435 0.260
1.953
Right Orbito-Frontal
-0.336 1.566
-0.205 -3.406 - 3.221 0.409
0.352
Right Antero-Medial
-0.178 1.417
-0.219 -3.512 - 3.093 -0.028
0.994
Right Antero-Lateral
-0.245 1.128
-0.367 -2.384 - 2.180 0.292
0.048
Right Postero-Medial
0.076 0.781
0.110 -1.252 - 2.243 0.644
0.985
Right Postero-Lateral
0.724 1.459
0.948 -3.116 - 4.125 -0.391
1.022
Right Occipital
0.538 2.517
0.702 -3.734 - 6.462 -0.014
-0.196
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Table B11. Descriptive statistics during the N150 for neurologically healthy controls
during the phonological task.
Mean
SD Median
Range
Skew Kurtosis
Spironelli & Angrilli ROIs
Left Anterior
-0.517 1.582
-0.347
-4.458 - 2.716 -0.443
0.963
Left Posterior
0.397 1.898
0.538
-5.677 - 3.416 -1.420
3.208
Right Anterior
-0.265 1.627
-0.485
-4.563 - 3.776
0.146
2.193
Right Posterior
3.676 2.256
4.022
-2.435 - 8.041 -0.523
1.008
Expanded ROIs
Left Orbito-Frontal
-0.606 1.648
-0.680
-5.214 - 3.092 -0.365
1.766
Left Antero-Medial
-0.522 1.148
-0.553
-3.056 - 2.498
0.226
1.017
Left Antero-Lateral
-0.502 0.990
-0.477
-2.891 - 1.792 -0.027
1.476
Left Postero-Medial
0.205 0.841
0.313
-1.177 - 1.872 -0.056
-0.835
Left Postero-Lateral
1.759 1.269
1.661
-1.380 - 4.151 -0.036
0.504
Left Occipital
0.575 2.398
0.859
-7.106 - 4.132 -1.407
3.077
Right Orbito-Frontal
-0.421 1.679
-0.454
-4.524 - 3.990
0.475
2.200
Right Antero-Medial
-0.448 1.096
-0.641
-2.570 - 3.013
1.178
3.115
Right Antero-Lateral
-0.327 1.080
-0.415
-3.153 - 2.720
0.472
3.048
Right Postero-Medial
0.275 0.809
0.275
-1.116 - 2.810
1.042
2.689
Right Postero-Lateral
0.854 1.514
0.443
-1.893 - 4.956
0.871
1.160
Right Occipital
0.901 3.097
1.159 -10.210 - 7.033 -1.616
6.101
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Table B12. Descriptive statistics during the N150 for PWCS during the phonological
task.
Mean
SD Median
Range
Skew Kurtosis
Spironelli & Angrilli ROIs
Left Anterior
-0.593 1.838
-0.796 -4.630 - 2.317 -0.128
-0.574
Left Posterior
0.565 2.011
0.701 -5.262 - 4.776 -0.739
1.811
Right Anterior
-0.762 1.324
-0.501 -4.737 - 1.578 -1.163
2.653
Right Posterior
4.289 1.775
4.860
0.168 - 7.284 -0.676
-0.167
Expanded ROIs
Left Orbito-Frontal
-0.842 1.696
-0.684 -4.316 - 2.221 -0.314
-0.590
Left Antero-Medial
-0.512 1.281
-0.716 -3.525 - 2.303 0.126
0.442
Left Antero-Lateral
-0.452 1.392
-0.535 -3.775 - 2.308 -0.263
0.289
Left Postero-Medial
0.231 0.837
0.230 -1.379 - 1.610 0.025
-0.862
Left Postero-Lateral
2.631 1.071
2.311 -0.417 - 4.575 -0.280
1.346
Left Occipital
0.656 2.756
1.196 -5.694 - 6.928 -0.486
1.142
Right Orbito-Frontal
-0.967 1.445
-0.546 -4.562 - 1.537 -0.469
0.206
Right Antero-Medial
-0.441 1.179
-0.540 -2.980 - 2.430 0.439
0.535
Right Antero-Lateral
-0.495 1.126
-0.546 -2.697 - 1.483 -0.300
-0.246
Right Postero-Medial
0.258 0.925
0.162 -1.678 - 2.833 0.696
1.599
Right Postero-Lateral
0.940 1.629
1.341 -3.163 - 4.091 -0.713
0.967
Right Occipital
1.006 2.373
1.573 -3.440 - 5.956 -0.137
-0.559

133

Table B13. Descriptive statistics during the N150 for neurologically healthy controls
during the semantic task.
Mean
SD
Median
Min
Skew Kurtosis
Spironelli & Angrilli ROIs
Left Anterior
-0.760 1.488
-0.585 -4.708 - 2.550 -0.381
1.219
Left Posterior
0.274 1.795
0.504 -4.675 - 3.264 -1.124
1.466
Right Anterior
-0.311 1.332
-0.444 -4.008 - 2.801 -0.294
2.029
Right Posterior
3.642 2.270
3.791 -2.037 - 7.929 -0.504
0.428
Expanded ROIs
Left Orbito-Frontal
-0.732 1.570
-0.617 -5.622 - 2.907 -0.729
3.298
Left Antero-Medial
-0.578 1.176
-0.606 -3.174 - 2.388 0.268
0.928
Left Antero-Lateral
-0.658 0.978
-0.814 -2.865 - 0.968 -0.415
0.234
Left Postero-Medial
0.221 0.732
0.149 -0.943 - 1.517 0.282
-0.864
Left Postero-Lateral
1.640 1.142
1.777 -1.725 - 3.508 -1.128
2.069
Left Occipital
0.411 2.121
0.375 -6.106 - 4.002 -1.311
2.527
Right Orbito-Frontal
-0.375 1.531
-0.366 -4.794 - 3.572 -0.254
2.855
Right Antero-Medial
-0.265 1.162
-0.426 -2.802 - 3.203 0.836
2.600
Right Antero-Lateral
-0.392 0.961
-0.360 -2.405 - 1.542 -0.158
0.142
Right Postero-Medial
0.423 0.764
0.306 -0.828 - 2.697 0.881
1.777
Right Postero-Lateral
0.926 1.549
0.693 -2.518 - 5.579 0.702
2.760
Right Occipital
0.917 3.065
0.780 -9.999 - 7.257 -1.552
6.065
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Table B14. Descriptive statistics during the N150 for PWCS during the semantic task.
Mean
SD
Median
Min
Skew Kurtosis
Spironelli & Angrilli ROIs
Left Anterior
-0.581
2.065
-0.932 -5.171 - 3.253 -0.203
0.092
Left Posterior
0.088
2.189
0.379 -5.804 - 5.162 -0.496
2.066
Right Anterior
-0.451
1.426
-0.625 -3.031 - 3.144 0.716
0.587
Right Posterior
3.847
1.797
3.884 -0.005 - 7.394 -0.331
0.053
Expanded ROIs
Left Orbito-Frontal
-0.619
1.859
-0.402 -5.521 - 2.134 -0.950
1.242
Left Antero-Medial
-0.227
1.249
0.023 -3.768 - 2.020 -0.957
1.724
Left Antero-Lateral
-0.310
1.708
-0.300 -4.656 - 3.223 -0.174
0.470
Left Postero-Medial
0.030
0.938
0.138 -2.237 - 1.558 -0.560
0.047
Left Postero-Lateral
2.149
1.284
2.010 -0.638 - 4.762 -0.079
0.115
Left Occipital
0.037
2.825
0.186 -7.137 - 7.227 -0.273
1.947
Right Orbito-Frontal
-0.551
1.492
-0.610 -4.197 - 2.568 -0.067
0.791
Right Antero-Medial
0.005
1.515
0.040 -3.522 - 4.142 0.683
2.678
Right Antero-Lateral -0.109
1.212
-0.556 -2.459 - 2.326 0.697
-0.048
Right Postero-Medial
0.124
1.113
0.012 -2.459 - 2.841 0.517
1.351
Right Postero-Lateral
0.843
1.478
0.686 -2.775 - 4.367 0.170
1.190
Right Occipital
0.511
2.408
0.665 -5.873 - 6.083 -0.357
1.327
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Table B15. Descriptive statistics during the N350 for neurologically healthy controls
during the orthographic task.
Mean
SD
Median
Range
Skew Kurtosis
Spironelli & Angrilli ROIs
Left Anterior
-0.539
1.398
-0.545 -2.998 - 2.308
0.108
-0.500
Left Posterior
0.070
1.286
0.148 -2.525 - 2.412 -0.047
-0.427
Right Anterior
-0.653
1.229
-0.667 -2.900 - 6.200 -0.007
-0.735
Right Posterior
2.992
1.787
3.113 -3.557 - 6.200 -1.939
6.934
Expanded ROIs
Left Orbito-Frontal
-0.620
1.376
-0.808 -3.863 - 1.744 -0.314
-0.234
Left Antero-Medial
0.008
0.766
0.083 -1.303 - 1.219 -0.102
-1.259
Left Antero-Lateral
0.063
1.043
-0.039 -2.110 - 2.805
0.366
0.782
Left Postero-Medial
0.870
0.767
0.931 -0.528 - 2.277 -0.069
-0.287
Left Postero-Lateral
1.625
0.954
1.711 -1.058 - 3.084 -0.987
1.345
Left Occipital
-0.134
1.672
-0.120 -3.304 - 3.425
0.231
-0.036
Right Orbito-Frontal
-0.773
1.293
-0.812 -3.124 - 1.498 -0.142
-0.727
Right Antero-Medial
-0.135
0.888
-0.194 -1.879 - 1.401
0.053
-0.595
Right Antero-Lateral
-0.252
0.931
-0.193 -2.166 - 1.402 -0.132
-0.559
Right Postero-Medial
0.182
0.591
0.090 -1.005 - 1.334
0.298
-0.219
Right Postero-Lateral
-0.241
0.990
-0.151 -2.543 - 2.216
0.130
0.811
Right Occipital
-0.339
1.692
-0.482 -3.274 - 4.236
0.948
1.165
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Table B16. Descriptive statistics during the N350 for PWCS during the orthographic
task.
Mean
SD
Median
Range
Skew Kurtosis
Spironelli & Angrilli ROIs
Left Anterior
-0.039
1.149
-0.257 -2.108 - 2.640
0.619
0.581
Left Posterior
0.324
1.572
0.092 -3.125 - 4.779
0.538
1.833
Right Anterior
-0.667
1.493
-0.540 -3.870 - 2.242 -0.066
0.293
Right Posterior
3.905
1.167
3.826 1.085 - 6.662
0.003
0.626
Expanded ROIs
Left Orbito-Frontal
-0.308
1.221
-0.364 -3.315 - 2.982
0.254
1.908
Left Antero-Medial
-0.168
0.895
-0.069 -1.592 - 1.481 -0.065
-1.015
Left Antero-Lateral
0.148
1.136
0.207 -1.446 - 3.709
1.298
2.586
Left Postero-Medial
0.339
0.986
0.308 -1.731 - 3.014
0.088
1.678
Left Postero-Lateral
2.212
1.636
2.117 -0.498 - 6.629
1.050
1.559
Left Occipital
0.411
1.699
0.210 -3.325 - 5.518
0.664
2.444
Right Orbito-Frontal
-0.517
1.533
-0.535 -3.765 - 2.610
0.055
0.128
Right Antero-Medial
-0.371
1.391
-0.181 -4.058 - 1.998 -0.672
0.801
Right Antero-Lateral
-0.444
1.237
-0.501 -3.326 - 2.036 -0.230
0.303
Right Postero-Medial
0.188
0.633
0.281 -1.553 - 1.219 -0.831
1.450
Right Postero-Lateral
0.208
1.200
-0.069 -1.594 - 3.575
1.083
1.339
Right Occipital
0.459
1.641
0.340 -4.266 - 4.351 -0.383
2.103
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Table B17. Descriptive statistics during the N350 for neurologically healthy controls
during the phonological task.
Mean
SD
Median
Range
Skew Kurtosis
Spironelli & Angrilli ROIs
Left Anterior
-0.660
1.154
-0.414 -2.968 - 1.728
-0.295
0.017
Left Posterior
0.240
1.139
0.082 -1.655 - 2.444
0.430
-0.478
Right Anterior
-0.883
1.178
-0.490 -3.268 - 0.616
-0.763
-0.426
Right Posterior
3.380
1.648
3.615 -2.720 - 5.831
-2.195
7.269
Expanded ROIs
Left Orbito-Frontal
-0.739
1.118
-0.381 -3.433 - 1.009
-0.974
0.372
Left Antero-Medial
-0.225
0.702
-0.208 -1.488 - 1.172
-0.028
-0.559
Left Antero-Lateral
-0.188
0.812
-0.205 -1.630 - 2.010
0.577
1.279
Left Postero-Medial
0.792
0.754
0.612 -0.431 - 2.581
0.798
0.207
Left Postero-Lateral
1.586
0.934
1.447 -1.293 - 3.158
-0.831
2.340
Left Occipital
0.144
1.455
0.139 -2.035 - 3.656
0.529
0.020
Right Orbito-Frontal
-1.023
1.160
-0.579 -3.510 - 0.508
-0.925
-0.195
Right Antero-Medial
-0.238
0.782
-0.145 -1.797 - 1.300
-0.154
-0.612
Right Antero-Lateral
-0.292
0.712
-0.137 -1.661 - 0.790
-0.301
-1.094
Right Postero-Medial
0.192
0.594
0.304 -1.582 - 1.311
-0.853
2.000
Right Postero-Lateral
0.110
0.924
0.202 -2.175 - 2.332
-0.076
1.070
Right Occipital
0.178
1.532
0.106 -2.397 - 3.948
0.552
0.327
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Table B18. Descriptive statistics during the N350 for PWCS during the phonological
task.
Mean
SD
Median
Range
Skew Kurtosis
Spironelli & Angrilli ROIs
Left Anterior
0.200
1.334
0.245 -3.644 - 2.173
-0.907
1.473
Left Posterior
-0.676
2.113
-0.305 -8.261 - 1.724
-1.855
5.361
Right Anterior
0.051
1.105
-0.014 -2.675 - 2.361
-0.286
0.729
Right Posterior
3.275
1.558
3.399
0.095 - 5.771
-0.611
-0.410
Expanded ROIs
Left Orbito-Frontal
-0.055
1.308
-0.091 -3.457 - 2.528
-0.237
0.720
Left Antero-Medial
0.259
1.169
0.094 -1.646 - 2.696
0.374
-0.426
Left Antero-Lateral
0.316
1.103
0.107 -1.936 - 2.434
0.140
-0.486
Left Postero-Medial
0.185
0.995
0.051 -1.460 - 3.065
0.771
1.303
Left Postero-Lateral
1.785
1.266
1.890 -1.872 - 4.680
-0.499
2.465
Left Occipital
-0.721
2.442
-0.434 -8.318 - 2.867
-1.218
2.459
Right Orbito-Frontal
-0.072
1.155
-0.121 -2.350 - 2.714
0.242
0.564
Right Antero-Medial
0.033
1.220
-0.124 -1.964 - 3.666
1.163
2.379
Right Antero-Lateral
0.122
1.112
0.056 -2.427 - 2.796
0.157
0.699
Right Postero-Medial
0.074
0.795
-0.117 -1.839 - 2.491
0.881
3.229
Right Postero-Lateral
-0.387
1.511
-0.039 -3.383 - 2.153
-0.607
-0.136
Right Occipital
-0.358
2.330
0.204 -7.737 - 2.759
-1.526
2.819

139

Table B19. Descriptive statistics during the N350 for neurologically healthy controls
during the semantic task.
Mean
SD
Median
Range
Skew Kurtosis
Spironelli & Angrilli ROIs
Left Anterior
-0.561
0.857
-0.599 -2.196 - 1.481
0.267
0.474
Left Posterior
0.094
1.236
0.105 -2.436 - 2.723
0.326
0.451
Right Anterior
-0.721
0.939
-0.739 -3.132 - 0.645 -0.880
0.448
Right Posterior
3.362
1.691
3.522 -2.738 - 5.805 -2.135
6.699
Expanded ROIs
Left Orbito-Frontal
-0.580
0.828
-0.572 -2.344 - 1.003 -0.252
0.198
Left Antero-Medial
-0.082
0.837
-0.075 -1.741 - 1.516 -0.118
-0.385
Left Antero-Lateral
-0.077
0.858
-0.124 -2.003 - 2.117
0.308
1.367
Left Postero-Medial
0.669
0.797
0.594 -0.681 - 2.438
0.304
-0.527
Left Postero-Lateral
1.481
1.067
1.409 -1.820 - 3.370 -0.948
2.612
Left Occipital
-0.026
1.572
-0.147 -2.837 - 3.942
0.702
1.115
Right Orbito-Frontal
-0.874
0.922
-0.623 -2.876 - 0.581 -0.467
-0.345
Right Antero-Medial
-0.076
0.851
0.038 -1.709 - 1.430 -0.025
-0.806
Right Antero-Lateral
-0.257
0.771
-0.342 -2.044 - 1.265 -0.169
-0.088
Right Postero-Medial
0.232
0.728
0.272 -1.245 - 1.760
0.105
-0.076
Right Postero-Lateral
0.058
0.966
0.000 -2.816 - 2.180 -0.639
2.348
Right Occipital
0.089
1.548
-0.096 -2.221 - 4.039
0.868
0.863
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Table B20. Descriptive statistics during the N350 for PWCS during the semantic task.
Mean
SD
Median
Range
Skew Kurtosis
Spironelli & Angrilli ROIs
Left Anterior
-0.559
1.597
-0.675 -3.324 - 3.795
0.790
1.108
Left Posterior
0.584
1.551
0.264 -2.085 - 5.118
1.280
2.185
Right Anterior
-0.745
1.108
-0.695 -2.844 - 1.263 -0.209
-0.486
Right Posterior
4.122
1.242
3.948 2.004 - 7.320
0.616
0.597
Expanded ROIs
Left Orbito-Frontal
-0.794
1.410
-0.794 -3.937 - 2.661
0.136
0.709
Left Antero-Medial
-0.343
1.078
-0.178 -2.538 - 1.772 -0.276
-0.278
Left Antero-Lateral
-0.229
1.452
-0.386 -2.053 - 5.604
2.555
9.659
Left Postero-Medial
0.481
0.811
0.280 -1.041 - 2.683
0.789
1.001
Left Postero-Lateral
2.234
1.642
1.903 -0.112 - 6.306
1.065
0.642
Left Occipital
0.617
1.707
0.488 -2.078 - 5.618
1.091
2.018
Right Orbito-Frontal
-0.897
1.219
-0.786 -2.773 - 1.383
0.034
-0.964
Right Antero-Medial
-0.429
1.104
-0.310 -2.637 - 1.599 -0.360
-0.128
Right Antero-Lateral
-0.420
1.105
-0.332 -2.815 - 1.927 -0.212
0.409
Right Postero-Medial
0.238
0.791
0.241 -1.986 - 1.758 -0.516
1.587
Right Postero-Lateral
0.446
1.569
0.178 -1.930 - 4.713
1.314
2.006
Right Occipital
0.723
1.537
0.694 -2.535 - 4.420
0.464
0.989
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